CANCER_STUDY_IDENTIFIER,PATIENT_ID,SAMPLE_ID,ONCOTREE_NAME,ONCOTREE_CODE
msk_impact_2017,P-0000004,P-0000004-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000015,P-0000015-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000023,P-0000023-T01-IM3,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0000024,P-0000024-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000025,P-0000025-T02-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000025,P-0000025-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000026,P-0000026-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000027,P-0000027-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000030,P-0000030-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000034,P-0000034-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000036,P-0000036-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000037,P-0000037-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000037,P-0000037-T02-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000039,P-0000039-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000041,P-0000041-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000042,P-0000042-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000043,P-0000043-T02-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000047,P-0000047-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000053,P-0000053-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000055,P-0000055-T01-IM3,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0000056,P-0000056-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000057,P-0000057-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000058,P-0000058-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000059,P-0000059-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000060,P-0000060-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000061,P-0000061-T01-IM3,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0000062,P-0000062-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0000063,P-0000063-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000064,P-0000064-T02-IM3,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0000065,P-0000065-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0000066,P-0000066-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000066,P-0000066-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000067,P-0000067-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000067,P-0000067-T02-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000068,P-0000068-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000069,P-0000069-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000071,P-0000071-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000073,P-0000073-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0000075,P-0000075-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000076,P-0000076-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000077,P-0000077-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000079,P-0000079-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000080,P-0000080-T01-IM3,Uterine Undifferentiated Carcinoma,UUC
msk_impact_2017,P-0000081,P-0000081-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000082,P-0000082-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000083,P-0000083-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000084,P-0000084-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000085,P-0000085-T02-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000086,P-0000086-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000088,P-0000088-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000092,P-0000092-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000093,P-0000093-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000095,P-0000095-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0000096,P-0000096-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000098,P-0000098-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000100,P-0000100-T02-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000102,P-0000102-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000103,P-0000103-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000104,P-0000104-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000105,P-0000105-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000106,P-0000106-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000107,P-0000107-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000108,P-0000108-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000110,P-0000110-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000112,P-0000112-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000113,P-0000113-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000114,P-0000114-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000114,P-0000114-T02-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000115,P-0000115-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0000116,P-0000116-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000117,P-0000117-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000118,P-0000118-T01-IM3,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0000119,P-0000119-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000120,P-0000120-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000121,P-0000121-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000122,P-0000122-T01-IM3,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0000123,P-0000123-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000125,P-0000125-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000126,P-0000126-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000127,P-0000127-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000127,P-0000127-T02-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000129,P-0000129-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000130,P-0000130-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000131,P-0000131-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000132,P-0000132-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000133,P-0000133-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000134,P-0000134-T02-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000134,P-0000134-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000135,P-0000135-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0000136,P-0000136-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000137,P-0000137-T01-IM3,Gastric Type Mucinous Carcinoma,GCEMU
msk_impact_2017,P-0000138,P-0000138-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000138,P-0000138-T02-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000140,P-0000140-T01-IM3,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0000141,P-0000141-T01-IM3,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0000142,P-0000142-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0000143,P-0000143-T01-IM3,Testicular Mesothelioma,TMESO
msk_impact_2017,P-0000144,P-0000144-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000145,P-0000145-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000146,P-0000146-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0000147,P-0000147-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000148,P-0000148-T01-IM3,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0000148,P-0000148-T02-IM3,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0000149,P-0000149-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000149,P-0000149-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000151,P-0000151-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000152,P-0000152-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000152,P-0000152-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000153,P-0000153-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000153,P-0000153-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000154,P-0000154-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000155,P-0000155-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0000156,P-0000156-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000157,P-0000157-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0000158,P-0000158-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000159,P-0000159-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000160,P-0000160-T01-IM3,Breast Invasive Mixed Mucinous Carcinoma,IMMC
msk_impact_2017,P-0000161,P-0000161-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000162,P-0000162-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000163,P-0000163-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000165,P-0000165-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000167,P-0000167-T02-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000167,P-0000167-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000168,P-0000168-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000170,P-0000170-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000171,P-0000171-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0000174,P-0000174-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000175,P-0000175-T03-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000178,P-0000178-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000180,P-0000180-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000180,P-0000180-T02-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000181,P-0000181-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000182,P-0000182-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000183,P-0000183-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000184,P-0000184-T01-IM3,Urethral Squamous Cell Carcinoma,USCC
msk_impact_2017,P-0000185,P-0000185-T01-IM3,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0000186,P-0000186-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000187,P-0000187-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0000188,P-0000188-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000189,P-0000189-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000190,P-0000190-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000191,P-0000191-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000192,P-0000192-T02-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000193,P-0000193-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000195,P-0000195-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000196,P-0000196-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000197,P-0000197-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000199,P-0000199-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000201,P-0000201-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000202,P-0000202-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000203,P-0000203-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000204,P-0000204-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000204,P-0000204-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000205,P-0000205-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000206,P-0000206-T01-IM3,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0000207,P-0000207-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000208,P-0000208-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000208,P-0000208-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000209,P-0000209-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000210,P-0000210-T01-IM3,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0000211,P-0000211-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000212,P-0000212-T01-IM3,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0000214,P-0000214-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000215,P-0000215-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000216,P-0000216-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000216,P-0000216-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000217,P-0000217-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0000218,P-0000218-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000219,P-0000219-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000220,P-0000220-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000221,P-0000221-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000222,P-0000222-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000223,P-0000223-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0000224,P-0000224-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000225,P-0000225-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000226,P-0000226-T01-IM3,Alveolar Rhabdomyosarcoma,ARMS
msk_impact_2017,P-0000227,P-0000227-T01-IM3,Clear Cell Odontogenic Carcinoma,CCOC
msk_impact_2017,P-0000228,P-0000228-T03-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000228,P-0000228-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000230,P-0000230-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000231,P-0000231-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000232,P-0000232-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0000233,P-0000233-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000234,P-0000234-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000234,P-0000234-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000235,P-0000235-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000236,P-0000236-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000237,P-0000237-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0000238,P-0000238-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000239,P-0000239-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000240,P-0000240-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000241,P-0000241-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000242,P-0000242-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000242,P-0000242-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000244,P-0000244-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000245,P-0000245-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000246,P-0000246-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000247,P-0000247-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000247,P-0000247-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000247,P-0000247-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000249,P-0000249-T02-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000250,P-0000250-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000252,P-0000252-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000253,P-0000253-T02-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0000257,P-0000257-T01-IM3,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0000258,P-0000258-T02-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0000259,P-0000259-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000260,P-0000260-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000261,P-0000261-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000263,P-0000263-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000266,P-0000266-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000267,P-0000267-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000268,P-0000268-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000269,P-0000269-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0000270,P-0000270-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000271,P-0000271-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000272,P-0000272-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0000273,P-0000273-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000274,P-0000274-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000275,P-0000275-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000276,P-0000276-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000277,P-0000277-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0000278,P-0000278-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000280,P-0000280-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000281,P-0000281-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000281,P-0000281-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000282,P-0000282-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000282,P-0000282-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000283,P-0000283-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0000284,P-0000284-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0000285,P-0000285-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0000286,P-0000286-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000287,P-0000287-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000288,P-0000288-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000289,P-0000289-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000290,P-0000290-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000291,P-0000291-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000292,P-0000292-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000293,P-0000293-T01-IM3,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0000295,P-0000295-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000296,P-0000296-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000298,P-0000298-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000299,P-0000299-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0000300,P-0000300-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000301,P-0000301-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000302,P-0000302-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000303,P-0000303-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000306,P-0000306-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000307,P-0000307-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000308,P-0000308-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000309,P-0000309-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000309,P-0000309-T03-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000313,P-0000313-T01-IM3,Acinic Cell Carcinoma,ACCC
msk_impact_2017,P-0000314,P-0000314-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0000315,P-0000315-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000316,P-0000316-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000317,P-0000317-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000318,P-0000318-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000319,P-0000319-T01-IM3,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0000320,P-0000320-T02-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0000320,P-0000320-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0000321,P-0000321-T02-IM3,Uterine Undifferentiated Carcinoma,UUC
msk_impact_2017,P-0000322,P-0000322-T01-IM3,Choriocarcinoma,BCCA
msk_impact_2017,P-0000323,P-0000323-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000324,P-0000324-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000325,P-0000325-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0000326,P-0000326-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000327,P-0000327-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000328,P-0000328-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000329,P-0000329-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000332,P-0000332-T01-IM3,"Pleural Mesothelioma, Sarcomatoid Type",PLSMESO
msk_impact_2017,P-0000333,P-0000333-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000334,P-0000334-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000335,P-0000335-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000335,P-0000335-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000336,P-0000336-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000337,P-0000337-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000337,P-0000337-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000339,P-0000339-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000340,P-0000340-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000341,P-0000341-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000342,P-0000342-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0000343,P-0000343-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000344,P-0000344-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000345,P-0000345-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000346,P-0000346-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000347,P-0000347-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000348,P-0000348-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000349,P-0000349-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000350,P-0000350-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0000350,P-0000350-T02-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0000351,P-0000351-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000352,P-0000352-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000353,P-0000353-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000354,P-0000354-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000355,P-0000355-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000356,P-0000356-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000357,P-0000357-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000358,P-0000358-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000359,P-0000359-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000360,P-0000360-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000361,P-0000361-T01-IM3,Ossifying Fibromyxoid Tumor,OFMT
msk_impact_2017,P-0000362,P-0000362-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000363,P-0000363-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000364,P-0000364-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000365,P-0000365-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0000366,P-0000366-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000367,P-0000367-T01-IM3,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0000368,P-0000368-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000369,P-0000369-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000370,P-0000370-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000372,P-0000372-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0000373,P-0000373-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000373,P-0000373-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000374,P-0000374-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000375,P-0000375-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000376,P-0000376-T01-IM3,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0000376,P-0000376-T02-IM3,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0000377,P-0000377-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000377,P-0000377-T03-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000377,P-0000377-T04-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000377,P-0000377-T05-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000377,P-0000377-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000378,P-0000378-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000379,P-0000379-T02-IM3,Myxoid Chondrosarcoma,MYCHS
msk_impact_2017,P-0000380,P-0000380-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000381,P-0000381-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000382,P-0000382-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000383,P-0000383-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000384,P-0000384-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0000386,P-0000386-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000386,P-0000386-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000387,P-0000387-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000388,P-0000388-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000390,P-0000390-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000391,P-0000391-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000392,P-0000392-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000394,P-0000394-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0000395,P-0000395-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000396,P-0000396-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0000397,P-0000397-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000398,P-0000398-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000399,P-0000399-T01-IM3,Skin Adnexal Carcinoma,SKAC
msk_impact_2017,P-0000400,P-0000400-T01-IM3,Urethral Adenocarcinoma,UAD
msk_impact_2017,P-0000401,P-0000401-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000402,P-0000402-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000403,P-0000403-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000404,P-0000404-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000405,P-0000405-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000406,P-0000406-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0000407,P-0000407-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000408,P-0000408-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000409,P-0000409-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000410,P-0000410-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000411,P-0000411-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000412,P-0000412-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000413,P-0000413-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000414,P-0000414-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000415,P-0000415-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000416,P-0000416-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000417,P-0000417-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000418,P-0000418-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000419,P-0000419-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000420,P-0000420-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0000421,P-0000421-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0000422,P-0000422-T02-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000422,P-0000422-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000423,P-0000423-T01-IM3,Plasmacytoid/Signet Ring Cell Bladder Carcinoma,SRCBC
msk_impact_2017,P-0000423,P-0000423-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000425,P-0000425-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000426,P-0000426-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000427,P-0000427-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000428,P-0000428-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000429,P-0000429-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000431,P-0000431-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000432,P-0000432-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000433,P-0000433-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0000434,P-0000434-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000435,P-0000435-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000436,P-0000436-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000438,P-0000438-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000439,P-0000439-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000440,P-0000440-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000441,P-0000441-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000441,P-0000441-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000442,P-0000442-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000443,P-0000443-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000444,P-0000444-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000444,P-0000444-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000445,P-0000445-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000446,P-0000446-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000447,P-0000447-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000448,P-0000448-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000449,P-0000449-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000449,P-0000449-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000450,P-0000450-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0000451,P-0000451-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000452,P-0000452-T01-IM3,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0000453,P-0000453-T01-IM3,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0000454,P-0000454-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0000455,P-0000455-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0000456,P-0000456-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000457,P-0000457-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0000458,P-0000458-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000459,P-0000459-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000460,P-0000460-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000461,P-0000461-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000462,P-0000462-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000463,P-0000463-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000464,P-0000464-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000465,P-0000465-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000466,P-0000466-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000467,P-0000467-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0000468,P-0000468-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000469,P-0000469-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000470,P-0000470-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000471,P-0000471-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000472,P-0000472-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000473,P-0000473-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000474,P-0000474-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000475,P-0000475-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0000476,P-0000476-T01-IM3,Anaplastic Ependymoma,APE
msk_impact_2017,P-0000477,P-0000477-T01-IM3,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0000478,P-0000478-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000479,P-0000479-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000480,P-0000480-T01-IM3,Sweat Gland Carcinoma/Apocrine Eccrine Carcinoma,AECA
msk_impact_2017,P-0000481,P-0000481-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000482,P-0000482-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000483,P-0000483-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000484,P-0000484-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000485,P-0000485-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000486,P-0000486-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0000488,P-0000488-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000489,P-0000489-T01-IM3,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0000490,P-0000490-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000491,P-0000491-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000493,P-0000493-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000494,P-0000494-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000495,P-0000495-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000497,P-0000497-T01-IM3,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0000499,P-0000499-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000500,P-0000500-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000501,P-0000501-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000501,P-0000501-T02-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000502,P-0000502-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000503,P-0000503-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000504,P-0000504-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000505,P-0000505-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000506,P-0000506-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000507,P-0000507-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000508,P-0000508-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000509,P-0000509-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000509,P-0000509-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000510,P-0000510-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000511,P-0000511-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0000512,P-0000512-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0000513,P-0000513-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000514,P-0000514-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000514,P-0000514-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000515,P-0000515-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000516,P-0000516-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000517,P-0000517-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000519,P-0000519-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000520,P-0000520-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000521,P-0000521-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000522,P-0000522-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000523,P-0000523-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000524,P-0000524-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000525,P-0000525-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000525,P-0000525-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000525,P-0000525-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000526,P-0000526-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000527,P-0000527-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000530,P-0000530-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000531,P-0000531-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000532,P-0000532-T02-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000532,P-0000532-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000533,P-0000533-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000535,P-0000535-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000536,P-0000536-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000538,P-0000538-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000539,P-0000539-T02-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0000541,P-0000541-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000541,P-0000541-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000542,P-0000542-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000543,P-0000543-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000544,P-0000544-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000546,P-0000546-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000547,P-0000547-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000550,P-0000550-T05-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000552,P-0000552-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000553,P-0000553-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000553,P-0000553-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000554,P-0000554-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000555,P-0000555-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000557,P-0000557-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000558,P-0000558-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000560,P-0000560-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000561,P-0000561-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0000562,P-0000562-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0000563,P-0000563-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000564,P-0000564-T01-IM3,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0000566,P-0000566-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0000569,P-0000569-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000570,P-0000570-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000571,P-0000571-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000572,P-0000572-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000573,P-0000573-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0000574,P-0000574-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000575,P-0000575-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0000576,P-0000576-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000578,P-0000578-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0000579,P-0000579-T01-IM3,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0000580,P-0000580-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000581,P-0000581-T01-IM3,"Pleural Mesothelioma, Biphasic Type",PLBMESO
msk_impact_2017,P-0000582,P-0000582-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0000583,P-0000583-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000584,P-0000584-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000585,P-0000585-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000586,P-0000586-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0000587,P-0000587-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000588,P-0000588-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000589,P-0000589-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000590,P-0000590-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0000591,P-0000591-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000592,P-0000592-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0000593,P-0000593-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000594,P-0000594-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000595,P-0000595-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000595,P-0000595-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000596,P-0000596-T01-IM3,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0000597,P-0000597-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000598,P-0000598-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000599,P-0000599-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000600,P-0000600-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000602,P-0000602-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000603,P-0000603-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000604,P-0000604-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000605,P-0000605-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000606,P-0000606-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000607,P-0000607-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000609,P-0000609-T01-IM3,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0000610,P-0000610-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000611,P-0000611-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000612,P-0000612-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000613,P-0000613-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000614,P-0000614-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000615,P-0000615-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000616,P-0000616-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000616,P-0000616-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000617,P-0000617-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000618,P-0000618-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000619,P-0000619-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000620,P-0000620-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000621,P-0000621-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0000622,P-0000622-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000623,P-0000623-T02-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000623,P-0000623-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000624,P-0000624-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000624,P-0000624-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000625,P-0000625-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000626,P-0000626-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000627,P-0000627-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000628,P-0000628-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000628,P-0000628-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000629,P-0000629-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0000630,P-0000630-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000632,P-0000632-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000633,P-0000633-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000635,P-0000635-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000636,P-0000636-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000637,P-0000637-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000638,P-0000638-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000639,P-0000639-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000640,P-0000640-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000640,P-0000640-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000640,P-0000640-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000641,P-0000641-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000642,P-0000642-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000643,P-0000643-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000644,P-0000644-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000645,P-0000645-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000646,P-0000646-T02-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000647,P-0000647-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000648,P-0000648-T01-IM3,Teratoma,TT
msk_impact_2017,P-0000649,P-0000649-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000650,P-0000650-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000651,P-0000651-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000652,P-0000652-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0000653,P-0000653-T01-IM3,Gliosarcoma,GSARC
msk_impact_2017,P-0000654,P-0000654-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000655,P-0000655-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000655,P-0000655-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000655,P-0000655-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000656,P-0000656-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0000657,P-0000657-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000657,P-0000657-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000658,P-0000658-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000659,P-0000659-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000660,P-0000660-T01-IM3,Follicular Dendritic Cell Sarcoma,FDCS
msk_impact_2017,P-0000661,P-0000661-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000662,P-0000662-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0000663,P-0000663-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000664,P-0000664-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000665,P-0000665-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000666,P-0000666-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000667,P-0000667-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0000668,P-0000668-T01-IM3,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0000669,P-0000669-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000670,P-0000670-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000671,P-0000671-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000672,P-0000672-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000673,P-0000673-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0000674,P-0000674-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000675,P-0000675-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000675,P-0000675-T02-IM3,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0000676,P-0000676-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000677,P-0000677-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000678,P-0000678-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000679,P-0000679-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0000680,P-0000680-T01-IM3,Myxofibrosarcoma,MFS
msk_impact_2017,P-0000681,P-0000681-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000681,P-0000681-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000682,P-0000682-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000683,P-0000683-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000684,P-0000684-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000685,P-0000685-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000686,P-0000686-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000687,P-0000687-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000688,P-0000688-T01-IM3,Gastric Type Mucinous Carcinoma,GCEMU
msk_impact_2017,P-0000689,P-0000689-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000689,P-0000689-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000690,P-0000690-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000690,P-0000690-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000690,P-0000690-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000691,P-0000691-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000692,P-0000692-T01-IM3,Sex Cord Stromal Tumor,SCST
msk_impact_2017,P-0000693,P-0000693-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0000694,P-0000694-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000695,P-0000695-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000696,P-0000696-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0000697,P-0000697-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000698,P-0000698-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0000699,P-0000699-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000700,P-0000700-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0000702,P-0000702-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000703,P-0000703-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000704,P-0000704-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000705,P-0000705-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0000706,P-0000706-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000707,P-0000707-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000708,P-0000708-T01-IM3,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0000709,P-0000709-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000710,P-0000710-T01-IM3,Chondroblastoma,CHBL
msk_impact_2017,P-0000711,P-0000711-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0000713,P-0000713-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000714,P-0000714-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000715,P-0000715-T03-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000716,P-0000716-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000717,P-0000717-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000718,P-0000718-T01-IM3,Myxoid Chondrosarcoma,MYCHS
msk_impact_2017,P-0000719,P-0000719-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0000720,P-0000720-T01-IM3,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0000721,P-0000721-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000722,P-0000722-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0000723,P-0000723-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0000724,P-0000724-T01-IM3,Bladder Adenocarcinoma,BLAD
msk_impact_2017,P-0000725,P-0000725-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000726,P-0000726-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000728,P-0000728-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000729,P-0000729-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000730,P-0000730-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000731,P-0000731-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000732,P-0000732-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000733,P-0000733-T01-IM3,Intimal Sarcoma,INTS
msk_impact_2017,P-0000735,P-0000735-T01-IM3,Thymic Carcinoma,THYC
msk_impact_2017,P-0000736,P-0000736-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000737,P-0000737-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000738,P-0000738-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000739,P-0000739-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000739,P-0000739-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000740,P-0000740-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0000741,P-0000741-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000742,P-0000742-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000743,P-0000743-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0000744,P-0000744-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000745,P-0000745-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000746,P-0000746-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000747,P-0000747-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000748,P-0000748-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0000749,P-0000749-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0000750,P-0000750-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000751,P-0000751-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000754,P-0000754-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000755,P-0000755-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000756,P-0000756-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000757,P-0000757-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000758,P-0000758-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000758,P-0000758-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000759,P-0000759-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000760,P-0000760-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000761,P-0000761-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0000762,P-0000762-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000763,P-0000763-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000764,P-0000764-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000765,P-0000765-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000766,P-0000766-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000767,P-0000767-T01-IM3,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0000768,P-0000768-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0000769,P-0000769-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000770,P-0000770-T01-IM3,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0000771,P-0000771-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000772,P-0000772-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000774,P-0000774-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000775,P-0000775-T01-IM3,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0000776,P-0000776-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000777,P-0000777-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000778,P-0000778-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000779,P-0000779-T01-IM3,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0000780,P-0000780-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0000782,P-0000782-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000783,P-0000783-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0000784,P-0000784-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0000785,P-0000785-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000786,P-0000786-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0000787,P-0000787-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000788,P-0000788-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000789,P-0000789-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000790,P-0000790-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000791,P-0000791-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000792,P-0000792-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000793,P-0000793-T02-IM5,Esophageal Poorly Differentiated Carcinoma,EPDCA
msk_impact_2017,P-0000795,P-0000795-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000796,P-0000796-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0000797,P-0000797-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000797,P-0000797-T02-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000798,P-0000798-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000799,P-0000799-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0000800,P-0000800-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0000802,P-0000802-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000803,P-0000803-T01-IM3,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0000804,P-0000804-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000805,P-0000805-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000806,P-0000806-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0000807,P-0000807-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000808,P-0000808-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000809,P-0000809-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000811,P-0000811-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000812,P-0000812-T01-IM3,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0000813,P-0000813-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0000814,P-0000814-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0000815,P-0000815-T01-IM3,Chondroblastic Osteosarcoma,CHOS
msk_impact_2017,P-0000816,P-0000816-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000817,P-0000817-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0000818,P-0000818-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000819,P-0000819-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000820,P-0000820-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000820,P-0000820-T02-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000821,P-0000821-T01-IM3,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0000822,P-0000822-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000824,P-0000824-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0000825,P-0000825-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000826,P-0000826-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0000827,P-0000827-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000828,P-0000828-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000829,P-0000829-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0000830,P-0000830-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000831,P-0000831-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000835,P-0000835-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0000835,P-0000835-T02-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0000836,P-0000836-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0000837,P-0000837-T01-IM3,Breast Angiosarcoma,BA
msk_impact_2017,P-0000838,P-0000838-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000839,P-0000839-T02-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000839,P-0000839-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000840,P-0000840-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000841,P-0000841-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000842,P-0000842-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000842,P-0000842-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000843,P-0000843-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000845,P-0000845-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0000846,P-0000846-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0000847,P-0000847-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000848,P-0000848-T01-IM3,Chondrosarcoma,CHS
msk_impact_2017,P-0000849,P-0000849-T01-IM3,Clear Cell Sarcoma,CCS
msk_impact_2017,P-0000850,P-0000850-T01-IM3,Breast Angiosarcoma,BA
msk_impact_2017,P-0000851,P-0000851-T01-IM3,Alveolar Soft Part Sarcoma,ASPS
msk_impact_2017,P-0000852,P-0000852-T01-IM3,Uveal Melanoma,UM
msk_impact_2017,P-0000853,P-0000853-T01-IM3,Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma,HCCIHCH
msk_impact_2017,P-0000854,P-0000854-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0000855,P-0000855-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0000856,P-0000856-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0000857,P-0000857-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000858,P-0000858-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000859,P-0000859-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0000860,P-0000860-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000861,P-0000861-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000862,P-0000862-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000863,P-0000863-T01-IM3,Alveolar Soft Part Sarcoma,ASPS
msk_impact_2017,P-0000864,P-0000864-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000865,P-0000865-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000866,P-0000866-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0000867,P-0000867-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000868,P-0000868-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000869,P-0000869-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000870,P-0000870-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000871,P-0000871-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000872,P-0000872-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000873,P-0000873-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000874,P-0000874-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000875,P-0000875-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0000876,P-0000876-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000877,P-0000877-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000878,P-0000878-T01-IM3,Uterine Neuroendocrine Carcinoma,UNEC
msk_impact_2017,P-0000879,P-0000879-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0000879,P-0000879-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0000879,P-0000879-T03-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0000880,P-0000880-T01-IM3,Plasmacytoid/Signet Ring Cell Bladder Carcinoma,SRCBC
msk_impact_2017,P-0000881,P-0000881-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0000883,P-0000883-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0000883,P-0000883-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000884,P-0000884-T01-IM3,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0000885,P-0000885-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000887,P-0000887-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000888,P-0000888-T01-IM3,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0000889,P-0000889-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000890,P-0000890-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000891,P-0000891-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000892,P-0000892-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000893,P-0000893-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000894,P-0000894-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000895,P-0000895-T01-IM3,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0000896,P-0000896-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0000897,P-0000897-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0000898,P-0000898-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000899,P-0000899-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000900,P-0000900-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000901,P-0000901-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000902,P-0000902-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0000903,P-0000903-T02-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000903,P-0000903-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000904,P-0000904-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0000905,P-0000905-T01-IM3,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0000906,P-0000906-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000907,P-0000907-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000908,P-0000908-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000909,P-0000909-T03-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000910,P-0000910-T01-IM3,Mucoepidermoid Carcinoma,MUCC
msk_impact_2017,P-0000911,P-0000911-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000912,P-0000912-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000913,P-0000913-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000913,P-0000913-T03-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000914,P-0000914-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0000916,P-0000916-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0000917,P-0000917-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000918,P-0000918-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000919,P-0000919-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0000920,P-0000920-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000921,P-0000921-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000922,P-0000922-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000923,P-0000923-T01-IM3,Myoepithelial Carcinoma,MYEC
msk_impact_2017,P-0000924,P-0000924-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000925,P-0000925-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0000926,P-0000926-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0000927,P-0000927-T01-IM3,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0000928,P-0000928-T01-IM3,Gliosarcoma,GSARC
msk_impact_2017,P-0000929,P-0000929-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000930,P-0000930-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0000931,P-0000931-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000932,P-0000932-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0000933,P-0000933-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000934,P-0000934-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0000935,P-0000935-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000936,P-0000936-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0000937,P-0000937-T01-IM3,Chordoma,CHDM
msk_impact_2017,P-0000938,P-0000938-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0000939,P-0000939-T02-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0000939,P-0000939-T01-IM3,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0000940,P-0000940-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000941,P-0000941-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000942,P-0000942-T01-IM3,Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma,HCCIHCH
msk_impact_2017,P-0000943,P-0000943-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0000944,P-0000944-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000945,P-0000945-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0000946,P-0000946-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000947,P-0000947-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0000948,P-0000948-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000949,P-0000949-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0000950,P-0000950-T02-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0000950,P-0000950-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0000951,P-0000951-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0000952,P-0000952-T02-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000952,P-0000952-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000952,P-0000952-T03-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0000954,P-0000954-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0000955,P-0000955-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0000956,P-0000956-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0000957,P-0000957-T01-IM3,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0000958,P-0000958-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0000960,P-0000960-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0000961,P-0000961-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000962,P-0000962-T01-IM3,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0000963,P-0000963-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000964,P-0000964-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000964,P-0000964-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000965,P-0000965-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000966,P-0000966-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000966,P-0000966-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000967,P-0000967-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0000968,P-0000968-T01-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0000969,P-0000969-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000970,P-0000970-T01-IM3,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0000972,P-0000972-T01-IM3,Myxoid Chondrosarcoma,MYCHS
msk_impact_2017,P-0000973,P-0000973-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000976,P-0000976-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0000977,P-0000977-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000978,P-0000978-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000978,P-0000978-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000979,P-0000979-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000980,P-0000980-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0000982,P-0000982-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000982,P-0000982-T02-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000984,P-0000984-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000985,P-0000985-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0000987,P-0000987-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000988,P-0000988-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0000989,P-0000989-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0000990,P-0000990-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0000991,P-0000991-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0000992,P-0000992-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0000993,P-0000993-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0000994,P-0000994-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000995,P-0000995-T01-IM3,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0000997,P-0000997-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000997,P-0000997-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0000998,P-0000998-T01-IM3,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0000999,P-0000999-T01-IM3,Well-Differentiated Neuroendocrine Tumors of the Stomach,SWDNET
msk_impact_2017,P-0001000,P-0001000-T01-IM3,Alveolar Soft Part Sarcoma,ASPS
msk_impact_2017,P-0001001,P-0001001-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001002,P-0001002-T01-IM3,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0001003,P-0001003-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001004,P-0001004-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001005,P-0001005-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0001006,P-0001006-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0001007,P-0001007-T02-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0001007,P-0001007-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0001008,P-0001008-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001009,P-0001009-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001010,P-0001010-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001010,P-0001010-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001011,P-0001011-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001012,P-0001012-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001013,P-0001013-T01-IM3,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0001014,P-0001014-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001015,P-0001015-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001016,P-0001016-T01-IM3,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0001017,P-0001017-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001018,P-0001018-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001019,P-0001019-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001020,P-0001020-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001021,P-0001021-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001023,P-0001023-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001026,P-0001026-T01-IM3,Small Cell Osteosarcoma,SCOS
msk_impact_2017,P-0001027,P-0001027-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0001028,P-0001028-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0001029,P-0001029-T01-IM3,Acral Melanoma,ACRM
msk_impact_2017,P-0001030,P-0001030-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0001031,P-0001031-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001032,P-0001032-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001034,P-0001034-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001035,P-0001035-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0001036,P-0001036-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001037,P-0001037-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001038,P-0001038-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0001039,P-0001039-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001040,P-0001040-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001040,P-0001040-T02-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001041,P-0001041-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0001042,P-0001042-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0001043,P-0001043-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001044,P-0001044-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0001046,P-0001046-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001047,P-0001047-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0001047,P-0001047-T02-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0001048,P-0001048-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001049,P-0001049-T01-IM3,Gliosarcoma,GSARC
msk_impact_2017,P-0001050,P-0001050-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001051,P-0001051-T01-IM3,Ependymoma,EPM
msk_impact_2017,P-0001052,P-0001052-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001053,P-0001053-T01-IM3,Gliosarcoma,GSARC
msk_impact_2017,P-0001054,P-0001054-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001054,P-0001054-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001055,P-0001055-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001056,P-0001056-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0001057,P-0001057-T01-IM3,Gastric Type Mucinous Carcinoma,GCEMU
msk_impact_2017,P-0001058,P-0001058-T01-IM3,Choriocarcinoma,BCCA
msk_impact_2017,P-0001059,P-0001059-T02-IM3,Penile Squamous Cell Carcinoma,PSCC
msk_impact_2017,P-0001060,P-0001060-T01-IM3,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0001061,P-0001061-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0001062,P-0001062-T02-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0001063,P-0001063-T01-IM3,Thymic Carcinoma,THYC
msk_impact_2017,P-0001070,P-0001070-T01-IM3,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0001071,P-0001071-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001073,P-0001073-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001074,P-0001074-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001076,P-0001076-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0001077,P-0001077-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001078,P-0001078-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001079,P-0001079-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001080,P-0001080-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001081,P-0001081-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001082,P-0001082-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0001083,P-0001083-T01-IM3,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0001084,P-0001084-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001085,P-0001085-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0001086,P-0001086-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001087,P-0001087-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0001088,P-0001088-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0001089,P-0001089-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001090,P-0001090-T01-IM3,Spindle Cell Rhabdomyosarcoma,SCRMS
msk_impact_2017,P-0001091,P-0001091-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001092,P-0001092-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001093,P-0001093-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001094,P-0001094-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0001095,P-0001095-T01-IM3,Uterine Smooth Muscle Tumor of Uncertain Malignant Potential,USTUMP
msk_impact_2017,P-0001096,P-0001096-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001097,P-0001097-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001097,P-0001097-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001098,P-0001098-T01-IM3,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0001099,P-0001099-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001100,P-0001100-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001101,P-0001101-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0001102,P-0001102-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0001103,P-0001103-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0001104,P-0001104-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001104,P-0001104-T05-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001104,P-0001104-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001104,P-0001104-T03-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001105,P-0001105-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001106,P-0001106-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001107,P-0001107-T01-IM3,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0001108,P-0001108-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001109,P-0001109-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0001110,P-0001110-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0001111,P-0001111-T01-IM3,Chondroblastic Osteosarcoma,CHOS
msk_impact_2017,P-0001112,P-0001112-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001113,P-0001113-T01-IM3,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0001114,P-0001114-T02-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001114,P-0001114-T03-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001115,P-0001115-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001117,P-0001117-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001118,P-0001118-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001120,P-0001120-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0001121,P-0001121-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001123,P-0001123-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001123,P-0001123-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001124,P-0001124-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0001125,P-0001125-T01-IM3,Myxofibrosarcoma,MFS
msk_impact_2017,P-0001126,P-0001126-T01-IM3,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0001127,P-0001127-T02-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001128,P-0001128-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001129,P-0001129-T01-IM3,Myxoid Chondrosarcoma,MYCHS
msk_impact_2017,P-0001130,P-0001130-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001131,P-0001131-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001135,P-0001135-T02-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001136,P-0001136-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001137,P-0001137-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001138,P-0001138-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001140,P-0001140-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001141,P-0001141-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001144,P-0001144-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001146,P-0001146-T01-IM3,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0001149,P-0001149-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001150,P-0001150-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001151,P-0001151-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001152,P-0001152-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001153,P-0001153-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001154,P-0001154-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001155,P-0001155-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001156,P-0001156-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001157,P-0001157-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001157,P-0001157-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001158,P-0001158-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001163,P-0001163-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001164,P-0001164-T01-IM3,High-Grade Endometrial Stromal Sarcoma,HGESS
msk_impact_2017,P-0001165,P-0001165-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001166,P-0001166-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001168,P-0001168-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001169,P-0001169-T01-IM3,Meningioma,MNG
msk_impact_2017,P-0001170,P-0001170-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001171,P-0001171-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001172,P-0001172-T02-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001173,P-0001173-T01-IM3,Intimal Sarcoma,INTS
msk_impact_2017,P-0001174,P-0001174-T01-IM3,Acral Melanoma,ACRM
msk_impact_2017,P-0001175,P-0001175-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001176,P-0001176-T01-IM3,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0001177,P-0001177-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0001179,P-0001179-T01-IM3,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0001180,P-0001180-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001181,P-0001181-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001182,P-0001182-T01-IM3,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0001183,P-0001183-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001184,P-0001184-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001184,P-0001184-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001185,P-0001185-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001186,P-0001186-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0001187,P-0001187-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001188,P-0001188-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001189,P-0001189-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001190,P-0001190-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001191,P-0001191-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0001192,P-0001192-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001193,P-0001193-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001194,P-0001194-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001195,P-0001195-T01-IM3,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0001196,P-0001196-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001197,P-0001197-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001198,P-0001198-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0001199,P-0001199-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001200,P-0001200-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001201,P-0001201-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001202,P-0001202-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001203,P-0001203-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001204,P-0001204-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001204,P-0001204-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001204,P-0001204-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001205,P-0001205-T01-IM3,Hemangiopericytoma of the Central Nervous System,HPCCNS
msk_impact_2017,P-0001206,P-0001206-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001208,P-0001208-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001209,P-0001209-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001210,P-0001210-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001211,P-0001211-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001212,P-0001212-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001214,P-0001214-T01-IM3,Mucoepidermoid Carcinoma,MUCC
msk_impact_2017,P-0001215,P-0001215-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001216,P-0001216-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0001217,P-0001217-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0001218,P-0001218-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001219,P-0001219-T02-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0001219,P-0001219-T03-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0001220,P-0001220-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001221,P-0001221-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001221,P-0001221-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001222,P-0001222-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0001223,P-0001223-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001224,P-0001224-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001225,P-0001225-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001226,P-0001226-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001227,P-0001227-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001228,P-0001228-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001229,P-0001229-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0001230,P-0001230-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001231,P-0001231-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001232,P-0001232-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0001232,P-0001232-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0001233,P-0001233-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0001234,P-0001234-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0001235,P-0001235-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0001236,P-0001236-T02-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001236,P-0001236-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001237,P-0001237-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001238,P-0001238-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001239,P-0001239-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001240,P-0001240-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0001241,P-0001241-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001241,P-0001241-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001242,P-0001242-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001242,P-0001242-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001242,P-0001242-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001244,P-0001244-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001246,P-0001246-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0001247,P-0001247-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001248,P-0001248-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001250,P-0001250-T01-IM3,Oligodendroglioma,ODG
msk_impact_2017,P-0001251,P-0001251-T01-IM3,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0001253,P-0001253-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001254,P-0001254-T02-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001255,P-0001255-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0001257,P-0001257-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001258,P-0001258-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001259,P-0001259-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0001260,P-0001260-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001261,P-0001261-T01-IM3,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0001262,P-0001262-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001263,P-0001263-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0001265,P-0001265-T01-IM3,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0001266,P-0001266-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0001267,P-0001267-T01-IM3,Sertoli-Leydig Cell Tumor,SLCT
msk_impact_2017,P-0001268,P-0001268-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001269,P-0001269-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001272,P-0001272-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001273,P-0001273-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0001274,P-0001274-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001275,P-0001275-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001276,P-0001276-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001278,P-0001278-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001279,P-0001279-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0001280,P-0001280-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0001281,P-0001281-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001283,P-0001283-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001284,P-0001284-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001285,P-0001285-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001286,P-0001286-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001287,P-0001287-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001288,P-0001288-T01-IM3,Chordoma,CHDM
msk_impact_2017,P-0001289,P-0001289-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001290,P-0001290-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0001292,P-0001292-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001293,P-0001293-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001294,P-0001294-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001295,P-0001295-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001296,P-0001296-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001296,P-0001296-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001297,P-0001297-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001298,P-0001298-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001299,P-0001299-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001300,P-0001300-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001300,P-0001300-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001301,P-0001301-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001302,P-0001302-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001303,P-0001303-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001303,P-0001303-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001303,P-0001303-T03-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001304,P-0001304-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0001305,P-0001305-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001306,P-0001306-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001307,P-0001307-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001308,P-0001308-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001309,P-0001309-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001310,P-0001310-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001311,P-0001311-T01-IM3,Endometrioid Ovarian Cancer,EOV
msk_impact_2017,P-0001312,P-0001312-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001314,P-0001314-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001315,P-0001315-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001315,P-0001315-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001316,P-0001316-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001317,P-0001317-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001318,P-0001318-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001319,P-0001319-T05-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001319,P-0001319-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001320,P-0001320-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0001321,P-0001321-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001322,P-0001322-T01-IM3,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0001323,P-0001323-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001324,P-0001324-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001325,P-0001325-T02-IM5,Prostate Small Cell Carcinoma,PRSCC
msk_impact_2017,P-0001325,P-0001325-T01-IM3,Prostate Small Cell Carcinoma,PRSCC
msk_impact_2017,P-0001326,P-0001326-T01-IM3,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0001327,P-0001327-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001328,P-0001328-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0001330,P-0001330-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001331,P-0001331-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001332,P-0001332-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001332,P-0001332-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001335,P-0001335-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001336,P-0001336-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001337,P-0001337-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001338,P-0001338-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001338,P-0001338-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001339,P-0001339-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001340,P-0001340-T01-IM3,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0001341,P-0001341-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001342,P-0001342-T02-IM5,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0001342,P-0001342-T01-IM3,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0001343,P-0001343-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0001345,P-0001345-T01-IM3,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0001346,P-0001346-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001347,P-0001347-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001348,P-0001348-T02-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0001348,P-0001348-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0001350,P-0001350-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001351,P-0001351-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001351,P-0001351-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001352,P-0001352-T01-IM3,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0001354,P-0001354-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001355,P-0001355-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001357,P-0001357-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001358,P-0001358-T02-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0001359,P-0001359-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001361,P-0001361-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001362,P-0001362-T01-IM3,Thymic Carcinoma,THYC
msk_impact_2017,P-0001363,P-0001363-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001364,P-0001364-T01-IM3,Perivascular Epithelioid Cell Tumor,PECOMA
msk_impact_2017,P-0001364,P-0001364-T02-IM3,Perivascular Epithelioid Cell Tumor,PECOMA
msk_impact_2017,P-0001365,P-0001365-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001365,P-0001365-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001366,P-0001366-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001367,P-0001367-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001368,P-0001368-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001369,P-0001369-T01-IM3,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0001370,P-0001370-T01-IM3,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0001372,P-0001372-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001373,P-0001373-T01-IM3,Myoepithelial Carcinoma,MYEC
msk_impact_2017,P-0001374,P-0001374-T01-IM3,Squamous Cell Carcinoma of the Vulva/Vagina,VSC
msk_impact_2017,P-0001375,P-0001375-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001376,P-0001376-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0001377,P-0001377-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0001377,P-0001377-T02-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0001380,P-0001380-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001381,P-0001381-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001382,P-0001382-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001383,P-0001383-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001384,P-0001384-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0001385,P-0001385-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001388,P-0001388-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001389,P-0001389-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001390,P-0001390-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001391,P-0001391-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001392,P-0001392-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0001393,P-0001393-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001394,P-0001394-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001395,P-0001395-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001396,P-0001396-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001396,P-0001396-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001397,P-0001397-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001398,P-0001398-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0001400,P-0001400-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001401,P-0001401-T02-IM3,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0001402,P-0001402-T01-IM3,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0001402,P-0001402-T02-IM3,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0001403,P-0001403-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001405,P-0001405-T01-IM3,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0001406,P-0001406-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001407,P-0001407-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001408,P-0001408-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0001409,P-0001409-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001410,P-0001410-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001411,P-0001411-T01-IM3,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0001412,P-0001412-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001413,P-0001413-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001415,P-0001415-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001416,P-0001416-T01-IM3,Skin Adnexal Carcinoma,SKAC
msk_impact_2017,P-0001417,P-0001417-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001417,P-0001417-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001418,P-0001418-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0001419,P-0001419-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001420,P-0001420-T02-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001420,P-0001420-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001421,P-0001421-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001422,P-0001422-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001423,P-0001423-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001424,P-0001424-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001424,P-0001424-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001425,P-0001425-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001426,P-0001426-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001427,P-0001427-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001428,P-0001428-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001429,P-0001429-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001430,P-0001430-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001431,P-0001431-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001432,P-0001432-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0001432,P-0001432-T01-IM3,Neuroblastoma,NBL
msk_impact_2017,P-0001433,P-0001433-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001434,P-0001434-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001435,P-0001435-T01-IM3,Teratoma,TT
msk_impact_2017,P-0001436,P-0001436-T01-IM3,Osteoblastic Osteosarcoma,OSOS
msk_impact_2017,P-0001436,P-0001436-T02-IM3,Osteoblastic Osteosarcoma,OSOS
msk_impact_2017,P-0001437,P-0001437-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001438,P-0001438-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0001439,P-0001439-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001440,P-0001440-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001441,P-0001441-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001442,P-0001442-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001442,P-0001442-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001443,P-0001443-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001444,P-0001444-T01-IM3,Acral Melanoma,ACRM
msk_impact_2017,P-0001445,P-0001445-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001446,P-0001446-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001447,P-0001447-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001448,P-0001448-T01-IM3,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0001449,P-0001449-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001449,P-0001449-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001450,P-0001450-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0001451,P-0001451-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001452,P-0001452-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001453,P-0001453-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001454,P-0001454-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001454,P-0001454-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001456,P-0001456-T01-IM3,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0001457,P-0001457-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001458,P-0001458-T01-IM3,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0001459,P-0001459-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001460,P-0001460-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0001461,P-0001461-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001462,P-0001462-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001463,P-0001463-T01-IM3,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0001464,P-0001464-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001465,P-0001465-T01-IM3,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0001467,P-0001467-T01-IM3,Head and Neck Squamous Cell Carcinoma of Unknown Primary,HNSCUP
msk_impact_2017,P-0001468,P-0001468-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0001469,P-0001469-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001470,P-0001470-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001471,P-0001471-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001472,P-0001472-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001473,P-0001473-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001474,P-0001474-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001475,P-0001475-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001478,P-0001478-T01-IM3,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0001479,P-0001479-T01-IM3,Low-Grade Fibromyxoid Sarcoma,LGFMS
msk_impact_2017,P-0001481,P-0001481-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001482,P-0001482-T01-IM3,Extraskeletal Myxoid Chondrosarcoma,EMCHS
msk_impact_2017,P-0001483,P-0001483-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001484,P-0001484-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001484,P-0001484-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001485,P-0001485-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001487,P-0001487-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001488,P-0001488-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0001489,P-0001489-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001491,P-0001491-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001493,P-0001493-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001494,P-0001494-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001495,P-0001495-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001495,P-0001495-T03-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001495,P-0001495-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001496,P-0001496-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001497,P-0001497-T01-IM3,Ovarian Seromucinous Carcinoma,OSMCA
msk_impact_2017,P-0001498,P-0001498-T02-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001499,P-0001499-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001500,P-0001500-T02-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001501,P-0001501-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0001502,P-0001502-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001503,P-0001503-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001504,P-0001504-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001505,P-0001505-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001505,P-0001505-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001506,P-0001506-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001507,P-0001507-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001508,P-0001508-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001509,P-0001509-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001510,P-0001510-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001511,P-0001511-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0001512,P-0001512-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001513,P-0001513-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001514,P-0001514-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001515,P-0001515-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001516,P-0001516-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001516,P-0001516-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001517,P-0001517-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001518,P-0001518-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0001519,P-0001519-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001520,P-0001520-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001521,P-0001521-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0001522,P-0001522-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0001523,P-0001523-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0001524,P-0001524-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001525,P-0001525-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001526,P-0001526-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001526,P-0001526-T03-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001526,P-0001526-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001527,P-0001527-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0001528,P-0001528-T03-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001528,P-0001528-T02-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001529,P-0001529-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001530,P-0001530-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001531,P-0001531-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001532,P-0001532-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001533,P-0001533-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001534,P-0001534-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001535,P-0001535-T01-IM3,Thymoma,THYM
msk_impact_2017,P-0001536,P-0001536-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001537,P-0001537-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001538,P-0001538-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0001539,P-0001539-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001540,P-0001540-T01-IM3,Osteosarcoma,OS
msk_impact_2017,P-0001541,P-0001541-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0001542,P-0001542-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001543,P-0001543-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001544,P-0001544-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0001545,P-0001545-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001546,P-0001546-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001547,P-0001547-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0001548,P-0001548-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0001549,P-0001549-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001550,P-0001550-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001551,P-0001551-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001551,P-0001551-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001552,P-0001552-T02-IM5,Meningioma,MNG
msk_impact_2017,P-0001553,P-0001553-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001553,P-0001553-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001554,P-0001554-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001555,P-0001555-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0001556,P-0001556-T01-IM3,Anaplastic Meningioma,ANM
msk_impact_2017,P-0001557,P-0001557-T01-IM3,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0001558,P-0001558-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001559,P-0001559-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001560,P-0001560-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001561,P-0001561-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001562,P-0001562-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001563,P-0001563-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001564,P-0001564-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001565,P-0001565-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0001566,P-0001566-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001568,P-0001568-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001569,P-0001569-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001570,P-0001570-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001571,P-0001571-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001572,P-0001572-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001573,P-0001573-T01-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0001574,P-0001574-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001575,P-0001575-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001576,P-0001576-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001577,P-0001577-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001578,P-0001578-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001579,P-0001579-T01-IM3,Wilms' Tumor,WT
msk_impact_2017,P-0001580,P-0001580-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001581,P-0001581-T02-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0001582,P-0001582-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001583,P-0001583-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001585,P-0001585-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001586,P-0001586-T02-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0001589,P-0001589-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001591,P-0001591-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0001594,P-0001594-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001595,P-0001595-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0001596,P-0001596-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0001597,P-0001597-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0001598,P-0001598-T01-IM3,Sinonasal Squamous Cell Carcinoma,SNSC
msk_impact_2017,P-0001598,P-0001598-T02-IM5,Sinonasal Squamous Cell Carcinoma,SNSC
msk_impact_2017,P-0001599,P-0001599-T03-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001600,P-0001600-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001601,P-0001601-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001602,P-0001602-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0001603,P-0001603-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001604,P-0001604-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001605,P-0001605-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001606,P-0001606-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001607,P-0001607-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001608,P-0001608-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001609,P-0001609-T01-IM3,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0001610,P-0001610-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001611,P-0001611-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001612,P-0001612-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0001613,P-0001613-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001613,P-0001613-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001614,P-0001614-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0001615,P-0001615-T01-IM3,Uterine Myxoid Leiomyosarcoma,UMLMS
msk_impact_2017,P-0001616,P-0001616-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001618,P-0001618-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001619,P-0001619-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0001620,P-0001620-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001621,P-0001621-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0001622,P-0001622-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001623,P-0001623-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001624,P-0001624-T01-IM3,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0001625,P-0001625-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001627,P-0001627-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001627,P-0001627-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001628,P-0001628-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001629,P-0001629-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001630,P-0001630-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001631,P-0001631-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001631,P-0001631-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001632,P-0001632-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001633,P-0001633-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001634,P-0001634-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001635,P-0001635-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001636,P-0001636-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001637,P-0001637-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001638,P-0001638-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001639,P-0001639-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001640,P-0001640-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001641,P-0001641-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0001642,P-0001642-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0001642,P-0001642-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0001642,P-0001642-T03-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0001643,P-0001643-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001645,P-0001645-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001646,P-0001646-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001647,P-0001647-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001648,P-0001648-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001649,P-0001649-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001652,P-0001652-T01-IM3,Sclerosing Epithelioid Fibrosarcoma,SEF
msk_impact_2017,P-0001653,P-0001653-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0001654,P-0001654-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0001654,P-0001654-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001655,P-0001655-T01-IM3,Cervical Adenosquamous Carcinoma,CEAS
msk_impact_2017,P-0001656,P-0001656-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0001657,P-0001657-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001658,P-0001658-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001659,P-0001659-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0001660,P-0001660-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001661,P-0001661-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001662,P-0001662-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001663,P-0001663-T01-IM3,Teratoma,TT
msk_impact_2017,P-0001664,P-0001664-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001665,P-0001665-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001667,P-0001667-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0001669,P-0001669-T01-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0001670,P-0001670-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001671,P-0001671-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0001672,P-0001672-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001673,P-0001673-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001675,P-0001675-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0001676,P-0001676-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001677,P-0001677-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001678,P-0001678-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001679,P-0001679-T01-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0001680,P-0001680-T02-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001680,P-0001680-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001681,P-0001681-T01-IM3,"Serous Borderline Ovarian Tumor, Micropapillary",SBMOV
msk_impact_2017,P-0001681,P-0001681-T02-IM3,"Serous Borderline Ovarian Tumor, Micropapillary",SBMOV
msk_impact_2017,P-0001682,P-0001682-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0001683,P-0001683-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001684,P-0001684-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001684,P-0001684-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001685,P-0001685-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001685,P-0001685-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001686,P-0001686-T01-IM3,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0001687,P-0001687-T01-IM3,Prostate Small Cell Carcinoma,PRSCC
msk_impact_2017,P-0001688,P-0001688-T01-IM3,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0001688,P-0001688-T02-IM5,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0001690,P-0001690-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001692,P-0001692-T02-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001692,P-0001692-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001693,P-0001693-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001694,P-0001694-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001695,P-0001695-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001696,P-0001696-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001697,P-0001697-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001698,P-0001698-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001699,P-0001699-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001699,P-0001699-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001700,P-0001700-T01-IM3,Endometrioid Ovarian Cancer,EOV
msk_impact_2017,P-0001701,P-0001701-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001702,P-0001702-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001703,P-0001703-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0001704,P-0001704-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001705,P-0001705-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001706,P-0001706-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001707,P-0001707-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001708,P-0001708-T01-IM3,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0001709,P-0001709-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0001710,P-0001710-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001711,P-0001711-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0001713,P-0001713-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001714,P-0001714-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001715,P-0001715-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001716,P-0001716-T01-IM3,Uveal Melanoma,UM
msk_impact_2017,P-0001717,P-0001717-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001718,P-0001718-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001720,P-0001720-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001721,P-0001721-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001722,P-0001722-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001723,P-0001723-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0001724,P-0001724-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001725,P-0001725-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0001726,P-0001726-T01-IM3,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0001727,P-0001727-T01-IM3,Chordoma,CHDM
msk_impact_2017,P-0001728,P-0001728-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001729,P-0001729-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001730,P-0001730-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001731,P-0001731-T01-IM3,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0001731,P-0001731-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001732,P-0001732-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001733,P-0001733-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001734,P-0001734-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001735,P-0001735-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0001736,P-0001736-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0001737,P-0001737-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0001738,P-0001738-T01-IM3,Renal Mucinous Tubular Spindle Cell Carcinoma,MTSCC
msk_impact_2017,P-0001739,P-0001739-T01-IM3,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0001740,P-0001740-T01-IM3,Embryonal Carcinoma,BEC
msk_impact_2017,P-0001741,P-0001741-T02-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001741,P-0001741-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001742,P-0001742-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001743,P-0001743-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001744,P-0001744-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0001745,P-0001745-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001746,P-0001746-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001747,P-0001747-T02-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001747,P-0001747-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001749,P-0001749-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001750,P-0001750-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001751,P-0001751-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001752,P-0001752-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001753,P-0001753-T01-IM3,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0001754,P-0001754-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001755,P-0001755-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001756,P-0001756-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001757,P-0001757-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001758,P-0001758-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001759,P-0001759-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001760,P-0001760-T01-IM3,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0001761,P-0001761-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001762,P-0001762-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001763,P-0001763-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001764,P-0001764-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001766,P-0001766-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001767,P-0001767-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001768,P-0001768-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001769,P-0001769-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0001771,P-0001771-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001773,P-0001773-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001774,P-0001774-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001775,P-0001775-T01-IM3,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0001776,P-0001776-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001777,P-0001777-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001778,P-0001778-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001779,P-0001779-T01-IM3,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0001780,P-0001780-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001781,P-0001781-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001782,P-0001782-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001783,P-0001783-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0001784,P-0001784-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001785,P-0001785-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001785,P-0001785-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001787,P-0001787-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001788,P-0001788-T01-IM3,Uveal Melanoma,UM
msk_impact_2017,P-0001790,P-0001790-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0001791,P-0001791-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001793,P-0001793-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001794,P-0001794-T01-IM3,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0001795,P-0001795-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001795,P-0001795-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001796,P-0001796-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001797,P-0001797-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001798,P-0001798-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001799,P-0001799-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001800,P-0001800-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001801,P-0001801-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001802,P-0001802-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001803,P-0001803-T01-IM3,Penile Squamous Cell Carcinoma,PSCC
msk_impact_2017,P-0001804,P-0001804-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0001805,P-0001805-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001806,P-0001806-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001807,P-0001807-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001808,P-0001808-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001809,P-0001809-T01-IM3,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0001810,P-0001810-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0001811,P-0001811-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001812,P-0001812-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0001813,P-0001813-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001813,P-0001813-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001814,P-0001814-T01-IM3,Uterine Myxoid Leiomyosarcoma,UMLMS
msk_impact_2017,P-0001816,P-0001816-T01-IM3,Pheochromocytoma,PHC
msk_impact_2017,P-0001817,P-0001817-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001817,P-0001817-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001818,P-0001818-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001819,P-0001819-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001820,P-0001820-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0001821,P-0001821-T01-IM3,Uterine Epithelioid Leiomyosarcoma,UELMS
msk_impact_2017,P-0001822,P-0001822-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001823,P-0001823-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0001824,P-0001824-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001825,P-0001825-T01-IM3,Uterine Epithelioid Leiomyosarcoma,UELMS
msk_impact_2017,P-0001826,P-0001826-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001827,P-0001827-T01-IM3,Chondrosarcoma,CHS
msk_impact_2017,P-0001828,P-0001828-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001829,P-0001829-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001829,P-0001829-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001830,P-0001830-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001830,P-0001830-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001832,P-0001832-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001833,P-0001833-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001834,P-0001834-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001835,P-0001835-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001835,P-0001835-T02-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001836,P-0001836-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001837,P-0001837-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001838,P-0001838-T01-IM3,Undifferentiated Uterine Sarcoma,UUS
msk_impact_2017,P-0001839,P-0001839-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001840,P-0001840-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001840,P-0001840-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001841,P-0001841-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001842,P-0001842-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001843,P-0001843-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001843,P-0001843-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001844,P-0001844-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001845,P-0001845-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001846,P-0001846-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001847,P-0001847-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001848,P-0001848-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0001849,P-0001849-T01-IM3,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0001850,P-0001850-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001851,P-0001851-T01-IM3,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0001852,P-0001852-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001853,P-0001853-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0001854,P-0001854-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001855,P-0001855-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0001856,P-0001856-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001857,P-0001857-T01-IM3,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0001858,P-0001858-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001859,P-0001859-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001859,P-0001859-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001860,P-0001860-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001861,P-0001861-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001862,P-0001862-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001863,P-0001863-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0001864,P-0001864-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001866,P-0001866-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0001867,P-0001867-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001868,P-0001868-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0001869,P-0001869-T01-IM3,Embryonal Carcinoma,BEC
msk_impact_2017,P-0001870,P-0001870-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0001871,P-0001871-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0001872,P-0001872-T01-IM3,Myoepithelial Carcinoma,MYEC
msk_impact_2017,P-0001874,P-0001874-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001875,P-0001875-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001876,P-0001876-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001876,P-0001876-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001877,P-0001877-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001878,P-0001878-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0001879,P-0001879-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001879,P-0001879-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001880,P-0001880-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0001881,P-0001881-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0001882,P-0001882-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001882,P-0001882-T02-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001883,P-0001883-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001884,P-0001884-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001884,P-0001884-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001885,P-0001885-T01-IM3,Hemangiopericytoma of the Central Nervous System,HPCCNS
msk_impact_2017,P-0001886,P-0001886-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001887,P-0001887-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001888,P-0001888-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001889,P-0001889-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001890,P-0001890-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0001891,P-0001891-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001892,P-0001892-T01-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0001893,P-0001893-T01-IM3,Lung Carcinoid,LUCA
msk_impact_2017,P-0001894,P-0001894-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001895,P-0001895-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0001896,P-0001896-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0001897,P-0001897-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001898,P-0001898-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001899,P-0001899-T01-IM3,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0001901,P-0001901-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0001902,P-0001902-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001903,P-0001903-T01-IM3,Hypopharynx Squamous Cell Carcinoma,HPHSC
msk_impact_2017,P-0001904,P-0001904-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001904,P-0001904-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0001906,P-0001906-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001907,P-0001907-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001908,P-0001908-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001909,P-0001909-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001910,P-0001910-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001911,P-0001911-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001912,P-0001912-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0001913,P-0001913-T02-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0001914,P-0001914-T01-IM3,Astrocytoma,ASTR
msk_impact_2017,P-0001915,P-0001915-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001916,P-0001916-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001917,P-0001917-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0001918,P-0001918-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0001919,P-0001919-T01-IM3,Dermatofibrosarcoma Protuberans,DFSP
msk_impact_2017,P-0001920,P-0001920-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0001921,P-0001921-T01-IM3,Astrocytoma,ASTR
msk_impact_2017,P-0001922,P-0001922-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0001923,P-0001923-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001924,P-0001924-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0001925,P-0001925-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001926,P-0001926-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0001927,P-0001927-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001928,P-0001928-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0001929,P-0001929-T01-IM3,Astrocytoma,ASTR
msk_impact_2017,P-0001930,P-0001930-T01-IM3,Thymic Carcinoma,THYC
msk_impact_2017,P-0001931,P-0001931-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001932,P-0001932-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001933,P-0001933-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0001934,P-0001934-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001935,P-0001935-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001936,P-0001936-T01-IM3,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0001937,P-0001937-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0001939,P-0001939-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001940,P-0001940-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001941,P-0001941-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001941,P-0001941-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001942,P-0001942-T03-IM3,Mixed Cervical Carcinoma,MCCE
msk_impact_2017,P-0001943,P-0001943-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001944,P-0001944-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001945,P-0001945-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001946,P-0001946-T01-IM3,Ossifying Fibromyxoid Tumor,OFMT
msk_impact_2017,P-0001947,P-0001947-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0001948,P-0001948-T01-IM3,Follicular Dendritic Cell Sarcoma,FDCS
msk_impact_2017,P-0001949,P-0001949-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0001952,P-0001952-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001952,P-0001952-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001954,P-0001954-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0001955,P-0001955-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001956,P-0001956-T01-IM3,Neuroblastoma,NBL
msk_impact_2017,P-0001957,P-0001957-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001959,P-0001959-T01-IM3,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0001961,P-0001961-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001961,P-0001961-T03-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001961,P-0001961-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001963,P-0001963-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0001964,P-0001964-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001965,P-0001965-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001966,P-0001966-T01-IM3,"Ovarian Cancer, Other",OOVC
msk_impact_2017,P-0001967,P-0001967-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0001968,P-0001968-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0001970,P-0001970-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001971,P-0001971-T01-IM3,Astrocytoma,ASTR
msk_impact_2017,P-0001972,P-0001972-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001973,P-0001973-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0001974,P-0001974-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0001975,P-0001975-T01-IM3,Astrocytoma,ASTR
msk_impact_2017,P-0001976,P-0001976-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001977,P-0001977-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001978,P-0001978-T01-IM3,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0001979,P-0001979-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001980,P-0001980-T01-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0001982,P-0001982-T01-IM3,Osteosarcoma,OS
msk_impact_2017,P-0001983,P-0001983-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0001984,P-0001984-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0001985,P-0001985-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001986,P-0001986-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001987,P-0001987-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0001988,P-0001988-T01-IM3,Pilocytic Astrocytoma,PAST
msk_impact_2017,P-0001989,P-0001989-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0001990,P-0001990-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0001991,P-0001991-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0001992,P-0001992-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0001993,P-0001993-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0001994,P-0001994-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0001995,P-0001995-T01-IM3,Pineal Parenchymal Tumor of Intermediate Differentiation,PPTID
msk_impact_2017,P-0001996,P-0001996-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0001997,P-0001997-T01-IM3,Schwannoma,SCHW
msk_impact_2017,P-0001998,P-0001998-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0001999,P-0001999-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0002000,P-0002000-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002000,P-0002000-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002001,P-0002001-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002002,P-0002002-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002003,P-0002003-T01-IM3,Melanotic Schwannoma,MSCHW
msk_impact_2017,P-0002004,P-0002004-T01-IM3,Uterine Dedifferentiated Carcinoma,UDDC
msk_impact_2017,P-0002005,P-0002005-T01-IM3,Hemangioblastoma,HMBL
msk_impact_2017,P-0002006,P-0002006-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002007,P-0002007-T01-IM3,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0002008,P-0002008-T01-IM3,Angiosarcoma,ANGS
msk_impact_2017,P-0002009,P-0002009-T01-IM3,Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma,HCCIHCH
msk_impact_2017,P-0002010,P-0002010-T02-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0002010,P-0002010-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0002011,P-0002011-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002012,P-0002012-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0002013,P-0002013-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002014,P-0002014-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002015,P-0002015-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002015,P-0002015-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002016,P-0002016-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002017,P-0002017-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002018,P-0002018-T01-IM3,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0002019,P-0002019-T01-IM3,Uveal Melanoma,UM
msk_impact_2017,P-0002020,P-0002020-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0002021,P-0002021-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002022,P-0002022-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002023,P-0002023-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002024,P-0002024-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002025,P-0002025-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002026,P-0002026-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002027,P-0002027-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002028,P-0002028-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002029,P-0002029-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002030,P-0002030-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0002032,P-0002032-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002033,P-0002033-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002034,P-0002034-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0002035,P-0002035-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002036,P-0002036-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002037,P-0002037-T01-IM3,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0002038,P-0002038-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002039,P-0002039-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002040,P-0002040-T01-IM3,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0002042,P-0002042-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002043,P-0002043-T01-IM3,Oligoastrocytoma,OAST
msk_impact_2017,P-0002044,P-0002044-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002045,P-0002045-T01-IM3,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0002046,P-0002046-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002047,P-0002047-T01-IM3,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0002048,P-0002048-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002049,P-0002049-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002050,P-0002050-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0002051,P-0002051-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0002052,P-0002052-T01-IM3,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0002053,P-0002053-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002054,P-0002054-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002054,P-0002054-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002055,P-0002055-T02-IM5,Follicular Thyroid Cancer,THFO
msk_impact_2017,P-0002056,P-0002056-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002057,P-0002057-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002058,P-0002058-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002059,P-0002059-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002060,P-0002060-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002061,P-0002061-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0002063,P-0002063-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002064,P-0002064-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002066,P-0002066-T01-IM3,Pleomorphic Rhabdomyosarcoma,PLRMS
msk_impact_2017,P-0002068,P-0002068-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002069,P-0002069-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002070,P-0002070-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002071,P-0002071-T01-IM3,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0002071,P-0002071-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002072,P-0002072-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002073,P-0002073-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0002075,P-0002075-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002076,P-0002076-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002077,P-0002077-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0002078,P-0002078-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002079,P-0002079-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002080,P-0002080-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002081,P-0002081-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002082,P-0002082-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0002083,P-0002083-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002084,P-0002084-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0002085,P-0002085-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002085,P-0002085-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002086,P-0002086-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0002087,P-0002087-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002088,P-0002088-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002088,P-0002088-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002091,P-0002091-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002091,P-0002091-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002092,P-0002092-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0002093,P-0002093-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002094,P-0002094-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0002095,P-0002095-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002096,P-0002096-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002097,P-0002097-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002098,P-0002098-T01-IM3,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0002099,P-0002099-T02-IM3,Seminoma,SEM
msk_impact_2017,P-0002100,P-0002100-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002101,P-0002101-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002102,P-0002102-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002103,P-0002103-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002105,P-0002105-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002106,P-0002106-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002107,P-0002107-T01-IM3,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0002108,P-0002108-T01-IM3,Epithelial-Myoepithelial Carcinoma,EMYOCA
msk_impact_2017,P-0002109,P-0002109-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0002110,P-0002110-T01-IM3,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0002111,P-0002111-T01-IM3,Myxofibrosarcoma,MFS
msk_impact_2017,P-0002115,P-0002115-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0002116,P-0002116-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002117,P-0002117-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002118,P-0002118-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002119,P-0002119-T01-IM3,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0002119,P-0002119-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002120,P-0002120-T01-IM3,Embryonal Carcinoma,BEC
msk_impact_2017,P-0002121,P-0002121-T01-IM3,Embryonal Carcinoma,BEC
msk_impact_2017,P-0002122,P-0002122-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002123,P-0002123-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002123,P-0002123-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002124,P-0002124-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002125,P-0002125-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0002126,P-0002126-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002127,P-0002127-T01-IM3,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0002128,P-0002128-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002129,P-0002129-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002130,P-0002130-T02-IM3,Fibrosarcoma,FIBS
msk_impact_2017,P-0002131,P-0002131-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002132,P-0002132-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002133,P-0002133-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002134,P-0002134-T01-IM3,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0002134,P-0002134-T02-IM3,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0002135,P-0002135-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002136,P-0002136-T01-IM3,Mixed Ovarian Carcinoma,MXOV
msk_impact_2017,P-0002137,P-0002137-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0002138,P-0002138-T01-IM3,Gliosarcoma,GSARC
msk_impact_2017,P-0002139,P-0002139-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002140,P-0002140-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0002141,P-0002141-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002142,P-0002142-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0002143,P-0002143-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002144,P-0002144-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002145,P-0002145-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002146,P-0002146-T01-IM3,Plasmacytoid/Signet Ring Cell Bladder Carcinoma,SRCBC
msk_impact_2017,P-0002147,P-0002147-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002148,P-0002148-T01-IM3,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0002149,P-0002149-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002149,P-0002149-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002150,P-0002150-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002151,P-0002151-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002152,P-0002152-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002153,P-0002153-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002154,P-0002154-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002155,P-0002155-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002156,P-0002156-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002157,P-0002157-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002159,P-0002159-T01-IM3,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0002160,P-0002160-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002161,P-0002161-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0002162,P-0002162-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0002163,P-0002163-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002164,P-0002164-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002165,P-0002165-T01-IM3,Acral Melanoma,ACRM
msk_impact_2017,P-0002166,P-0002166-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002166,P-0002166-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002167,P-0002167-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002168,P-0002168-T01-IM3,Acinic Cell Carcinoma,ACCC
msk_impact_2017,P-0002169,P-0002169-T01-IM3,Embryonal Carcinoma,BEC
msk_impact_2017,P-0002170,P-0002170-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0002171,P-0002171-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002172,P-0002172-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0002174,P-0002174-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0002176,P-0002176-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002177,P-0002177-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002178,P-0002178-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002179,P-0002179-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0002181,P-0002181-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002181,P-0002181-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002182,P-0002182-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002183,P-0002183-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002184,P-0002184-T01-IM3,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0002185,P-0002185-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0002186,P-0002186-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002187,P-0002187-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002188,P-0002188-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002189,P-0002189-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0002190,P-0002190-T01-IM3,Osteoblastic Osteosarcoma,OSOS
msk_impact_2017,P-0002190,P-0002190-T02-IM5,Osteosarcoma,OS
msk_impact_2017,P-0002191,P-0002191-T01-IM3,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0002192,P-0002192-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002193,P-0002193-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0002194,P-0002194-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002195,P-0002195-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0002196,P-0002196-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002197,P-0002197-T01-IM3,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0002198,P-0002198-T01-IM3,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0002199,P-0002199-T01-IM3,Bladder Adenocarcinoma,BLAD
msk_impact_2017,P-0002200,P-0002200-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0002200,P-0002200-T02-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0002202,P-0002202-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002203,P-0002203-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0002203,P-0002203-T02-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002204,P-0002204-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0002205,P-0002205-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0002206,P-0002206-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002207,P-0002207-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002208,P-0002208-T02-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0002208,P-0002208-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0002208,P-0002208-T03-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0002209,P-0002209-T02-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0002209,P-0002209-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0002210,P-0002210-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0002211,P-0002211-T01-IM3,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0002212,P-0002212-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002213,P-0002213-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002214,P-0002214-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0002215,P-0002215-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002216,P-0002216-T01-IM3,Oligodendroglioma,ODG
msk_impact_2017,P-0002217,P-0002217-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002218,P-0002218-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002218,P-0002218-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002219,P-0002219-T01-IM3,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0002220,P-0002220-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0002221,P-0002221-T02-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002221,P-0002221-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002222,P-0002222-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002223,P-0002223-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002224,P-0002224-T01-IM3,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0002225,P-0002225-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002225,P-0002225-T02-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002226,P-0002226-T01-IM3,"Uterine Sarcoma, Other",OUSARC
msk_impact_2017,P-0002226,P-0002226-T02-IM5,"Uterine Sarcoma, Other",OUSARC
msk_impact_2017,P-0002227,P-0002227-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002228,P-0002228-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002229,P-0002229-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002230,P-0002230-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002231,P-0002231-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0002232,P-0002232-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002233,P-0002233-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002234,P-0002234-T02-IM3,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0002234,P-0002234-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002235,P-0002235-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002236,P-0002236-T01-IM3,Neuroblastoma,NBL
msk_impact_2017,P-0002237,P-0002237-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002239,P-0002239-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0002240,P-0002240-T01-IM3,Ewing Sarcoma,ES
msk_impact_2017,P-0002242,P-0002242-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002242,P-0002242-T02-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002243,P-0002243-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002244,P-0002244-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002245,P-0002245-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002247,P-0002247-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002248,P-0002248-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002249,P-0002249-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0002250,P-0002250-T01-IM3,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0002251,P-0002251-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002252,P-0002252-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0002253,P-0002253-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002253,P-0002253-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002254,P-0002254-T01-IM3,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0002255,P-0002255-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002256,P-0002256-T02-IM5,"Uterine Sarcoma, Other",OUSARC
msk_impact_2017,P-0002257,P-0002257-T01-IM3,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0002258,P-0002258-T01-IM3,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0002259,P-0002259-T01-IM3,Chordoma,CHDM
msk_impact_2017,P-0002260,P-0002260-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002262,P-0002262-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0002263,P-0002263-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0002265,P-0002265-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002265,P-0002265-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002266,P-0002266-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002267,P-0002267-T01-IM3,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0002268,P-0002268-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002269,P-0002269-T01-IM3,Chondroblastic Osteosarcoma,CHOS
msk_impact_2017,P-0002270,P-0002270-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002272,P-0002272-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002273,P-0002273-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002273,P-0002273-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002273,P-0002273-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002274,P-0002274-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002275,P-0002275-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002276,P-0002276-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002277,P-0002277-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0002278,P-0002278-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002279,P-0002279-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002280,P-0002280-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0002281,P-0002281-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002283,P-0002283-T01-IM3,Dermatofibroma,DF
msk_impact_2017,P-0002284,P-0002284-T01-IM3,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0002285,P-0002285-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002286,P-0002286-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002287,P-0002287-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002288,P-0002288-T01-IM3,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0002289,P-0002289-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002290,P-0002290-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002291,P-0002291-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002292,P-0002292-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002293,P-0002293-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002294,P-0002294-T01-IM3,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0002294,P-0002294-T02-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002295,P-0002295-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002296,P-0002296-T01-IM3,Prostate Small Cell Carcinoma,PRSCC
msk_impact_2017,P-0002297,P-0002297-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002298,P-0002298-T01-IM3,Oligodendroglioma,ODG
msk_impact_2017,P-0002299,P-0002299-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0002301,P-0002301-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0002302,P-0002302-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002303,P-0002303-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002304,P-0002304-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002305,P-0002305-T01-IM3,Acral Melanoma,ACRM
msk_impact_2017,P-0002306,P-0002306-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002307,P-0002307-T01-IM3,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0002308,P-0002308-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002308,P-0002308-T02-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002309,P-0002309-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002310,P-0002310-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002311,P-0002311-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002312,P-0002312-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002313,P-0002313-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002314,P-0002314-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002315,P-0002315-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0002316,P-0002316-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002317,P-0002317-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0002318,P-0002318-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0002319,P-0002319-T01-IM3,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0002320,P-0002320-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002321,P-0002321-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002322,P-0002322-T01-IM3,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0002323,P-0002323-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002324,P-0002324-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002326,P-0002326-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0002326,P-0002326-T02-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0002327,P-0002327-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002328,P-0002328-T02-IM5,Head and Neck Neuroendocrine Carcinoma,HNNE
msk_impact_2017,P-0002328,P-0002328-T01-IM3,Head and Neck Neuroendocrine Carcinoma,HNNE
msk_impact_2017,P-0002329,P-0002329-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002330,P-0002330-T01-IM3,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0002331,P-0002331-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002332,P-0002332-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002333,P-0002333-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002334,P-0002334-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002335,P-0002335-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0002336,P-0002336-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002337,P-0002337-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0002338,P-0002338-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002339,P-0002339-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002340,P-0002340-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002341,P-0002341-T01-IM3,Penile Squamous Cell Carcinoma,PSCC
msk_impact_2017,P-0002342,P-0002342-T01-IM3,Inflammatory Myofibroblastic Tumor,IMT
msk_impact_2017,P-0002343,P-0002343-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002344,P-0002344-T01-IM3,Choriocarcinoma,BCCA
msk_impact_2017,P-0002345,P-0002345-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0002347,P-0002347-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002348,P-0002348-T01-IM3,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0002349,P-0002349-T02-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002351,P-0002351-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002353,P-0002353-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002354,P-0002354-T01-IM3,Alveolar Soft Part Sarcoma,ASPS
msk_impact_2017,P-0002356,P-0002356-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002357,P-0002357-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0002358,P-0002358-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002359,P-0002359-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002360,P-0002360-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0002361,P-0002361-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0002362,P-0002362-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002363,P-0002363-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002364,P-0002364-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002366,P-0002366-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002367,P-0002367-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0002368,P-0002368-T02-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002369,P-0002369-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002370,P-0002370-T01-IM3,Thymoma,THYM
msk_impact_2017,P-0002373,P-0002373-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002374,P-0002374-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002375,P-0002375-T01-IM3,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0002376,P-0002376-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002377,P-0002377-T01-IM3,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0002378,P-0002378-T01-IM3,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0002379,P-0002379-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0002380,P-0002380-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002382,P-0002382-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002383,P-0002383-T01-IM3,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0002384,P-0002384-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002385,P-0002385-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002386,P-0002386-T02-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002386,P-0002386-T03-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002386,P-0002386-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002387,P-0002387-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002388,P-0002388-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002390,P-0002390-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002391,P-0002391-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002392,P-0002392-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002393,P-0002393-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0002394,P-0002394-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002395,P-0002395-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002396,P-0002396-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002397,P-0002397-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002398,P-0002398-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002398,P-0002398-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002399,P-0002399-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002400,P-0002400-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002401,P-0002401-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0002402,P-0002402-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002403,P-0002403-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002404,P-0002404-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002405,P-0002405-T01-IM3,Sweat Gland Adenocarcinoma,SGAD
msk_impact_2017,P-0002406,P-0002406-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002407,P-0002407-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002408,P-0002408-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002408,P-0002408-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002409,P-0002409-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002410,P-0002410-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002411,P-0002411-T01-IM3,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0002412,P-0002412-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002413,P-0002413-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002414,P-0002414-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0002415,P-0002415-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002416,P-0002416-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002417,P-0002417-T02-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002417,P-0002417-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002418,P-0002418-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002419,P-0002419-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002420,P-0002420-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002421,P-0002421-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002422,P-0002422-T01-IM3,Mucosal Melanoma of the Urethra,URMM
msk_impact_2017,P-0002423,P-0002423-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002424,P-0002424-T01-IM3,"Squamous Cell Carcinoma, NOS",SCCNOS
msk_impact_2017,P-0002425,P-0002425-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002426,P-0002426-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002428,P-0002428-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002429,P-0002429-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002430,P-0002430-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002431,P-0002431-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002433,P-0002433-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002434,P-0002434-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002435,P-0002435-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002436,P-0002436-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0002437,P-0002437-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002438,P-0002438-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002439,P-0002439-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002440,P-0002440-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002441,P-0002441-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002442,P-0002442-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002443,P-0002443-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002444,P-0002444-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002445,P-0002445-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002446,P-0002446-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002447,P-0002447-T01-IM3,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0002448,P-0002448-T02-IM3,Osteosarcoma,OS
msk_impact_2017,P-0002449,P-0002449-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0002449,P-0002449-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0002450,P-0002450-T01-IM3,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0002451,P-0002451-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002451,P-0002451-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002452,P-0002452-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002453,P-0002453-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002454,P-0002454-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002455,P-0002455-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002456,P-0002456-T01-IM3,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0002457,P-0002457-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0002458,P-0002458-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002459,P-0002459-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002460,P-0002460-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002461,P-0002461-T02-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0002462,P-0002462-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002463,P-0002463-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002463,P-0002463-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002464,P-0002464-T01-IM3,Uveal Melanoma,UM
msk_impact_2017,P-0002464,P-0002464-T02-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0002465,P-0002465-T01-IM3,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0002466,P-0002466-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002467,P-0002467-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0002468,P-0002468-T01-IM3,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0002469,P-0002469-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0002470,P-0002470-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002472,P-0002472-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002473,P-0002473-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002474,P-0002474-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002475,P-0002475-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002476,P-0002476-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0002477,P-0002477-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002478,P-0002478-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002479,P-0002479-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002480,P-0002480-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0002481,P-0002481-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0002482,P-0002482-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002483,P-0002483-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002485,P-0002485-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002486,P-0002486-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0002487,P-0002487-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002488,P-0002488-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002489,P-0002489-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002490,P-0002490-T01-IM3,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0002491,P-0002491-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002492,P-0002492-T01-IM3,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0002493,P-0002493-T01-IM3,Hepatoblastoma,LIHB
msk_impact_2017,P-0002495,P-0002495-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002496,P-0002496-T01-IM3,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0002497,P-0002497-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002499,P-0002499-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002500,P-0002500-T01-IM3,Head and Neck Squamous Cell Carcinoma of Unknown Primary,HNSCUP
msk_impact_2017,P-0002501,P-0002501-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0002502,P-0002502-T01-IM3,"Pleural Mesothelioma, Biphasic Type",PLBMESO
msk_impact_2017,P-0002503,P-0002503-T01-IM3,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0002505,P-0002505-T01-IM3,Well-Differentiated Neuroendocrine Tumor of the Rectum,RWDNET
msk_impact_2017,P-0002506,P-0002506-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002506,P-0002506-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002507,P-0002507-T01-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0002508,P-0002508-T01-IM3,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0002509,P-0002509-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002510,P-0002510-T01-IM3,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0002511,P-0002511-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002512,P-0002512-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002512,P-0002512-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002513,P-0002513-T02-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002514,P-0002514-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002515,P-0002515-T01-IM3,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0002516,P-0002516-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002517,P-0002517-T01-IM3,Uveal Melanoma,UM
msk_impact_2017,P-0002519,P-0002519-T01-IM3,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0002520,P-0002520-T01-IM3,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0002522,P-0002522-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002523,P-0002523-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002524,P-0002524-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002525,P-0002525-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002526,P-0002526-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002527,P-0002527-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002528,P-0002528-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002529,P-0002529-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002530,P-0002530-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0002531,P-0002531-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002532,P-0002532-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002533,P-0002533-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002534,P-0002534-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002536,P-0002536-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002537,P-0002537-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002537,P-0002537-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002538,P-0002538-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002539,P-0002539-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002540,P-0002540-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002542,P-0002542-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002543,P-0002543-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002544,P-0002544-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002545,P-0002545-T01-IM3,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0002546,P-0002546-T01-IM3,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0002547,P-0002547-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002548,P-0002548-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002549,P-0002549-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002551,P-0002551-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002552,P-0002552-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002553,P-0002553-T01-IM3,Mucinous Stomach Adenocarcinoma,MSTAD
msk_impact_2017,P-0002555,P-0002555-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0002556,P-0002556-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002557,P-0002557-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002558,P-0002558-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002559,P-0002559-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002562,P-0002562-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002562,P-0002562-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002563,P-0002563-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002564,P-0002564-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002565,P-0002565-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002566,P-0002566-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002567,P-0002567-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002568,P-0002568-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002569,P-0002569-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002570,P-0002570-T01-IM3,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0002571,P-0002571-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002572,P-0002572-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0002573,P-0002573-T01-IM3,Endometrioid Ovarian Cancer,EOV
msk_impact_2017,P-0002574,P-0002574-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002575,P-0002575-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002576,P-0002576-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002577,P-0002577-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0002578,P-0002578-T01-IM3,Neuroblastoma,NBL
msk_impact_2017,P-0002579,P-0002579-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002580,P-0002580-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002581,P-0002581-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002582,P-0002582-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0002583,P-0002583-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002584,P-0002584-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002585,P-0002585-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002586,P-0002586-T01-IM3,Bladder Adenocarcinoma,BLAD
msk_impact_2017,P-0002587,P-0002587-T01-IM3,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0002588,P-0002588-T01-IM3,Myxofibrosarcoma,MFS
msk_impact_2017,P-0002589,P-0002589-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002590,P-0002590-T01-IM3,Dermatofibrosarcoma Protuberans,DFSP
msk_impact_2017,P-0002591,P-0002591-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002592,P-0002592-T01-IM3,Hypopharynx Squamous Cell Carcinoma,HPHSC
msk_impact_2017,P-0002593,P-0002593-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002594,P-0002594-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002594,P-0002594-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002595,P-0002595-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002596,P-0002596-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002597,P-0002597-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002599,P-0002599-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002601,P-0002601-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002602,P-0002602-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002603,P-0002603-T01-IM3,Sinonasal Squamous Cell Carcinoma,SNSC
msk_impact_2017,P-0002604,P-0002604-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0002604,P-0002604-T01-IM3,Neuroblastoma,NBL
msk_impact_2017,P-0002605,P-0002605-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002606,P-0002606-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002607,P-0002607-T01-IM3,Plasmacytoid/Signet Ring Cell Bladder Carcinoma,SRCBC
msk_impact_2017,P-0002608,P-0002608-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002609,P-0002609-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002610,P-0002610-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002611,P-0002611-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002613,P-0002613-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002614,P-0002614-T02-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002614,P-0002614-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002615,P-0002615-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002615,P-0002615-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002616,P-0002616-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002617,P-0002617-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002619,P-0002619-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002620,P-0002620-T01-IM3,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0002620,P-0002620-T02-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0002621,P-0002621-T02-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0002622,P-0002622-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002622,P-0002622-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002624,P-0002624-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002625,P-0002625-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002627,P-0002627-T01-IM3,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0002629,P-0002629-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002630,P-0002630-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002631,P-0002631-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002632,P-0002632-T02-IM5,Renal Medullary Carcinoma,MRC
msk_impact_2017,P-0002633,P-0002633-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002634,P-0002634-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0002635,P-0002635-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002636,P-0002636-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002637,P-0002637-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0002638,P-0002638-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002639,P-0002639-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002640,P-0002640-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002641,P-0002641-T01-IM3,Osteosarcoma,OS
msk_impact_2017,P-0002642,P-0002642-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0002643,P-0002643-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002645,P-0002645-T01-IM3,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0002646,P-0002646-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002647,P-0002647-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002647,P-0002647-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002648,P-0002648-T02-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0002648,P-0002648-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002649,P-0002649-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002650,P-0002650-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002651,P-0002651-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002652,P-0002652-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002653,P-0002653-T01-IM3,Signet Ring Cell Adenocarcinoma of the Colon and Rectum,SRCCR
msk_impact_2017,P-0002654,P-0002654-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002655,P-0002655-T01-IM3,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0002656,P-0002656-T01-IM3,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002657,P-0002657-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002658,P-0002658-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0002659,P-0002659-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002660,P-0002660-T01-IM3,Ovarian Epithelial Tumor,OVT
msk_impact_2017,P-0002661,P-0002661-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002662,P-0002662-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0002663,P-0002663-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002664,P-0002664-T01-IM3,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0002665,P-0002665-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002666,P-0002666-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002667,P-0002667-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002668,P-0002668-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002669,P-0002669-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0002670,P-0002670-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002671,P-0002671-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002672,P-0002672-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002673,P-0002673-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002674,P-0002674-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002675,P-0002675-T01-IM3,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0002676,P-0002676-T01-IM3,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0002677,P-0002677-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002678,P-0002678-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002679,P-0002679-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002680,P-0002680-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002682,P-0002682-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002683,P-0002683-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002684,P-0002684-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002685,P-0002685-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0002687,P-0002687-T01-IM3,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0002688,P-0002688-T02-IM3,Seminoma,SEM
msk_impact_2017,P-0002689,P-0002689-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002691,P-0002691-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0002692,P-0002692-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002694,P-0002694-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002695,P-0002695-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002696,P-0002696-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002697,P-0002697-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0002698,P-0002698-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0002700,P-0002700-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002701,P-0002701-T01-IM3,Chordoma,CHDM
msk_impact_2017,P-0002702,P-0002702-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002703,P-0002703-T01-IM3,Soft Tissue Myoepithelial Carcinoma,STMYEC
msk_impact_2017,P-0002705,P-0002705-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002706,P-0002706-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002707,P-0002707-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002707,P-0002707-T03-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002708,P-0002708-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0002709,P-0002709-T01-IM3,Large Cell Lung Carcinoma,LCLC
msk_impact_2017,P-0002710,P-0002710-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002712,P-0002712-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002713,P-0002713-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002714,P-0002714-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0002715,P-0002715-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002716,P-0002716-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002717,P-0002717-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0002718,P-0002718-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002719,P-0002719-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0002720,P-0002720-T01-IM3,Osteosarcoma,OS
msk_impact_2017,P-0002721,P-0002721-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002722,P-0002722-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002723,P-0002723-T01-IM3,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0002724,P-0002724-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002725,P-0002725-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002726,P-0002726-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002728,P-0002728-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002729,P-0002729-T01-IM3,Astrocytoma,ASTR
msk_impact_2017,P-0002730,P-0002730-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002731,P-0002731-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002732,P-0002732-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002733,P-0002733-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0002734,P-0002734-T01-IM3,Ependymoma,EPM
msk_impact_2017,P-0002735,P-0002735-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002736,P-0002736-T01-IM3,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0002737,P-0002737-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002738,P-0002738-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0002738,P-0002738-T02-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0002740,P-0002740-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002741,P-0002741-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002743,P-0002743-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002744,P-0002744-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002745,P-0002745-T01-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0002746,P-0002746-T01-IM3,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0002747,P-0002747-T01-IM3,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0002748,P-0002748-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002749,P-0002749-T02-IM3,Signet Ring Cell Type of the Appendix,SRAP
msk_impact_2017,P-0002750,P-0002750-T02-IM3,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0002751,P-0002751-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002752,P-0002752-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002753,P-0002753-T01-IM3,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0002754,P-0002754-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002755,P-0002755-T02-IM3,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0002755,P-0002755-T01-IM3,Salivary Adenocarcinoma,SAAD
msk_impact_2017,P-0002756,P-0002756-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002756,P-0002756-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002756,P-0002756-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002757,P-0002757-T01-IM3,Intimal Sarcoma,INTS
msk_impact_2017,P-0002758,P-0002758-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002759,P-0002759-T01-IM3,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0002761,P-0002761-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002762,P-0002762-T02-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0002763,P-0002763-T01-IM3,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0002764,P-0002764-T01-IM3,Chondrosarcoma,CHS
msk_impact_2017,P-0002765,P-0002765-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002766,P-0002766-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002767,P-0002767-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002768,P-0002768-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002769,P-0002769-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002770,P-0002770-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002771,P-0002771-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002772,P-0002772-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002773,P-0002773-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002775,P-0002775-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002776,P-0002776-T01-IM3,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0002777,P-0002777-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002778,P-0002778-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002779,P-0002779-T01-IM3,Small Bowel Cancer,SBC
msk_impact_2017,P-0002780,P-0002780-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002781,P-0002781-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002782,P-0002782-T01-IM3,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0002783,P-0002783-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002784,P-0002784-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0002786,P-0002786-T01-IM3,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0002787,P-0002787-T01-IM3,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0002788,P-0002788-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002789,P-0002789-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002791,P-0002791-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002792,P-0002792-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002793,P-0002793-T02-IM3,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0002794,P-0002794-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002794,P-0002794-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002795,P-0002795-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002796,P-0002796-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002797,P-0002797-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0002798,P-0002798-T01-IM3,Uveal Melanoma,UM
msk_impact_2017,P-0002799,P-0002799-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002800,P-0002800-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002801,P-0002801-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002802,P-0002802-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002803,P-0002803-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002804,P-0002804-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002805,P-0002805-T01-IM3,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0002806,P-0002806-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002807,P-0002807-T01-IM3,Uterine Epithelioid Leiomyosarcoma,UELMS
msk_impact_2017,P-0002808,P-0002808-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002809,P-0002809-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002810,P-0002810-T01-IM3,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0002811,P-0002811-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0002812,P-0002812-T01-IM3,Uterine Epithelioid Leiomyosarcoma,UELMS
msk_impact_2017,P-0002813,P-0002813-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002814,P-0002814-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002815,P-0002815-T01-IM3,Oligodendroglioma,ODG
msk_impact_2017,P-0002816,P-0002816-T01-IM3,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0002817,P-0002817-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002818,P-0002818-T01-IM3,Head and Neck Neuroendocrine Carcinoma,HNNE
msk_impact_2017,P-0002819,P-0002819-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0002820,P-0002820-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002821,P-0002821-T01-IM3,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0002822,P-0002822-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0002823,P-0002823-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002824,P-0002824-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002825,P-0002825-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0002825,P-0002825-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0002826,P-0002826-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002827,P-0002827-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002828,P-0002828-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002829,P-0002829-T01-IM3,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0002830,P-0002830-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002832,P-0002832-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002833,P-0002833-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002835,P-0002835-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002836,P-0002836-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002837,P-0002837-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002838,P-0002838-T03-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002838,P-0002838-T02-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002839,P-0002839-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002840,P-0002840-T02-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002840,P-0002840-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002841,P-0002841-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002842,P-0002842-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002843,P-0002843-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002843,P-0002843-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002844,P-0002844-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002845,P-0002845-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0002846,P-0002846-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002847,P-0002847-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002848,P-0002848-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002849,P-0002849-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002850,P-0002850-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002851,P-0002851-T01-IM3,Chondrosarcoma,CHS
msk_impact_2017,P-0002852,P-0002852-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002853,P-0002853-T01-IM3,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0002854,P-0002854-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0002855,P-0002855-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002856,P-0002856-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0002858,P-0002858-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002859,P-0002859-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002860,P-0002860-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002861,P-0002861-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002862,P-0002862-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002863,P-0002863-T01-IM3,Chordoma,CHDM
msk_impact_2017,P-0002864,P-0002864-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002865,P-0002865-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002866,P-0002866-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002867,P-0002867-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0002868,P-0002868-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0002869,P-0002869-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002870,P-0002870-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002871,P-0002871-T01-IM3,Lymphoepithelioma-like Carcinoma of the Lung,LECLC
msk_impact_2017,P-0002872,P-0002872-T01-IM3,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0002873,P-0002873-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002874,P-0002874-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002875,P-0002875-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002876,P-0002876-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002877,P-0002877-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002878,P-0002878-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002879,P-0002879-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002880,P-0002880-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002881,P-0002881-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0002882,P-0002882-T01-IM3,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0002883,P-0002883-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0002883,P-0002883-T01-IM3,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0002884,P-0002884-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002885,P-0002885-T01-IM3,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0002886,P-0002886-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002887,P-0002887-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0002888,P-0002888-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002889,P-0002889-T01-IM3,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0002890,P-0002890-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002891,P-0002891-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002892,P-0002892-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002893,P-0002893-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002894,P-0002894-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002895,P-0002895-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002896,P-0002896-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0002897,P-0002897-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002898,P-0002898-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002898,P-0002898-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002898,P-0002898-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002899,P-0002899-T01-IM3,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0002900,P-0002900-T01-IM3,Rosette-forming Glioneuronal Tumor of the Fourth Ventricle,RGNT
msk_impact_2017,P-0002901,P-0002901-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002901,P-0002901-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002902,P-0002902-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0002903,P-0002903-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002904,P-0002904-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002905,P-0002905-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002906,P-0002906-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002907,P-0002907-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002908,P-0002908-T01-IM3,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0002909,P-0002909-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002910,P-0002910-T02-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002911,P-0002911-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0002912,P-0002912-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002913,P-0002913-T01-IM3,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0002914,P-0002914-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0002915,P-0002915-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002916,P-0002916-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002916,P-0002916-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002917,P-0002917-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002919,P-0002919-T01-IM3,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0002920,P-0002920-T02-IM5,Salivary Adenocarcinoma,SAAD
msk_impact_2017,P-0002920,P-0002920-T01-IM3,Salivary Adenocarcinoma,SAAD
msk_impact_2017,P-0002921,P-0002921-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002922,P-0002922-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002936,P-0002936-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0002937,P-0002937-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0002939,P-0002939-T01-IM3,Sinonasal Squamous Cell Carcinoma,SNSC
msk_impact_2017,P-0002940,P-0002940-T01-IM3,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0002941,P-0002941-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002942,P-0002942-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002943,P-0002943-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0002944,P-0002944-T01-IM3,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0002945,P-0002945-T01-IM3,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0002946,P-0002946-T01-IM3,Paraganglioma,PGNG
msk_impact_2017,P-0002947,P-0002947-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002948,P-0002948-T02-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0002949,P-0002949-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002950,P-0002950-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002951,P-0002951-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002952,P-0002952-T01-IM3,Chordoma,CHDM
msk_impact_2017,P-0002953,P-0002953-T01-IM3,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0002954,P-0002954-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002955,P-0002955-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002956,P-0002956-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002957,P-0002957-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002958,P-0002958-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002959,P-0002959-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002959,P-0002959-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002960,P-0002960-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0002961,P-0002961-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002962,P-0002962-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002963,P-0002963-T01-IM3,Oligodendroglioma,ODG
msk_impact_2017,P-0002964,P-0002964-T02-IM3,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0002964,P-0002964-T01-IM3,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0002965,P-0002965-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0002966,P-0002966-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002967,P-0002967-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0002968,P-0002968-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0002969,P-0002969-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002970,P-0002970-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002971,P-0002971-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002971,P-0002971-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002972,P-0002972-T01-IM3,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0002973,P-0002973-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0002974,P-0002974-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002975,P-0002975-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002975,P-0002975-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002976,P-0002976-T01-IM3,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0002977,P-0002977-T01-IM3,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0002978,P-0002978-T02-IM5,Mammary Analogue Secretory Carcinoma of Salivary Gland Origin,HNMASC
msk_impact_2017,P-0002978,P-0002978-T04-IM5,Mammary Analogue Secretory Carcinoma of Salivary Gland Origin,HNMASC
msk_impact_2017,P-0002978,P-0002978-T03-IM5,Mammary Analogue Secretory Carcinoma of Salivary Gland Origin,HNMASC
msk_impact_2017,P-0002979,P-0002979-T01-IM3,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0002979,P-0002979-T02-IM3,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0002980,P-0002980-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002981,P-0002981-T01-IM3,Astrocytoma,ASTR
msk_impact_2017,P-0002981,P-0002981-T02-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0002982,P-0002982-T01-IM3,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0002983,P-0002983-T01-IM3,Thymoma,THYM
msk_impact_2017,P-0002984,P-0002984-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002985,P-0002985-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0002986,P-0002986-T01-IM3,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0002987,P-0002987-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0002989,P-0002989-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002990,P-0002990-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002990,P-0002990-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0002991,P-0002991-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0002992,P-0002992-T01-IM3,Neuroblastoma,NBL
msk_impact_2017,P-0002993,P-0002993-T01-IM3,Acral Melanoma,ACRM
msk_impact_2017,P-0002994,P-0002994-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0002995,P-0002995-T01-IM3,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0002996,P-0002996-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002996,P-0002996-T02-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0002997,P-0002997-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0002998,P-0002998-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0002999,P-0002999-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003000,P-0003000-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003001,P-0003001-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003002,P-0003002-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003003,P-0003003-T01-IM3,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0003004,P-0003004-T01-IM3,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0003005,P-0003005-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003006,P-0003006-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003007,P-0003007-T01-IM3,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003008,P-0003008-T01-IM3,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003009,P-0003009-T01-IM3,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0003010,P-0003010-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003011,P-0003011-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003012,P-0003012-T01-IM3,Gallbladder Cancer,GBC
msk_impact_2017,P-0003013,P-0003013-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003014,P-0003014-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0003015,P-0003015-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0003016,P-0003016-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003017,P-0003017-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003018,P-0003018-T01-IM3,Choriocarcinoma,BCCA
msk_impact_2017,P-0003019,P-0003019-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0003020,P-0003020-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003021,P-0003021-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003022,P-0003022-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0003023,P-0003023-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003024,P-0003024-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003025,P-0003025-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003025,P-0003025-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003026,P-0003026-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003027,P-0003027-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003028,P-0003028-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003029,P-0003029-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003030,P-0003030-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003031,P-0003031-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0003032,P-0003032-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0003033,P-0003033-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003033,P-0003033-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003034,P-0003034-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003035,P-0003035-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003036,P-0003036-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0003037,P-0003037-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003038,P-0003038-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0003039,P-0003039-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003040,P-0003040-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003041,P-0003041-T01-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0003042,P-0003042-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003043,P-0003043-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0003044,P-0003044-T01-IM3,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003045,P-0003045-T01-IM3,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0003046,P-0003046-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003047,P-0003047-T01-IM3,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0003048,P-0003048-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003049,P-0003049-T01-IM3,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0003050,P-0003050-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003051,P-0003051-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003052,P-0003052-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003053,P-0003053-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003054,P-0003054-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003054,P-0003054-T02-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0003055,P-0003055-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003056,P-0003056-T01-IM3,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003057,P-0003057-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003058,P-0003058-T01-IM3,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0003059,P-0003059-T01-IM3,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0003060,P-0003060-T01-IM3,Synovial Sarcoma,SYNS
msk_impact_2017,P-0003061,P-0003061-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003062,P-0003062-T01-IM3,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003063,P-0003063-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003064,P-0003064-T01-IM3,Neuroblastoma,NBL
msk_impact_2017,P-0003064,P-0003064-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003065,P-0003065-T01-IM3,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0003066,P-0003066-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003067,P-0003067-T01-IM3,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003068,P-0003068-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003069,P-0003069-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003070,P-0003070-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003070,P-0003070-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003071,P-0003071-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003072,P-0003072-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003073,P-0003073-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0003074,P-0003074-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0003075,P-0003075-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0003077,P-0003077-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003078,P-0003078-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003079,P-0003079-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003080,P-0003080-T01-IM5,Head and Neck Squamous Cell Carcinoma of Unknown Primary,HNSCUP
msk_impact_2017,P-0003096,P-0003096-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003097,P-0003097-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003098,P-0003098-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0003099,P-0003099-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0003100,P-0003100-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0003101,P-0003101-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003101,P-0003101-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003101,P-0003101-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003102,P-0003102-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003103,P-0003103-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0003104,P-0003104-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003105,P-0003105-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003106,P-0003106-T01-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0003107,P-0003107-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003108,P-0003108-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003109,P-0003109-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0003110,P-0003110-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003111,P-0003111-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003113,P-0003113-T01-IM5,Endometrial Stromal Sarcoma,ESS
msk_impact_2017,P-0003114,P-0003114-T01-IM5,Systemic Mastocytosis,SM
msk_impact_2017,P-0003116,P-0003116-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003116,P-0003116-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003117,P-0003117-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003118,P-0003118-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003119,P-0003119-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003120,P-0003120-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0003122,P-0003122-T01-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0003123,P-0003123-T01-IM5,Intimal Sarcoma,INTS
msk_impact_2017,P-0003124,P-0003124-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003125,P-0003125-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003126,P-0003126-T01-IM5,Ependymoma,EPM
msk_impact_2017,P-0003127,P-0003127-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003128,P-0003128-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003129,P-0003129-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003130,P-0003130-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003131,P-0003131-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003132,P-0003132-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003133,P-0003133-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003134,P-0003134-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003135,P-0003135-T04-IM5,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0003136,P-0003136-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003137,P-0003137-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003138,P-0003138-T01-IM5,Uterine Adenosarcoma,UAS
msk_impact_2017,P-0003139,P-0003139-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003139,P-0003139-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003140,P-0003140-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003141,P-0003141-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003142,P-0003142-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003143,P-0003143-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0003144,P-0003144-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0003145,P-0003145-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003146,P-0003146-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0003147,P-0003147-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003149,P-0003149-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003150,P-0003150-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003150,P-0003150-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003152,P-0003152-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003153,P-0003153-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003154,P-0003154-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003155,P-0003155-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0003156,P-0003156-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003157,P-0003157-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003158,P-0003158-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0003159,P-0003159-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003160,P-0003160-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003161,P-0003161-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003162,P-0003162-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003164,P-0003164-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0003165,P-0003165-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003166,P-0003166-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003167,P-0003167-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003168,P-0003168-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0003169,P-0003169-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003170,P-0003170-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003171,P-0003171-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0003172,P-0003172-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003173,P-0003173-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003174,P-0003174-T01-IM5,Mature Teratoma,BMT
msk_impact_2017,P-0003175,P-0003175-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003176,P-0003176-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0003177,P-0003177-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003178,P-0003178-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0003179,P-0003179-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003179,P-0003179-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003180,P-0003180-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0003181,P-0003181-T01-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0003181,P-0003181-T02-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0003182,P-0003182-T01-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0003183,P-0003183-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003184,P-0003184-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003185,P-0003185-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003186,P-0003186-T01-IM5,Bladder Adenocarcinoma,BLAD
msk_impact_2017,P-0003187,P-0003187-T02-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003188,P-0003188-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003190,P-0003190-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003191,P-0003191-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0003192,P-0003192-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003193,P-0003193-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0003194,P-0003194-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0003195,P-0003195-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003196,P-0003196-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003197,P-0003197-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0003198,P-0003198-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003198,P-0003198-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003199,P-0003199-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003200,P-0003200-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003201,P-0003201-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003202,P-0003202-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003203,P-0003203-T01-IM5,Epithelial-Myoepithelial Carcinoma,EMYOCA
msk_impact_2017,P-0003204,P-0003204-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0003205,P-0003205-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003205,P-0003205-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003206,P-0003206-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003207,P-0003207-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003209,P-0003209-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003210,P-0003210-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003211,P-0003211-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003212,P-0003212-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0003213,P-0003213-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003214,P-0003214-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0003216,P-0003216-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003217,P-0003217-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0003218,P-0003218-T01-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0003219,P-0003219-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0003220,P-0003220-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003221,P-0003221-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0003222,P-0003222-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003223,P-0003223-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003223,P-0003223-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003224,P-0003224-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003225,P-0003225-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003226,P-0003226-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003227,P-0003227-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003228,P-0003228-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0003229,P-0003229-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003230,P-0003230-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003231,P-0003231-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003232,P-0003232-T01-IM5,Spindle Cell Rhabdomyosarcoma,SCRMS
msk_impact_2017,P-0003233,P-0003233-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003234,P-0003234-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003235,P-0003235-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0003236,P-0003236-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0003237,P-0003237-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003238,P-0003238-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003239,P-0003239-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0003240,P-0003240-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003241,P-0003241-T02-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0003241,P-0003241-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0003243,P-0003243-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003244,P-0003244-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0003245,P-0003245-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003246,P-0003246-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003247,P-0003247-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003248,P-0003248-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003249,P-0003249-T01-IM5,Intimal Sarcoma,INTS
msk_impact_2017,P-0003250,P-0003250-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003251,P-0003251-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0003253,P-0003253-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0003254,P-0003254-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0003255,P-0003255-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0003256,P-0003256-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003257,P-0003257-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003258,P-0003258-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003259,P-0003259-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003260,P-0003260-T02-IM5,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0003260,P-0003260-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0003261,P-0003261-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003262,P-0003262-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0003264,P-0003264-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003264,P-0003264-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003265,P-0003265-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003266,P-0003266-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0003267,P-0003267-T01-IM5,High-Grade Endometrial Stromal Sarcoma,HGESS
msk_impact_2017,P-0003268,P-0003268-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003269,P-0003269-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0003270,P-0003270-T02-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003271,P-0003271-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0003272,P-0003272-T01-IM5,Odontogenic Carcinoma,ODGC
msk_impact_2017,P-0003273,P-0003273-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003273,P-0003273-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003274,P-0003274-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003275,P-0003275-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003276,P-0003276-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003277,P-0003277-T01-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0003278,P-0003278-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003279,P-0003279-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003280,P-0003280-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0003281,P-0003281-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003282,P-0003282-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003283,P-0003283-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0003284,P-0003284-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0003285,P-0003285-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003286,P-0003286-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003287,P-0003287-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003289,P-0003289-T02-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0003289,P-0003289-T03-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0003290,P-0003290-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0003291,P-0003291-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0003292,P-0003292-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003293,P-0003293-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003294,P-0003294-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003294,P-0003294-T02-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0003295,P-0003295-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0003296,P-0003296-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0003297,P-0003297-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003298,P-0003298-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003299,P-0003299-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003300,P-0003300-T01-IM5,Langerhans Cell Histiocytosis,LCH
msk_impact_2017,P-0003301,P-0003301-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003302,P-0003302-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003303,P-0003303-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003306,P-0003306-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003307,P-0003307-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003308,P-0003308-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003309,P-0003309-T01-IM5,Waldenstrom Macroglobulinemia,WM
msk_impact_2017,P-0003311,P-0003311-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003313,P-0003313-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003314,P-0003314-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003315,P-0003315-T01-IM5,Yolk Sac Tumor,TYST
msk_impact_2017,P-0003316,P-0003316-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003317,P-0003317-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003317,P-0003317-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003319,P-0003319-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003320,P-0003320-T01-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0003321,P-0003321-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003322,P-0003322-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003323,P-0003323-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003324,P-0003324-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003324,P-0003324-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003325,P-0003325-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0003326,P-0003326-T01-IM5,Embryonal Carcinoma,EMBCA
msk_impact_2017,P-0003327,P-0003327-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003328,P-0003328-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0003329,P-0003329-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0003330,P-0003330-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0003331,P-0003331-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0003332,P-0003332-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0003333,P-0003333-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003334,P-0003334-T02-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0003335,P-0003335-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0003338,P-0003338-T01-IM5,Olfactory Neuroblastoma,ONBL
msk_impact_2017,P-0003339,P-0003339-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0003340,P-0003340-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0003342,P-0003342-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003343,P-0003343-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0003344,P-0003344-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003345,P-0003345-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003346,P-0003346-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0003347,P-0003347-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003348,P-0003348-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003349,P-0003349-T01-IM5,Yolk Sac Tumor,TYST
msk_impact_2017,P-0003350,P-0003350-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003351,P-0003351-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003352,P-0003352-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003353,P-0003353-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003354,P-0003354-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003355,P-0003355-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0003356,P-0003356-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003357,P-0003357-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003358,P-0003358-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003359,P-0003359-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0003360,P-0003360-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003361,P-0003361-T01-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0003362,P-0003362-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003363,P-0003363-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0003364,P-0003364-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0003365,P-0003365-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003366,P-0003366-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003367,P-0003367-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003368,P-0003368-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003370,P-0003370-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003371,P-0003371-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0003372,P-0003372-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003373,P-0003373-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003374,P-0003374-T01-IM5,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0003375,P-0003375-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003376,P-0003376-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003377,P-0003377-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003381,P-0003381-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003382,P-0003382-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0003383,P-0003383-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003385,P-0003385-T02-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0003388,P-0003388-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003389,P-0003389-T01-IM5,Bladder Adenocarcinoma,BLAD
msk_impact_2017,P-0003390,P-0003390-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003391,P-0003391-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003392,P-0003392-T01-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0003393,P-0003393-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003394,P-0003394-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003395,P-0003395-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003396,P-0003396-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003397,P-0003397-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003398,P-0003398-T01-IM5,Thymic Carcinoma,THYC
msk_impact_2017,P-0003400,P-0003400-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003401,P-0003401-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0003402,P-0003402-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003403,P-0003403-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003404,P-0003404-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003405,P-0003405-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0003406,P-0003406-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003407,P-0003407-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0003408,P-0003408-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003409,P-0003409-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003410,P-0003410-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003410,P-0003410-T02-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003411,P-0003411-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0003412,P-0003412-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003413,P-0003413-T01-IM5,Soft Tissue Myoepithelial Carcinoma,STMYEC
msk_impact_2017,P-0003414,P-0003414-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0003415,P-0003415-T01-IM5,Intimal Sarcoma,INTS
msk_impact_2017,P-0003416,P-0003416-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003417,P-0003417-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003419,P-0003419-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003421,P-0003421-T01-IM5,Ganglioglioma,GNG
msk_impact_2017,P-0003422,P-0003422-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0003423,P-0003423-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003424,P-0003424-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003425,P-0003425-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003426,P-0003426-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003428,P-0003428-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0003429,P-0003429-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003430,P-0003430-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0003431,P-0003431-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003432,P-0003432-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003433,P-0003433-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003434,P-0003434-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003435,P-0003435-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0003436,P-0003436-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003437,P-0003437-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003438,P-0003438-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003439,P-0003439-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003440,P-0003440-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0003442,P-0003442-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003444,P-0003444-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003445,P-0003445-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0003446,P-0003446-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003447,P-0003447-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003448,P-0003448-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0003449,P-0003449-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003450,P-0003450-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003451,P-0003451-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003453,P-0003453-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0003455,P-0003455-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003456,P-0003456-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003457,P-0003457-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003458,P-0003458-T02-IM5,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0003459,P-0003459-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003460,P-0003460-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003461,P-0003461-T02-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0003462,P-0003462-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0003463,P-0003463-T02-IM5,Seminoma,SEM
msk_impact_2017,P-0003464,P-0003464-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0003465,P-0003465-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003466,P-0003466-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003467,P-0003467-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003468,P-0003468-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003468,P-0003468-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003469,P-0003469-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003470,P-0003470-T01-IM5,Granular Cell Tumor,GCT
msk_impact_2017,P-0003471,P-0003471-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003472,P-0003472-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0003473,P-0003473-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0003474,P-0003474-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003475,P-0003475-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003476,P-0003476-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0003477,P-0003477-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003478,P-0003478-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003479,P-0003479-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003480,P-0003480-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003481,P-0003481-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003482,P-0003482-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003483,P-0003483-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003484,P-0003484-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0003485,P-0003485-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0003486,P-0003486-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0003487,P-0003487-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003488,P-0003488-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003489,P-0003489-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003490,P-0003490-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003491,P-0003491-T02-IM5,Well-Differentiated Neuroendocrine Tumor of the Appendix,AWDNET
msk_impact_2017,P-0003491,P-0003491-T01-IM5,Well-Differentiated Neuroendocrine Tumor of the Appendix,AWDNET
msk_impact_2017,P-0003492,P-0003492-T01-IM5,Olfactory Neuroblastoma,ONBL
msk_impact_2017,P-0003493,P-0003493-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003494,P-0003494-T01-IM5,Mesenchymal Chondrosarcoma,MCHS
msk_impact_2017,P-0003495,P-0003495-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003496,P-0003496-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0003498,P-0003498-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0003499,P-0003499-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003500,P-0003500-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0003501,P-0003501-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0003502,P-0003502-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003503,P-0003503-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0003504,P-0003504-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003504,P-0003504-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003505,P-0003505-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003506,P-0003506-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003507,P-0003507-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003508,P-0003508-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003509,P-0003509-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003510,P-0003510-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003511,P-0003511-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003511,P-0003511-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003511,P-0003511-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003512,P-0003512-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0003513,P-0003513-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003514,P-0003514-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003515,P-0003515-T01-IM5,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0003516,P-0003516-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003517,P-0003517-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003518,P-0003518-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003519,P-0003519-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003520,P-0003520-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003521,P-0003521-T02-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0003522,P-0003522-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003523,P-0003523-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003523,P-0003523-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003524,P-0003524-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003526,P-0003526-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003527,P-0003527-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003528,P-0003528-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003529,P-0003529-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003530,P-0003530-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003531,P-0003531-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003532,P-0003532-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003532,P-0003532-T02-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003533,P-0003533-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003533,P-0003533-T03-IM5,Teratoma with Malignant Transformation,TMT
msk_impact_2017,P-0003534,P-0003534-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0003535,P-0003535-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003536,P-0003536-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003536,P-0003536-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003537,P-0003537-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003538,P-0003538-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003538,P-0003538-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003539,P-0003539-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003540,P-0003540-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003541,P-0003541-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003542,P-0003542-T01-IM5,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0003543,P-0003543-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0003544,P-0003544-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0003545,P-0003545-T01-IM5,Chordoma,CHDM
msk_impact_2017,P-0003546,P-0003546-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003546,P-0003546-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003547,P-0003547-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003548,P-0003548-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0003550,P-0003550-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003551,P-0003551-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003552,P-0003552-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003553,P-0003553-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003554,P-0003554-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0003555,P-0003555-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003556,P-0003556-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003557,P-0003557-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003558,P-0003558-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003559,P-0003559-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003560,P-0003560-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0003561,P-0003561-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003562,P-0003562-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003563,P-0003563-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0003564,P-0003564-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003565,P-0003565-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003566,P-0003566-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003567,P-0003567-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003568,P-0003568-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003569,P-0003569-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003570,P-0003570-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0003571,P-0003571-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003572,P-0003572-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003573,P-0003573-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003573,P-0003573-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003575,P-0003575-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003576,P-0003576-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0003577,P-0003577-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003578,P-0003578-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0003579,P-0003579-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0003580,P-0003580-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003581,P-0003581-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003582,P-0003582-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003583,P-0003583-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003583,P-0003583-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003584,P-0003584-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003586,P-0003586-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003587,P-0003587-T01-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0003589,P-0003589-T02-IM5,Choriocarcinoma,TCCA
msk_impact_2017,P-0003590,P-0003590-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003591,P-0003591-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003592,P-0003592-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003592,P-0003592-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003593,P-0003593-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0003594,P-0003594-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003595,P-0003595-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003596,P-0003596-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003597,P-0003597-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003597,P-0003597-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003598,P-0003598-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003598,P-0003598-T03-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003598,P-0003598-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003599,P-0003599-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0003600,P-0003600-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003601,P-0003601-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0003602,P-0003602-T02-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0003602,P-0003602-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003603,P-0003603-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003604,P-0003604-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003605,P-0003605-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003606,P-0003606-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003607,P-0003607-T01-IM5,Urethral Squamous Cell Carcinoma,USCC
msk_impact_2017,P-0003608,P-0003608-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003609,P-0003609-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003610,P-0003610-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003611,P-0003611-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003612,P-0003612-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0003613,P-0003613-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0003614,P-0003614-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0003615,P-0003615-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0003616,P-0003616-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003616,P-0003616-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003617,P-0003617-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0003618,P-0003618-T01-IM5,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0003619,P-0003619-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003620,P-0003620-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003620,P-0003620-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003621,P-0003621-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003622,P-0003622-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003623,P-0003623-T01-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0003624,P-0003624-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003625,P-0003625-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003626,P-0003626-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003627,P-0003627-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003628,P-0003628-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003630,P-0003630-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003630,P-0003630-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003631,P-0003631-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0003632,P-0003632-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003633,P-0003633-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0003634,P-0003634-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003635,P-0003635-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003636,P-0003636-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003637,P-0003637-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003638,P-0003638-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0003639,P-0003639-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0003640,P-0003640-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003641,P-0003641-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003642,P-0003642-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003643,P-0003643-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0003644,P-0003644-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003645,P-0003645-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003646,P-0003646-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0003647,P-0003647-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003648,P-0003648-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003649,P-0003649-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003650,P-0003650-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003651,P-0003651-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0003652,P-0003652-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0003653,P-0003653-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003654,P-0003654-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003655,P-0003655-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003656,P-0003656-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003657,P-0003657-T01-IM5,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0003658,P-0003658-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0003658,P-0003658-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0003659,P-0003659-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0003660,P-0003660-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003661,P-0003661-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0003662,P-0003662-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003664,P-0003664-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0003665,P-0003665-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003666,P-0003666-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003667,P-0003667-T01-IM5,Pituicytoma,PTCY
msk_impact_2017,P-0003668,P-0003668-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0003669,P-0003669-T01-IM5,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0003670,P-0003670-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003671,P-0003671-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003672,P-0003672-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0003673,P-0003673-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0003674,P-0003674-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0003676,P-0003676-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003677,P-0003677-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003678,P-0003678-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003679,P-0003679-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003681,P-0003681-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003682,P-0003682-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003683,P-0003683-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003684,P-0003684-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003686,P-0003686-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0003687,P-0003687-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0003688,P-0003688-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0003689,P-0003689-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003690,P-0003690-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003691,P-0003691-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0003692,P-0003692-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003693,P-0003693-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003693,P-0003693-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003694,P-0003694-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003695,P-0003695-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003696,P-0003696-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0003698,P-0003698-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003699,P-0003699-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0003700,P-0003700-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003701,P-0003701-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003702,P-0003702-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003703,P-0003703-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0003704,P-0003704-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0003705,P-0003705-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0003706,P-0003706-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0003707,P-0003707-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0003708,P-0003708-T01-IM5,Serous Borderline Ovarian Tumor,SBOV
msk_impact_2017,P-0003709,P-0003709-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003710,P-0003710-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0003711,P-0003711-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0003712,P-0003712-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003713,P-0003713-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003714,P-0003714-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003715,P-0003715-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003716,P-0003716-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003717,P-0003717-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003719,P-0003719-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003720,P-0003720-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003721,P-0003721-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003722,P-0003722-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003723,P-0003723-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0003724,P-0003724-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0003725,P-0003725-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003726,P-0003726-T02-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0003726,P-0003726-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0003727,P-0003727-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003728,P-0003728-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0003729,P-0003729-T01-IM5,Testicular Mesothelioma,TMESO
msk_impact_2017,P-0003730,P-0003730-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003731,P-0003731-T01-IM5,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0003732,P-0003732-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003733,P-0003733-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003734,P-0003734-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003735,P-0003735-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003736,P-0003736-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0003737,P-0003737-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003738,P-0003738-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003739,P-0003739-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0003740,P-0003740-T01-IM5,Urachal Adenocarcinoma,UA
msk_impact_2017,P-0003741,P-0003741-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003742,P-0003742-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003743,P-0003743-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003744,P-0003744-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003745,P-0003745-T02-IM5,Choriocarcinoma,TCCA
msk_impact_2017,P-0003746,P-0003746-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0003747,P-0003747-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0003748,P-0003748-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003749,P-0003749-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0003750,P-0003750-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003751,P-0003751-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003752,P-0003752-T03-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003752,P-0003752-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003753,P-0003753-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003754,P-0003754-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0003755,P-0003755-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0003756,P-0003756-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0003757,P-0003757-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0003758,P-0003758-T01-IM5,Prostate Small Cell Carcinoma,PRSCC
msk_impact_2017,P-0003759,P-0003759-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003760,P-0003760-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003761,P-0003761-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003762,P-0003762-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003762,P-0003762-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003763,P-0003763-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003764,P-0003764-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0003765,P-0003765-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0003766,P-0003766-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003767,P-0003767-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0003768,P-0003768-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0003770,P-0003770-T01-IM5,Renal Mucinous Tubular Spindle Cell Carcinoma,MTSCC
msk_impact_2017,P-0003770,P-0003770-T02-IM5,Renal Mucinous Tubular Spindle Cell Carcinoma,MTSCC
msk_impact_2017,P-0003770,P-0003770-T03-IM5,Renal Mucinous Tubular Spindle Cell Carcinoma,MTSCC
msk_impact_2017,P-0003771,P-0003771-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0003772,P-0003772-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003773,P-0003773-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003774,P-0003774-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003775,P-0003775-T01-IM5,Hepatoblastoma,LIHB
msk_impact_2017,P-0003776,P-0003776-T01-IM5,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,CLLSLL
msk_impact_2017,P-0003777,P-0003777-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003778,P-0003778-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0003779,P-0003779-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003780,P-0003780-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003781,P-0003781-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003782,P-0003782-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003783,P-0003783-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003784,P-0003784-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003785,P-0003785-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003786,P-0003786-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0003787,P-0003787-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003788,P-0003788-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003789,P-0003789-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003790,P-0003790-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003790,P-0003790-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003791,P-0003791-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003792,P-0003792-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003793,P-0003793-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003794,P-0003794-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0003795,P-0003795-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003796,P-0003796-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003797,P-0003797-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0003798,P-0003798-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0003799,P-0003799-T02-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0003799,P-0003799-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003801,P-0003801-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003802,P-0003802-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0003803,P-0003803-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003804,P-0003804-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0003805,P-0003805-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003806,P-0003806-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0003807,P-0003807-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003808,P-0003808-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003809,P-0003809-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003810,P-0003810-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003811,P-0003811-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003812,P-0003812-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003813,P-0003813-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003814,P-0003814-T01-IM5,Urethral Adenocarcinoma,UAD
msk_impact_2017,P-0003816,P-0003816-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003817,P-0003817-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003818,P-0003818-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003819,P-0003819-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003820,P-0003820-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003821,P-0003821-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0003822,P-0003822-T02-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0003823,P-0003823-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003824,P-0003824-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003825,P-0003825-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0003826,P-0003826-T01-IM5,Plasmacytoid/Signet Ring Cell Bladder Carcinoma,SRCBC
msk_impact_2017,P-0003827,P-0003827-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003828,P-0003828-T01-IM5,Skin Adnexal Carcinoma,SKAC
msk_impact_2017,P-0003829,P-0003829-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003830,P-0003830-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0003831,P-0003831-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0003832,P-0003832-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003833,P-0003833-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0003834,P-0003834-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0003835,P-0003835-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0003836,P-0003836-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0003838,P-0003838-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003838,P-0003838-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003839,P-0003839-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003840,P-0003840-T01-IM5,Sarcomatoid Carcinoma of the Urinary Bladder,SCB
msk_impact_2017,P-0003841,P-0003841-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003842,P-0003842-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0003843,P-0003843-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003843,P-0003843-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0003844,P-0003844-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003845,P-0003845-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0003846,P-0003846-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0003847,P-0003847-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003848,P-0003848-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003849,P-0003849-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0003850,P-0003850-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003851,P-0003851-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0003852,P-0003852-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003853,P-0003853-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003854,P-0003854-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003854,P-0003854-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003855,P-0003855-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0003856,P-0003856-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003857,P-0003857-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003858,P-0003858-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003859,P-0003859-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003860,P-0003860-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003861,P-0003861-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003862,P-0003862-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0003863,P-0003863-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003864,P-0003864-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0003865,P-0003865-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003866,P-0003866-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003866,P-0003866-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003867,P-0003867-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0003868,P-0003868-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003869,P-0003869-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003870,P-0003870-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003871,P-0003871-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003872,P-0003872-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003873,P-0003873-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003874,P-0003874-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0003875,P-0003875-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0003876,P-0003876-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0003877,P-0003877-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003878,P-0003878-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003879,P-0003879-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003880,P-0003880-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0003881,P-0003881-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0003882,P-0003882-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003884,P-0003884-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0003885,P-0003885-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0003886,P-0003886-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0003888,P-0003888-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003889,P-0003889-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0003890,P-0003890-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003891,P-0003891-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003892,P-0003892-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003893,P-0003893-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0003894,P-0003894-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003895,P-0003895-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0003898,P-0003898-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0003899,P-0003899-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0003900,P-0003900-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0003901,P-0003901-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003902,P-0003902-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003903,P-0003903-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003903,P-0003903-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003908,P-0003908-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003909,P-0003909-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003911,P-0003911-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0003912,P-0003912-T01-IM3,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0003913,P-0003913-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003914,P-0003914-T01-IM3,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0003915,P-0003915-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003916,P-0003916-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0003918,P-0003918-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003920,P-0003920-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003921,P-0003921-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003923,P-0003923-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003925,P-0003925-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003926,P-0003926-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0003927,P-0003927-T01-IM3,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0003928,P-0003928-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0003929,P-0003929-T01-IM3,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0003930,P-0003930-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003932,P-0003932-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0003933,P-0003933-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003934,P-0003934-T02-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0003934,P-0003934-T03-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0003934,P-0003934-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0003935,P-0003935-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0003936,P-0003936-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003937,P-0003937-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003937,P-0003937-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003938,P-0003938-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003939,P-0003939-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003940,P-0003940-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003941,P-0003941-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003942,P-0003942-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003943,P-0003943-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0003944,P-0003944-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003945,P-0003945-T01-IM3,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003946,P-0003946-T01-IM3,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0003947,P-0003947-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003948,P-0003948-T01-IM3,Leiomyosarcoma,LMS
msk_impact_2017,P-0003949,P-0003949-T01-IM5,Chordoma,CHDM
msk_impact_2017,P-0003950,P-0003950-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003950,P-0003950-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003951,P-0003951-T01-IM3,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0003953,P-0003953-T01-IM5,Epithelioid Hemangioendothelioma,EHAE
msk_impact_2017,P-0003954,P-0003954-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0003955,P-0003955-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0003958,P-0003958-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003958,P-0003958-T02-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0003959,P-0003959-T01-IM3,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0003960,P-0003960-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003961,P-0003961-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003962,P-0003962-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0003962,P-0003962-T03-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0003963,P-0003963-T01-IM3,Seminoma,SEM
msk_impact_2017,P-0003964,P-0003964-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003965,P-0003965-T01-IM5,Pheochromocytoma,PHC
msk_impact_2017,P-0003966,P-0003966-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0003967,P-0003967-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003968,P-0003968-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0003970,P-0003970-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003970,P-0003970-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003971,P-0003971-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003972,P-0003972-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0003973,P-0003973-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0003974,P-0003974-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003977,P-0003977-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0003978,P-0003978-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0003980,P-0003980-T01-IM3,Undifferentiated Uterine Sarcoma,UUS
msk_impact_2017,P-0003981,P-0003981-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0003982,P-0003982-T01-IM3,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0003983,P-0003983-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0003984,P-0003984-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0003985,P-0003985-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003986,P-0003986-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0003987,P-0003987-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0003990,P-0003990-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0003993,P-0003993-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0003994,P-0003994-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0003995,P-0003995-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0003996,P-0003996-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0003998,P-0003998-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0003999,P-0003999-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004000,P-0004000-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0004001,P-0004001-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004002,P-0004002-T01-IM3,Yolk Sac Tumor,BYST
msk_impact_2017,P-0004005,P-0004005-T01-IM3,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004006,P-0004006-T01-IM3,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0004007,P-0004007-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004007,P-0004007-T02-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004008,P-0004008-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004010,P-0004010-T01-IM3,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0004011,P-0004011-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004012,P-0004012-T01-IM3,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0004014,P-0004014-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004015,P-0004015-T01-IM3,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0004016,P-0004016-T01-IM5,Esophageal Poorly Differentiated Carcinoma,EPDCA
msk_impact_2017,P-0004017,P-0004017-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0004018,P-0004018-T01-IM3,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0004019,P-0004019-T01-IM3,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0004020,P-0004020-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004021,P-0004021-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004023,P-0004023-T01-IM3,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004025,P-0004025-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004026,P-0004026-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004027,P-0004027-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0004028,P-0004028-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004029,P-0004029-T02-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0004029,P-0004029-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0004030,P-0004030-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004031,P-0004031-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004032,P-0004032-T01-IM5,Anaplastic Ganglioglioma,AGNG
msk_impact_2017,P-0004034,P-0004034-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004035,P-0004035-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004038,P-0004038-T01-IM3,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004039,P-0004039-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004040,P-0004040-T02-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004041,P-0004041-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0004042,P-0004042-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0004043,P-0004043-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004044,P-0004044-T01-IM3,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004045,P-0004045-T01-IM3,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004046,P-0004046-T02-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0004046,P-0004046-T01-IM3,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0004047,P-0004047-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0004048,P-0004048-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004050,P-0004050-T01-IM3,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004051,P-0004051-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004052,P-0004052-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004054,P-0004054-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004055,P-0004055-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0004056,P-0004056-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004057,P-0004057-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004058,P-0004058-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004059,P-0004059-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0004060,P-0004060-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0004061,P-0004061-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004062,P-0004062-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0004063,P-0004063-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004064,P-0004064-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004065,P-0004065-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004066,P-0004066-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004066,P-0004066-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004067,P-0004067-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004068,P-0004068-T01-IM5,Thymic Carcinoma,THYC
msk_impact_2017,P-0004069,P-0004069-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004070,P-0004070-T02-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0004071,P-0004071-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0004072,P-0004072-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0004073,P-0004073-T01-IM5,Oligoastrocytoma,OAST
msk_impact_2017,P-0004074,P-0004074-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004075,P-0004075-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004076,P-0004076-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0004077,P-0004077-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0004078,P-0004078-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0004079,P-0004079-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0004080,P-0004080-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0004081,P-0004081-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0004082,P-0004082-T01-IM5,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0004083,P-0004083-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004084,P-0004084-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0004085,P-0004085-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004086,P-0004086-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004087,P-0004087-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004088,P-0004088-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0004089,P-0004089-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004090,P-0004090-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004091,P-0004091-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004092,P-0004092-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004093,P-0004093-T01-IM5,Squamous Cell Carcinoma of the Vulva/Vagina,VSC
msk_impact_2017,P-0004095,P-0004095-T01-IM5,Choriocarcinoma,UCCA
msk_impact_2017,P-0004096,P-0004096-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004097,P-0004097-T01-IM5,Chondroblastic Osteosarcoma,CHOS
msk_impact_2017,P-0004098,P-0004098-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0004099,P-0004099-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004100,P-0004100-T01-IM5,Solitary Fibrous Tumor of the Central Nervous System,SFTCNS
msk_impact_2017,P-0004101,P-0004101-T01-IM5,Paraganglioma,PGNG
msk_impact_2017,P-0004102,P-0004102-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0004103,P-0004103-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004104,P-0004104-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004105,P-0004105-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004106,P-0004106-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0004107,P-0004107-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0004108,P-0004108-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004109,P-0004109-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0004110,P-0004110-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004111,P-0004111-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0004112,P-0004112-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0004113,P-0004113-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004114,P-0004114-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004115,P-0004115-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004116,P-0004116-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0004117,P-0004117-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004118,P-0004118-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0004119,P-0004119-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004120,P-0004120-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004121,P-0004121-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0004121,P-0004121-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004122,P-0004122-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004123,P-0004123-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004124,P-0004124-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004125,P-0004125-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004126,P-0004126-T02-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0004127,P-0004127-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0004128,P-0004128-T01-IM5,Intimal Sarcoma,INTS
msk_impact_2017,P-0004129,P-0004129-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004129,P-0004129-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004130,P-0004130-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0004130,P-0004130-T02-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0004131,P-0004131-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004132,P-0004132-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004133,P-0004133-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004135,P-0004135-T01-IM5,Choriocarcinoma,UCCA
msk_impact_2017,P-0004136,P-0004136-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004137,P-0004137-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004138,P-0004138-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004139,P-0004139-T01-IM5,Squamous Cell Carcinoma of the Vulva/Vagina,VSC
msk_impact_2017,P-0004140,P-0004140-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0004140,P-0004140-T02-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0004140,P-0004140-T03-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004141,P-0004141-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004142,P-0004142-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004143,P-0004143-T01-IM5,Epithelioid Hemangioendothelioma,EHAE
msk_impact_2017,P-0004145,P-0004145-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0004146,P-0004146-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004147,P-0004147-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0004148,P-0004148-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0004149,P-0004149-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004150,P-0004150-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004151,P-0004151-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004152,P-0004152-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004153,P-0004153-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004154,P-0004154-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0004155,P-0004155-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004156,P-0004156-T01-IM5,Well-Differentiated Neuroendocrine Tumor of the Appendix,AWDNET
msk_impact_2017,P-0004157,P-0004157-T01-IM5,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0004158,P-0004158-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004159,P-0004159-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0004160,P-0004160-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004161,P-0004161-T01-IM5,Well-Differentiated Neuroendocrine Tumor of the Rectum,RWDNET
msk_impact_2017,P-0004162,P-0004162-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004163,P-0004163-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0004164,P-0004164-T01-IM5,High-Grade Endometrial Stromal Sarcoma,HGESS
msk_impact_2017,P-0004165,P-0004165-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004166,P-0004166-T01-IM5,Gastric Type Mucinous Carcinoma,GCEMU
msk_impact_2017,P-0004167,P-0004167-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0004168,P-0004168-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004169,P-0004169-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004170,P-0004170-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004172,P-0004172-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004173,P-0004173-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004174,P-0004174-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0004175,P-0004175-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004176,P-0004176-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004177,P-0004177-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0004178,P-0004178-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004179,P-0004179-T01-IM5,Well-Differentiated Neuroendocrine Tumor of the Rectum,RWDNET
msk_impact_2017,P-0004180,P-0004180-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004181,P-0004181-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004182,P-0004182-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004183,P-0004183-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004183,P-0004183-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004183,P-0004183-T03-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0004184,P-0004184-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004185,P-0004185-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004186,P-0004186-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0004187,P-0004187-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004188,P-0004188-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004189,P-0004189-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004190,P-0004190-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0004191,P-0004191-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004192,P-0004192-T02-IM5,Signet Ring Cell Type of the Appendix,SRAP
msk_impact_2017,P-0004192,P-0004192-T01-IM5,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0004193,P-0004193-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004194,P-0004194-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004195,P-0004195-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004195,P-0004195-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004196,P-0004196-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004197,P-0004197-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004198,P-0004198-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0004199,P-0004199-T01-IM5,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0004200,P-0004200-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0004201,P-0004201-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004202,P-0004202-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004203,P-0004203-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004204,P-0004204-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0004205,P-0004205-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004206,P-0004206-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004207,P-0004207-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004208,P-0004208-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004209,P-0004209-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004210,P-0004210-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004211,P-0004211-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004212,P-0004212-T01-IM5,Collecting Duct Renal Cell Carcinoma,CDRCC
msk_impact_2017,P-0004213,P-0004213-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004214,P-0004214-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004215,P-0004215-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004216,P-0004216-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0004217,P-0004217-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0004218,P-0004218-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004219,P-0004219-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004220,P-0004220-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004221,P-0004221-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004222,P-0004222-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004223,P-0004223-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004224,P-0004224-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004225,P-0004225-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004226,P-0004226-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004227,P-0004227-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0004228,P-0004228-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0004229,P-0004229-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0004230,P-0004230-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004231,P-0004231-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004231,P-0004231-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004232,P-0004232-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004233,P-0004233-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004234,P-0004234-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0004235,P-0004235-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004236,P-0004236-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0004237,P-0004237-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004238,P-0004238-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004239,P-0004239-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0004240,P-0004240-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004241,P-0004241-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0004242,P-0004242-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004243,P-0004243-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004244,P-0004244-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004245,P-0004245-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004246,P-0004246-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004247,P-0004247-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0004248,P-0004248-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0004248,P-0004248-T02-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0004249,P-0004249-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004250,P-0004250-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004251,P-0004251-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004252,P-0004252-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0004253,P-0004253-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004255,P-0004255-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004256,P-0004256-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004257,P-0004257-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004257,P-0004257-T02-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004258,P-0004258-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004259,P-0004259-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004260,P-0004260-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004260,P-0004260-T02-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004261,P-0004261-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0004262,P-0004262-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004263,P-0004263-T01-IM5,Spindle Cell Carcinoma of the Lung,SPCC
msk_impact_2017,P-0004264,P-0004264-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004265,P-0004265-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0004266,P-0004266-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0004267,P-0004267-T01-IM5,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0004268,P-0004268-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0004269,P-0004269-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0004270,P-0004270-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004270,P-0004270-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004271,P-0004271-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004272,P-0004272-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0004273,P-0004273-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004274,P-0004274-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0004275,P-0004275-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0004276,P-0004276-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004277,P-0004277-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004278,P-0004278-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0004279,P-0004279-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004280,P-0004280-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0004281,P-0004281-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0004282,P-0004282-T03-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0004283,P-0004283-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004284,P-0004284-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004285,P-0004285-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004286,P-0004286-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004287,P-0004287-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0004288,P-0004288-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004289,P-0004289-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004290,P-0004290-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004291,P-0004291-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0004292,P-0004292-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004293,P-0004293-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004294,P-0004294-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0004295,P-0004295-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004297,P-0004297-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004298,P-0004298-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004300,P-0004300-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0004301,P-0004301-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004302,P-0004302-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004303,P-0004303-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004304,P-0004304-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0004305,P-0004305-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004306,P-0004306-T01-IM5,Extraskeletal Myxoid Chondrosarcoma,EMCHS
msk_impact_2017,P-0004307,P-0004307-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004309,P-0004309-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004310,P-0004310-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004311,P-0004311-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004312,P-0004312-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004313,P-0004313-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0004314,P-0004314-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004315,P-0004315-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004316,P-0004316-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004317,P-0004317-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004318,P-0004318-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004319,P-0004319-T01-IM5,Astroblastoma,ASTB
msk_impact_2017,P-0004320,P-0004320-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0004322,P-0004322-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004323,P-0004323-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004324,P-0004324-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004325,P-0004325-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004326,P-0004326-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004327,P-0004327-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004328,P-0004328-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004328,P-0004328-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004329,P-0004329-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004330,P-0004330-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004331,P-0004331-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0004333,P-0004333-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0004334,P-0004334-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0004335,P-0004335-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004336,P-0004336-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004337,P-0004337-T01-IM5,"Steroid Cell Tumor, NOS",SCT
msk_impact_2017,P-0004338,P-0004338-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004339,P-0004339-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004340,P-0004340-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0004341,P-0004341-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004342,P-0004342-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004343,P-0004343-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004344,P-0004344-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004345,P-0004345-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004346,P-0004346-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004347,P-0004347-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004348,P-0004348-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004349,P-0004349-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004350,P-0004350-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004351,P-0004351-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0004352,P-0004352-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0004353,P-0004353-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0004354,P-0004354-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0004355,P-0004355-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004356,P-0004356-T01-IM5,Signet Ring Cell Type of the Appendix,SRAP
msk_impact_2017,P-0004357,P-0004357-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0004358,P-0004358-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0004359,P-0004359-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004360,P-0004360-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004361,P-0004361-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004361,P-0004361-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004362,P-0004362-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004363,P-0004363-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0004364,P-0004364-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004364,P-0004364-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004364,P-0004364-T03-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004365,P-0004365-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0004366,P-0004366-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004367,P-0004367-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004368,P-0004368-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004369,P-0004369-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004370,P-0004370-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0004371,P-0004371-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0004372,P-0004372-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0004373,P-0004373-T02-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0004373,P-0004373-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004374,P-0004374-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004375,P-0004375-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004376,P-0004376-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004377,P-0004377-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0004378,P-0004378-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004379,P-0004379-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004380,P-0004380-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004381,P-0004381-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004382,P-0004382-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004383,P-0004383-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004384,P-0004384-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004385,P-0004385-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0004386,P-0004386-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004387,P-0004387-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004388,P-0004388-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004389,P-0004389-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004390,P-0004390-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004391,P-0004391-T01-IM5,Sebaceous Carcinoma,SEBA
msk_impact_2017,P-0004392,P-0004392-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004393,P-0004393-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004394,P-0004394-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0004395,P-0004395-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004396,P-0004396-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004397,P-0004397-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004398,P-0004398-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004399,P-0004399-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004400,P-0004400-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004401,P-0004401-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004402,P-0004402-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004403,P-0004403-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004404,P-0004404-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0004405,P-0004405-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0004406,P-0004406-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004407,P-0004407-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0004408,P-0004408-T01-IM5,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0004409,P-0004409-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0004410,P-0004410-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004411,P-0004411-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0004412,P-0004412-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004413,P-0004413-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004414,P-0004414-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004415,P-0004415-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004416,P-0004416-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0004417,P-0004417-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004419,P-0004419-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004420,P-0004420-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004421,P-0004421-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004423,P-0004423-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004424,P-0004424-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004425,P-0004425-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004426,P-0004426-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004427,P-0004427-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004428,P-0004428-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0004429,P-0004429-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004430,P-0004430-T02-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0004430,P-0004430-T03-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0004430,P-0004430-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0004431,P-0004431-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0004432,P-0004432-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004433,P-0004433-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004434,P-0004434-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004435,P-0004435-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004436,P-0004436-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004437,P-0004437-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004438,P-0004438-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004439,P-0004439-T01-IM5,Salivary Adenocarcinoma,SAAD
msk_impact_2017,P-0004440,P-0004440-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0004441,P-0004441-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004442,P-0004442-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004444,P-0004444-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004445,P-0004445-T01-IM5,Serous Borderline Ovarian Tumor,SBOV
msk_impact_2017,P-0004446,P-0004446-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0004447,P-0004447-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004448,P-0004448-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004449,P-0004449-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0004450,P-0004450-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004451,P-0004451-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0004452,P-0004452-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0004453,P-0004453-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0004454,P-0004454-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004455,P-0004455-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0004456,P-0004456-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0004457,P-0004457-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0004458,P-0004458-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004459,P-0004459-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004460,P-0004460-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004462,P-0004462-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004463,P-0004463-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004464,P-0004464-T01-IM5,Non-Hodgkin Lymphoma,NHL
msk_impact_2017,P-0004466,P-0004466-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004467,P-0004467-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0004468,P-0004468-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0004472,P-0004472-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004473,P-0004473-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0004474,P-0004474-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004476,P-0004476-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004477,P-0004477-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004478,P-0004478-T02-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0004481,P-0004481-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0004482,P-0004482-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004483,P-0004483-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004484,P-0004484-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004486,P-0004486-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0004488,P-0004488-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004489,P-0004489-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004491,P-0004491-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004492,P-0004492-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0004493,P-0004493-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0004494,P-0004494-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004495,P-0004495-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004496,P-0004496-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004497,P-0004497-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0004497,P-0004497-T02-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0004498,P-0004498-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0004499,P-0004499-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0004500,P-0004500-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004501,P-0004501-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004502,P-0004502-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004503,P-0004503-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0004504,P-0004504-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0004505,P-0004505-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0004506,P-0004506-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004507,P-0004507-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004508,P-0004508-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004509,P-0004509-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004510,P-0004510-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004511,P-0004511-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004512,P-0004512-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0004513,P-0004513-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0004514,P-0004514-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004515,P-0004515-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004516,P-0004516-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004516,P-0004516-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004517,P-0004517-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004518,P-0004518-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004519,P-0004519-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004520,P-0004520-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0004521,P-0004521-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004522,P-0004522-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004523,P-0004523-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004524,P-0004524-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004524,P-0004524-T02-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004526,P-0004526-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004527,P-0004527-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0004528,P-0004528-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0004529,P-0004529-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0004530,P-0004530-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004531,P-0004531-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0004532,P-0004532-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004533,P-0004533-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0004534,P-0004534-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0004535,P-0004535-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0004536,P-0004536-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0004537,P-0004537-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004538,P-0004538-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004539,P-0004539-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004540,P-0004540-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004541,P-0004541-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0004542,P-0004542-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004543,P-0004543-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0004544,P-0004544-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0004545,P-0004545-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004546,P-0004546-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004547,P-0004547-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0004548,P-0004548-T01-IM5,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0004549,P-0004549-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004550,P-0004550-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0004551,P-0004551-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004552,P-0004552-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004553,P-0004553-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004554,P-0004554-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004555,P-0004555-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004556,P-0004556-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004557,P-0004557-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004558,P-0004558-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004559,P-0004559-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0004560,P-0004560-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0004561,P-0004561-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004562,P-0004562-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004563,P-0004563-T01-IM5,Embryonal Carcinoma,EMBCA
msk_impact_2017,P-0004564,P-0004564-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004565,P-0004565-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004566,P-0004566-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004567,P-0004567-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004568,P-0004568-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0004569,P-0004569-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0004570,P-0004570-T01-IM5,Atypical Meningioma,ATM
msk_impact_2017,P-0004571,P-0004571-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004572,P-0004572-T01-IM5,Embryonal Carcinoma,EMBCA
msk_impact_2017,P-0004573,P-0004573-T01-IM5,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0004574,P-0004574-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0004576,P-0004576-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004577,P-0004577-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004578,P-0004578-T01-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0004580,P-0004580-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004584,P-0004584-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0004585,P-0004585-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0004588,P-0004588-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004589,P-0004589-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004590,P-0004590-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0004591,P-0004591-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004593,P-0004593-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004594,P-0004594-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004595,P-0004595-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004596,P-0004596-T01-IM5,"Uterine Sarcoma, Other",OUSARC
msk_impact_2017,P-0004597,P-0004597-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004597,P-0004597-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004598,P-0004598-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0004599,P-0004599-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0004600,P-0004600-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004600,P-0004600-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004601,P-0004601-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004602,P-0004602-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0004603,P-0004603-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0004604,P-0004604-T01-IM5,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0004605,P-0004605-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0004605,P-0004605-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0004606,P-0004606-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0004607,P-0004607-T03-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004607,P-0004607-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004608,P-0004608-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004609,P-0004609-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004610,P-0004610-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0004611,P-0004611-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004612,P-0004612-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004613,P-0004613-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004614,P-0004614-T01-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0004615,P-0004615-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004616,P-0004616-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0004617,P-0004617-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0004618,P-0004618-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004618,P-0004618-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004619,P-0004619-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0004620,P-0004620-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004621,P-0004621-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004622,P-0004622-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004622,P-0004622-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004623,P-0004623-T01-IM5,Thymic Carcinoma,THYC
msk_impact_2017,P-0004624,P-0004624-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004625,P-0004625-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0004626,P-0004626-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004627,P-0004627-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004628,P-0004628-T02-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0004629,P-0004629-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004630,P-0004630-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0004631,P-0004631-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004632,P-0004632-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0004633,P-0004633-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0004634,P-0004634-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004635,P-0004635-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0004636,P-0004636-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0004637,P-0004637-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004638,P-0004638-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0004639,P-0004639-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004640,P-0004640-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004641,P-0004641-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0004642,P-0004642-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004643,P-0004643-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004644,P-0004644-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004645,P-0004645-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004646,P-0004646-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004647,P-0004647-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004648,P-0004648-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004649,P-0004649-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004650,P-0004650-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0004651,P-0004651-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004652,P-0004652-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0004653,P-0004653-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0004654,P-0004654-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004655,P-0004655-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004656,P-0004656-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0004657,P-0004657-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004657,P-0004657-T02-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0004658,P-0004658-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004659,P-0004659-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004660,P-0004660-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0004661,P-0004661-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004662,P-0004662-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0004663,P-0004663-T01-IM5,"Pleural Mesothelioma, Biphasic Type",PLBMESO
msk_impact_2017,P-0004664,P-0004664-T01-IM5,Soft Tissue Myoepithelial Carcinoma,STMYEC
msk_impact_2017,P-0004665,P-0004665-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004666,P-0004666-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004667,P-0004667-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0004668,P-0004668-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0004669,P-0004669-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004670,P-0004670-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004671,P-0004671-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0004672,P-0004672-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004673,P-0004673-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004674,P-0004674-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0004675,P-0004675-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004676,P-0004676-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0004677,P-0004677-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004678,P-0004678-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004679,P-0004679-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004680,P-0004680-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0004680,P-0004680-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0004681,P-0004681-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004682,P-0004682-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0004683,P-0004683-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0004684,P-0004684-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004685,P-0004685-T02-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0004686,P-0004686-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0004687,P-0004687-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004688,P-0004688-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004689,P-0004689-T01-IM5,Diffuse Type Stomach Adenocarcinoma,DSTAD
msk_impact_2017,P-0004690,P-0004690-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004691,P-0004691-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004691,P-0004691-T02-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0004692,P-0004692-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004693,P-0004693-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004694,P-0004694-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004695,P-0004695-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004696,P-0004696-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004697,P-0004697-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004698,P-0004698-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004699,P-0004699-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004700,P-0004700-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004700,P-0004700-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004701,P-0004701-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0004702,P-0004702-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004702,P-0004702-T03-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004703,P-0004703-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004704,P-0004704-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004705,P-0004705-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0004706,P-0004706-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0004707,P-0004707-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004708,P-0004708-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0004709,P-0004709-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004710,P-0004710-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0004711,P-0004711-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0004712,P-0004712-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004713,P-0004713-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004714,P-0004714-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004716,P-0004716-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004717,P-0004717-T01-IM5,Endometrial Stromal Sarcoma,ESS
msk_impact_2017,P-0004718,P-0004718-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004719,P-0004719-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004720,P-0004720-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0004721,P-0004721-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0004722,P-0004722-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004723,P-0004723-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004724,P-0004724-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004725,P-0004725-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004726,P-0004726-T02-IM5,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0004726,P-0004726-T01-IM5,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0004727,P-0004727-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004728,P-0004728-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004729,P-0004729-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004730,P-0004730-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004731,P-0004731-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0004732,P-0004732-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004733,P-0004733-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004733,P-0004733-T02-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0004734,P-0004734-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0004735,P-0004735-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004736,P-0004736-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004737,P-0004737-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004738,P-0004738-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004739,P-0004739-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004740,P-0004740-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0004741,P-0004741-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0004742,P-0004742-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004743,P-0004743-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004744,P-0004744-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004745,P-0004745-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0004746,P-0004746-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0004747,P-0004747-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004748,P-0004748-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0004752,P-0004752-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004753,P-0004753-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004754,P-0004754-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004755,P-0004755-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004756,P-0004756-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004757,P-0004757-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004758,P-0004758-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004759,P-0004759-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004760,P-0004760-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004761,P-0004761-T01-IM5,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0004762,P-0004762-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004763,P-0004763-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004764,P-0004764-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0004765,P-0004765-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004766,P-0004766-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004768,P-0004768-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004769,P-0004769-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004770,P-0004770-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0004770,P-0004770-T02-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0004771,P-0004771-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004772,P-0004772-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0004773,P-0004773-T01-IM5,Soft Tissue Myoepithelial Carcinoma,STMYEC
msk_impact_2017,P-0004774,P-0004774-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0004775,P-0004775-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004776,P-0004776-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004777,P-0004777-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0004778,P-0004778-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004778,P-0004778-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004779,P-0004779-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0004780,P-0004780-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0004781,P-0004781-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004782,P-0004782-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004783,P-0004783-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0004784,P-0004784-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004785,P-0004785-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004786,P-0004786-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004787,P-0004787-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0004788,P-0004788-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004789,P-0004789-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004790,P-0004790-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004791,P-0004791-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0004792,P-0004792-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004793,P-0004793-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0004794,P-0004794-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0004795,P-0004795-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004796,P-0004796-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004798,P-0004798-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004799,P-0004799-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004800,P-0004800-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0004801,P-0004801-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004802,P-0004802-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004803,P-0004803-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004804,P-0004804-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0004805,P-0004805-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0004806,P-0004806-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004807,P-0004807-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004808,P-0004808-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004809,P-0004809-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004809,P-0004809-T02-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0004810,P-0004810-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004811,P-0004811-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004812,P-0004812-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0004813,P-0004813-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0004814,P-0004814-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0004815,P-0004815-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0004816,P-0004816-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004817,P-0004817-T02-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0004817,P-0004817-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0004818,P-0004818-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004819,P-0004819-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0004820,P-0004820-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004821,P-0004821-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004822,P-0004822-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004823,P-0004823-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004824,P-0004824-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004825,P-0004825-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0004826,P-0004826-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004827,P-0004827-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004828,P-0004828-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004829,P-0004829-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004830,P-0004830-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004831,P-0004831-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0004832,P-0004832-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0004834,P-0004834-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004835,P-0004835-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004836,P-0004836-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0004837,P-0004837-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004838,P-0004838-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004839,P-0004839-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004840,P-0004840-T01-IM5,Embryonal Carcinoma,EMBCA
msk_impact_2017,P-0004841,P-0004841-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004842,P-0004842-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0004843,P-0004843-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0004844,P-0004844-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004845,P-0004845-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004846,P-0004846-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004847,P-0004847-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004848,P-0004848-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0004849,P-0004849-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004850,P-0004850-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004851,P-0004851-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0004852,P-0004852-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0004853,P-0004853-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004854,P-0004854-T01-IM5,Mesenchymal Chondrosarcoma,MCHS
msk_impact_2017,P-0004855,P-0004855-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0004856,P-0004856-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004857,P-0004857-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004858,P-0004858-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004858,P-0004858-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004859,P-0004859-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004860,P-0004860-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004861,P-0004861-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004862,P-0004862-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004863,P-0004863-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004864,P-0004864-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004865,P-0004865-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004866,P-0004866-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004867,P-0004867-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004868,P-0004868-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0004869,P-0004869-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0004871,P-0004871-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0004872,P-0004872-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004873,P-0004873-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004874,P-0004874-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004875,P-0004875-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004876,P-0004876-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0004876,P-0004876-T02-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0004878,P-0004878-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004879,P-0004879-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0004880,P-0004880-T02-IM5,Seminoma,SEM
msk_impact_2017,P-0004880,P-0004880-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004881,P-0004881-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0004882,P-0004882-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004883,P-0004883-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004884,P-0004884-T01-IM5,Extraventricular Neurocytoma,EVN
msk_impact_2017,P-0004885,P-0004885-T01-IM5,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0004886,P-0004886-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004887,P-0004887-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0004888,P-0004888-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004889,P-0004889-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004890,P-0004890-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004891,P-0004891-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004892,P-0004892-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004893,P-0004893-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004894,P-0004894-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0004895,P-0004895-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004896,P-0004896-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004897,P-0004897-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004898,P-0004898-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004899,P-0004899-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0004900,P-0004900-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0004901,P-0004901-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0004902,P-0004902-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0004903,P-0004903-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004904,P-0004904-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004905,P-0004905-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0004906,P-0004906-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004907,P-0004907-T01-IM5,Bladder Squamous Cell Carcinoma,BLSC
msk_impact_2017,P-0004908,P-0004908-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004908,P-0004908-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004909,P-0004909-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004909,P-0004909-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004910,P-0004910-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004910,P-0004910-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004910,P-0004910-T04-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004910,P-0004910-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004911,P-0004911-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0004912,P-0004912-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004913,P-0004913-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004914,P-0004914-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004915,P-0004915-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0004916,P-0004916-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0004917,P-0004917-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0004918,P-0004918-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004919,P-0004919-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0004920,P-0004920-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004921,P-0004921-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004922,P-0004922-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0004923,P-0004923-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004924,P-0004924-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004925,P-0004925-T01-IM5,Thymic Carcinoma,THYC
msk_impact_2017,P-0004926,P-0004926-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0004927,P-0004927-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004928,P-0004928-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004929,P-0004929-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004929,P-0004929-T02-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0004930,P-0004930-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0004931,P-0004931-T02-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0004932,P-0004932-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0004933,P-0004933-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004934,P-0004934-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004935,P-0004935-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004936,P-0004936-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0004937,P-0004937-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0004938,P-0004938-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004939,P-0004939-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004940,P-0004940-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004941,P-0004941-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004942,P-0004942-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0004943,P-0004943-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0004944,P-0004944-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004945,P-0004945-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0004946,P-0004946-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0004947,P-0004947-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0004948,P-0004948-T01-IM5,Fibrosarcoma,FIBS
msk_impact_2017,P-0004949,P-0004949-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004950,P-0004950-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004951,P-0004951-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004952,P-0004952-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0004953,P-0004953-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004953,P-0004953-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004954,P-0004954-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004954,P-0004954-T02-IM5,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0004955,P-0004955-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0004956,P-0004956-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004957,P-0004957-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004958,P-0004958-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0004959,P-0004959-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0004960,P-0004960-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0004961,P-0004961-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004963,P-0004963-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004964,P-0004964-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0004965,P-0004965-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004967,P-0004967-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004968,P-0004968-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0004969,P-0004969-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0004970,P-0004970-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004971,P-0004971-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0004972,P-0004972-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0004973,P-0004973-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0004974,P-0004974-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004975,P-0004975-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004976,P-0004976-T01-IM5,Low-Grade Endometrial Stromal Sarcoma,LGESS
msk_impact_2017,P-0004977,P-0004977-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0004978,P-0004978-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004980,P-0004980-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004981,P-0004981-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004982,P-0004982-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0004983,P-0004983-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0004986,P-0004986-T01-IM5,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0004987,P-0004987-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0004988,P-0004988-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004989,P-0004989-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0004990,P-0004990-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004991,P-0004991-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0004994,P-0004994-T01-IM5,Mature T and NK Neoplasms,MTNN
msk_impact_2017,P-0004995,P-0004995-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0004996,P-0004996-T02-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0004997,P-0004997-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0004998,P-0004998-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0004999,P-0004999-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005000,P-0005000-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005002,P-0005002-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0005003,P-0005003-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005004,P-0005004-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0005005,P-0005005-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005006,P-0005006-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0005007,P-0005007-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0005008,P-0005008-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0005009,P-0005009-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005009,P-0005009-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005010,P-0005010-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005011,P-0005011-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005012,P-0005012-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0005013,P-0005013-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0005014,P-0005014-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005015,P-0005015-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005016,P-0005016-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005017,P-0005017-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005018,P-0005018-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005019,P-0005019-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005020,P-0005020-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005021,P-0005021-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005022,P-0005022-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0005023,P-0005023-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0005024,P-0005024-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005025,P-0005025-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005026,P-0005026-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005027,P-0005027-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0005028,P-0005028-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0005029,P-0005029-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005030,P-0005030-T02-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0005031,P-0005031-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005032,P-0005032-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005033,P-0005033-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005034,P-0005034-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005035,P-0005035-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005036,P-0005036-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005037,P-0005037-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005038,P-0005038-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005039,P-0005039-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005041,P-0005041-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005042,P-0005042-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005043,P-0005043-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005044,P-0005044-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005045,P-0005045-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005046,P-0005046-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0005047,P-0005047-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005048,P-0005048-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005049,P-0005049-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0005050,P-0005050-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005051,P-0005051-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005052,P-0005052-T01-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0005052,P-0005052-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005053,P-0005053-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005054,P-0005054-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005055,P-0005055-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0005057,P-0005057-T02-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0005058,P-0005058-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005059,P-0005059-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005060,P-0005060-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005061,P-0005061-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0005062,P-0005062-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0005063,P-0005063-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005064,P-0005064-T01-IM5,Prostate Small Cell Carcinoma,PRSCC
msk_impact_2017,P-0005065,P-0005065-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005065,P-0005065-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005066,P-0005066-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005067,P-0005067-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0005068,P-0005068-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005069,P-0005069-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005070,P-0005070-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005073,P-0005073-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005074,P-0005074-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005075,P-0005075-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005076,P-0005076-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005077,P-0005077-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005078,P-0005078-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005078,P-0005078-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005079,P-0005079-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005080,P-0005080-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005081,P-0005081-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005082,P-0005082-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0005083,P-0005083-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0005084,P-0005084-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005085,P-0005085-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0005086,P-0005086-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0005087,P-0005087-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005088,P-0005088-T02-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0005089,P-0005089-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005091,P-0005091-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005092,P-0005092-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0005093,P-0005093-T01-IM5,Mucoepidermoid Carcinoma,MUCC
msk_impact_2017,P-0005094,P-0005094-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005095,P-0005095-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005096,P-0005096-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0005097,P-0005097-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005098,P-0005098-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005098,P-0005098-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005099,P-0005099-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0005101,P-0005101-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005102,P-0005102-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005103,P-0005103-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005104,P-0005104-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005105,P-0005105-T01-IM5,Epithelioid Hemangioendothelioma,EHAE
msk_impact_2017,P-0005106,P-0005106-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005107,P-0005107-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005108,P-0005108-T01-IM5,High-Grade Endometrial Stromal Sarcoma,HGESS
msk_impact_2017,P-0005109,P-0005109-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005110,P-0005110-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0005111,P-0005111-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005112,P-0005112-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005113,P-0005113-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005114,P-0005114-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005115,P-0005115-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005116,P-0005116-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0005117,P-0005117-T02-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0005117,P-0005117-T01-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0005118,P-0005118-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005119,P-0005119-T02-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005120,P-0005120-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005121,P-0005121-T02-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0005122,P-0005122-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0005123,P-0005123-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005124,P-0005124-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005125,P-0005125-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005126,P-0005126-T01-IM5,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0005127,P-0005127-T02-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005127,P-0005127-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005128,P-0005128-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005129,P-0005129-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005130,P-0005130-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0005131,P-0005131-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005131,P-0005131-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005132,P-0005132-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005133,P-0005133-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005134,P-0005134-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005135,P-0005135-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0005136,P-0005136-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0005137,P-0005137-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005138,P-0005138-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0005139,P-0005139-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0005140,P-0005140-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005141,P-0005141-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005142,P-0005142-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005143,P-0005143-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005144,P-0005144-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005145,P-0005145-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005146,P-0005146-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005147,P-0005147-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005148,P-0005148-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005149,P-0005149-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0005150,P-0005150-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005150,P-0005150-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005151,P-0005151-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005152,P-0005152-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005153,P-0005153-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005154,P-0005154-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005155,P-0005155-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005156,P-0005156-T01-IM5,Endometrial Stromal Sarcoma,ESS
msk_impact_2017,P-0005157,P-0005157-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0005158,P-0005158-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005159,P-0005159-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005160,P-0005160-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005161,P-0005161-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005162,P-0005162-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005163,P-0005163-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005164,P-0005164-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005165,P-0005165-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005167,P-0005167-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005168,P-0005168-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005169,P-0005169-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0005170,P-0005170-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005171,P-0005171-T01-IM5,Malignant Lymphoma,MLYM
msk_impact_2017,P-0005172,P-0005172-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005173,P-0005173-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005174,P-0005174-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005175,P-0005175-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0005176,P-0005176-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005177,P-0005177-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005178,P-0005178-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005179,P-0005179-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005180,P-0005180-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0005181,P-0005181-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0005182,P-0005182-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0005183,P-0005183-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0005185,P-0005185-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005186,P-0005186-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0005187,P-0005187-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005189,P-0005189-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005190,P-0005190-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005191,P-0005191-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005192,P-0005192-T01-IM5,Histiocytic and Dendritic Cell Neoplasms,HDCN
msk_impact_2017,P-0005193,P-0005193-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005194,P-0005194-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005195,P-0005195-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0005196,P-0005196-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0005197,P-0005197-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005198,P-0005198-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005199,P-0005199-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005200,P-0005200-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005201,P-0005201-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0005202,P-0005202-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005203,P-0005203-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0005204,P-0005204-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0005205,P-0005205-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005206,P-0005206-T01-IM5,Urachal Adenocarcinoma,UA
msk_impact_2017,P-0005207,P-0005207-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005208,P-0005208-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0005209,P-0005209-T01-IM5,Head and Neck Neuroendocrine Carcinoma,HNNE
msk_impact_2017,P-0005210,P-0005210-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005211,P-0005211-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005212,P-0005212-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0005213,P-0005213-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005214,P-0005214-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005215,P-0005215-T01-IM5,Penile Squamous Cell Carcinoma,PSCC
msk_impact_2017,P-0005216,P-0005216-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005217,P-0005217-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005219,P-0005219-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005220,P-0005220-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005221,P-0005221-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005222,P-0005222-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0005223,P-0005223-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005224,P-0005224-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0005225,P-0005225-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005226,P-0005226-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005227,P-0005227-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005228,P-0005228-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005230,P-0005230-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0005231,P-0005231-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005232,P-0005232-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005233,P-0005233-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005234,P-0005234-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005235,P-0005235-T02-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0005235,P-0005235-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0005237,P-0005237-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005239,P-0005239-T01-IM5,"Squamous Cell Carcinoma, NOS",SCCNOS
msk_impact_2017,P-0005240,P-0005240-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005241,P-0005241-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005242,P-0005242-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005243,P-0005243-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0005244,P-0005244-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0005245,P-0005245-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005247,P-0005247-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005249,P-0005249-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0005250,P-0005250-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005251,P-0005251-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005252,P-0005252-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005253,P-0005253-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005254,P-0005254-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005255,P-0005255-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005256,P-0005256-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0005257,P-0005257-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005258,P-0005258-T01-IM5,Malignant Lymphoma,MLYM
msk_impact_2017,P-0005259,P-0005259-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005260,P-0005260-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005261,P-0005261-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005262,P-0005262-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0005263,P-0005263-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005264,P-0005264-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005265,P-0005265-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0005266,P-0005266-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005267,P-0005267-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005268,P-0005268-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0005268,P-0005268-T02-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0005270,P-0005270-T01-IM5,Pheochromocytoma,PHC
msk_impact_2017,P-0005271,P-0005271-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005272,P-0005272-T01-IM5,Anaplastic Ependymoma,APE
msk_impact_2017,P-0005273,P-0005273-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005274,P-0005274-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005275,P-0005275-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005276,P-0005276-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0005277,P-0005277-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005277,P-0005277-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005278,P-0005278-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005279,P-0005279-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0005280,P-0005280-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005281,P-0005281-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0005282,P-0005282-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005283,P-0005283-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005283,P-0005283-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005284,P-0005284-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005285,P-0005285-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0005285,P-0005285-T02-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0005286,P-0005286-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005288,P-0005288-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005289,P-0005289-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005290,P-0005290-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005291,P-0005291-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005292,P-0005292-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0005293,P-0005293-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005294,P-0005294-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0005295,P-0005295-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005296,P-0005296-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0005297,P-0005297-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005298,P-0005298-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005299,P-0005299-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005300,P-0005300-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005301,P-0005301-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0005302,P-0005302-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0005303,P-0005303-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0005304,P-0005304-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0005305,P-0005305-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0005306,P-0005306-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005307,P-0005307-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005308,P-0005308-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005309,P-0005309-T01-IM5,"Adenocarcinoma, NOS",ADNOS
msk_impact_2017,P-0005310,P-0005310-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0005311,P-0005311-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005311,P-0005311-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005312,P-0005312-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005313,P-0005313-T02-IM5,Adrenocortical Adenoma,ACA
msk_impact_2017,P-0005314,P-0005314-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005315,P-0005315-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005316,P-0005316-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005317,P-0005317-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005318,P-0005318-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0005319,P-0005319-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0005320,P-0005320-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005321,P-0005321-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005322,P-0005322-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005322,P-0005322-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005323,P-0005323-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0005324,P-0005324-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005325,P-0005325-T01-IM5,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0005325,P-0005325-T02-IM5,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0005326,P-0005326-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005327,P-0005327-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005328,P-0005328-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005329,P-0005329-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0005330,P-0005330-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005331,P-0005331-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0005332,P-0005332-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005333,P-0005333-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005334,P-0005334-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005335,P-0005335-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005336,P-0005336-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005337,P-0005337-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005338,P-0005338-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005339,P-0005339-T01-IM5,Small Cell Carcinoma of the Ovary,SCCO
msk_impact_2017,P-0005340,P-0005340-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0005341,P-0005341-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0005342,P-0005342-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005343,P-0005343-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0005344,P-0005344-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005345,P-0005345-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005346,P-0005346-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005347,P-0005347-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0005348,P-0005348-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005349,P-0005349-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005350,P-0005350-T01-IM5,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0005351,P-0005351-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005352,P-0005352-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005353,P-0005353-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0005354,P-0005354-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005355,P-0005355-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0005356,P-0005356-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005357,P-0005357-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005359,P-0005359-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005360,P-0005360-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005361,P-0005361-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0005361,P-0005361-T02-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0005362,P-0005362-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005363,P-0005363-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0005364,P-0005364-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005365,P-0005365-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005366,P-0005366-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005367,P-0005367-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005368,P-0005368-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005369,P-0005369-T01-IM5,Follicular Thyroid Cancer,THFO
msk_impact_2017,P-0005370,P-0005370-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005371,P-0005371-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0005372,P-0005372-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005373,P-0005373-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005374,P-0005374-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005375,P-0005375-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0005376,P-0005376-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005377,P-0005377-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0005378,P-0005378-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005379,P-0005379-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005380,P-0005380-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005381,P-0005381-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0005382,P-0005382-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0005383,P-0005383-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0005384,P-0005384-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005385,P-0005385-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005386,P-0005386-T01-IM5,Sweat Gland Adenocarcinoma,SGAD
msk_impact_2017,P-0005387,P-0005387-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0005388,P-0005388-T01-IM5,Malignant Lymphoma,MLYM
msk_impact_2017,P-0005390,P-0005390-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005391,P-0005391-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005392,P-0005392-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0005393,P-0005393-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005395,P-0005395-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005396,P-0005396-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0005397,P-0005397-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005398,P-0005398-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0005399,P-0005399-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005400,P-0005400-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0005404,P-0005404-T02-IM5,Small Cell Carcinoma of the Cervix,SCCE
msk_impact_2017,P-0005404,P-0005404-T01-IM5,Small Cell Carcinoma of the Cervix,SCCE
msk_impact_2017,P-0005409,P-0005409-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0005409,P-0005409-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0005416,P-0005416-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005417,P-0005417-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005418,P-0005418-T01-IM5,Cervical Adenosquamous Carcinoma,CEAS
msk_impact_2017,P-0005419,P-0005419-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0005420,P-0005420-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0005421,P-0005421-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005422,P-0005422-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005423,P-0005423-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005424,P-0005424-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005425,P-0005425-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0005426,P-0005426-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005427,P-0005427-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005428,P-0005428-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005429,P-0005429-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005430,P-0005430-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005431,P-0005431-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005432,P-0005432-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005434,P-0005434-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0005435,P-0005435-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005436,P-0005436-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005436,P-0005436-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005437,P-0005437-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005438,P-0005438-T01-IM5,Teratoma,TT
msk_impact_2017,P-0005439,P-0005439-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005440,P-0005440-T01-IM5,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0005441,P-0005441-T01-IM5,Embryonal Carcinoma,EMBCA
msk_impact_2017,P-0005442,P-0005442-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005443,P-0005443-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005444,P-0005444-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0005445,P-0005445-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005446,P-0005446-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005447,P-0005447-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0005448,P-0005448-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0005449,P-0005449-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005450,P-0005450-T01-IM5,Choriocarcinoma,TCCA
msk_impact_2017,P-0005451,P-0005451-T01-IM5,Non-Hodgkin Lymphoma,NHL
msk_impact_2017,P-0005452,P-0005452-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005453,P-0005453-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005454,P-0005454-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005455,P-0005455-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005456,P-0005456-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005457,P-0005457-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0005458,P-0005458-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005459,P-0005459-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005460,P-0005460-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005461,P-0005461-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005462,P-0005462-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005463,P-0005463-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005464,P-0005464-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005465,P-0005465-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0005466,P-0005466-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0005467,P-0005467-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005468,P-0005468-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005469,P-0005469-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005470,P-0005470-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0005471,P-0005471-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005472,P-0005472-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005473,P-0005473-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005474,P-0005474-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005474,P-0005474-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005475,P-0005475-T01-IM5,Mixed Cervical Carcinoma,MCCE
msk_impact_2017,P-0005475,P-0005475-T02-IM5,Mixed Cervical Carcinoma,MCCE
msk_impact_2017,P-0005476,P-0005476-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005477,P-0005477-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005478,P-0005478-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0005479,P-0005479-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005480,P-0005480-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005481,P-0005481-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005482,P-0005482-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0005483,P-0005483-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005483,P-0005483-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005484,P-0005484-T01-IM5,Fibrosarcoma,FIBS
msk_impact_2017,P-0005485,P-0005485-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005486,P-0005486-T01-IM5,Renal Medullary Carcinoma,MRC
msk_impact_2017,P-0005487,P-0005487-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005488,P-0005488-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005489,P-0005489-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005490,P-0005490-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005492,P-0005492-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005493,P-0005493-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005494,P-0005494-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005495,P-0005495-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005496,P-0005496-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005497,P-0005497-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005498,P-0005498-T01-IM5,Well-Differentiated Neuroendocrine Tumor of the Appendix,AWDNET
msk_impact_2017,P-0005499,P-0005499-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0005500,P-0005500-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0005501,P-0005501-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0005502,P-0005502-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005504,P-0005504-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005505,P-0005505-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005506,P-0005506-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0005507,P-0005507-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005508,P-0005508-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005509,P-0005509-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0005510,P-0005510-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005511,P-0005511-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005511,P-0005511-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005512,P-0005512-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0005513,P-0005513-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0005514,P-0005514-T01-IM5,Schwannoma,SCHW
msk_impact_2017,P-0005515,P-0005515-T01-IM5,Embryonal Carcinoma,BEC
msk_impact_2017,P-0005516,P-0005516-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0005517,P-0005517-T01-IM5,Secondary Osteosarcoma,SECOS
msk_impact_2017,P-0005518,P-0005518-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005519,P-0005519-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005520,P-0005520-T02-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005521,P-0005521-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0005522,P-0005522-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005523,P-0005523-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005524,P-0005524-T03-IM5,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0005525,P-0005525-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005526,P-0005526-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005527,P-0005527-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005528,P-0005528-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005529,P-0005529-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005530,P-0005530-T02-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005531,P-0005531-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0005532,P-0005532-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0005533,P-0005533-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005534,P-0005534-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005535,P-0005535-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005537,P-0005537-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005538,P-0005538-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005539,P-0005539-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005540,P-0005540-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0005541,P-0005541-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0005542,P-0005542-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005543,P-0005543-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005544,P-0005544-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005544,P-0005544-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005545,P-0005545-T01-IM5,Alveolar Rhabdomyosarcoma,ARMS
msk_impact_2017,P-0005546,P-0005546-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005547,P-0005547-T02-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0005548,P-0005548-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005549,P-0005549-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0005550,P-0005550-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005551,P-0005551-T02-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0005552,P-0005552-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005553,P-0005553-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005553,P-0005553-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005554,P-0005554-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0005555,P-0005555-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005556,P-0005556-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005557,P-0005557-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005558,P-0005558-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005560,P-0005560-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005561,P-0005561-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005562,P-0005562-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005563,P-0005563-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005564,P-0005564-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0005565,P-0005565-T01-IM5,T-Lymphoblastic Leukemia/Lymphoma,TLL
msk_impact_2017,P-0005566,P-0005566-T01-IM5,Atypical Meningioma,ATM
msk_impact_2017,P-0005567,P-0005567-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005568,P-0005568-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005569,P-0005569-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005570,P-0005570-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005571,P-0005571-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005572,P-0005572-T03-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0005573,P-0005573-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005574,P-0005574-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005575,P-0005575-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005576,P-0005576-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005577,P-0005577-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0005578,P-0005578-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005579,P-0005579-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0005580,P-0005580-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005581,P-0005581-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005582,P-0005582-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0005583,P-0005583-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005584,P-0005584-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005585,P-0005585-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0005586,P-0005586-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005587,P-0005587-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005588,P-0005588-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005589,P-0005589-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005590,P-0005590-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005591,P-0005591-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005592,P-0005592-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0005593,P-0005593-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005594,P-0005594-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0005595,P-0005595-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005596,P-0005596-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005597,P-0005597-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0005598,P-0005598-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0005599,P-0005599-T01-IM5,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0005600,P-0005600-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005600,P-0005600-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005601,P-0005601-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005602,P-0005602-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005602,P-0005602-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005603,P-0005603-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005604,P-0005604-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005605,P-0005605-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005606,P-0005606-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005607,P-0005607-T01-IM5,Extraskeletal Myxoid Chondrosarcoma,EMCHS
msk_impact_2017,P-0005608,P-0005608-T01-IM5,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0005609,P-0005609-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0005610,P-0005610-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005611,P-0005611-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0005612,P-0005612-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005613,P-0005613-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005614,P-0005614-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005615,P-0005615-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005615,P-0005615-T03-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005616,P-0005616-T02-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0005617,P-0005617-T02-IM5,Penile Squamous Cell Carcinoma,PSCC
msk_impact_2017,P-0005618,P-0005618-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005619,P-0005619-T02-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0005620,P-0005620-T02-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0005621,P-0005621-T02-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005622,P-0005622-T03-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005623,P-0005623-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005624,P-0005624-T02-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0005625,P-0005625-T02-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005626,P-0005626-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005627,P-0005627-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005628,P-0005628-T02-IM5,Desmoid/Aggressive Fibromatosis,DES
msk_impact_2017,P-0005629,P-0005629-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005630,P-0005630-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005631,P-0005631-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005632,P-0005632-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005633,P-0005633-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005634,P-0005634-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0005635,P-0005635-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005636,P-0005636-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005637,P-0005637-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0005638,P-0005638-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0005639,P-0005639-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005640,P-0005640-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005641,P-0005641-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005642,P-0005642-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005643,P-0005643-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005644,P-0005644-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005645,P-0005645-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005645,P-0005645-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005646,P-0005646-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0005647,P-0005647-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0005648,P-0005648-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0005649,P-0005649-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005650,P-0005650-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005651,P-0005651-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0005652,P-0005652-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005655,P-0005655-T02-IM5,Mucosal Melanoma of the Urethra,URMM
msk_impact_2017,P-0005655,P-0005655-T01-IM5,Mucosal Melanoma of the Urethra,URMM
msk_impact_2017,P-0005656,P-0005656-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0005662,P-0005662-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005664,P-0005664-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005666,P-0005666-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005670,P-0005670-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005671,P-0005671-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005672,P-0005672-T01-IM5,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0005673,P-0005673-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005674,P-0005674-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0005675,P-0005675-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0005676,P-0005676-T01-IM5,Pleomorphic Rhabdomyosarcoma,PLRMS
msk_impact_2017,P-0005677,P-0005677-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0005678,P-0005678-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0005679,P-0005679-T01-IM5,Renal Medullary Carcinoma,MRC
msk_impact_2017,P-0005680,P-0005680-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005681,P-0005681-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0005682,P-0005682-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005683,P-0005683-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005684,P-0005684-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0005685,P-0005685-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0005687,P-0005687-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0005688,P-0005688-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005689,P-0005689-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0005690,P-0005690-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005691,P-0005691-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005692,P-0005692-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005693,P-0005693-T01-IM5,Anaplastic Ependymoma,APE
msk_impact_2017,P-0005694,P-0005694-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005695,P-0005695-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0005696,P-0005696-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005697,P-0005697-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005698,P-0005698-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005699,P-0005699-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0005700,P-0005700-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0005701,P-0005701-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005702,P-0005702-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005703,P-0005703-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0005704,P-0005704-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005705,P-0005705-T01-IM5,Well-Differentiated Neuroendocrine Tumor of the Rectum,RWDNET
msk_impact_2017,P-0005707,P-0005707-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005708,P-0005708-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005709,P-0005709-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005710,P-0005710-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0005711,P-0005711-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005712,P-0005712-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005713,P-0005713-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005714,P-0005714-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0005715,P-0005715-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0005716,P-0005716-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005717,P-0005717-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005718,P-0005718-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005719,P-0005719-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005720,P-0005720-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005721,P-0005721-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005722,P-0005722-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005723,P-0005723-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0005724,P-0005724-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005725,P-0005725-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0005726,P-0005726-T02-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0005727,P-0005727-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005728,P-0005728-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0005729,P-0005729-T01-IM5,Histiocytic Dendritic Cell Sarcoma,HDCS
msk_impact_2017,P-0005730,P-0005730-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005731,P-0005731-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005732,P-0005732-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0005733,P-0005733-T02-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0005733,P-0005733-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0005734,P-0005734-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005735,P-0005735-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005736,P-0005736-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005737,P-0005737-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005738,P-0005738-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005739,P-0005739-T02-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0005740,P-0005740-T02-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005741,P-0005741-T01-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0005741,P-0005741-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005742,P-0005742-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005743,P-0005743-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005744,P-0005744-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0005745,P-0005745-T01-IM5,Serous Ovarian Cancer,SOC
msk_impact_2017,P-0005746,P-0005746-T01-IM5,Thymoma,THYM
msk_impact_2017,P-0005747,P-0005747-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005748,P-0005748-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005749,P-0005749-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0005750,P-0005750-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005751,P-0005751-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005752,P-0005752-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005753,P-0005753-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005753,P-0005753-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005754,P-0005754-T01-IM5,Yolk Sac Tumor,TYST
msk_impact_2017,P-0005755,P-0005755-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005756,P-0005756-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005757,P-0005757-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005758,P-0005758-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005759,P-0005759-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005760,P-0005760-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005761,P-0005761-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005762,P-0005762-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005763,P-0005763-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005765,P-0005765-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005766,P-0005766-T01-IM5,Mixed Ovarian Carcinoma,MXOV
msk_impact_2017,P-0005767,P-0005767-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005768,P-0005768-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005769,P-0005769-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005770,P-0005770-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005771,P-0005771-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005772,P-0005772-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0005773,P-0005773-T02-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0005774,P-0005774-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005775,P-0005775-T02-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0005776,P-0005776-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005777,P-0005777-T02-IM5,Yolk Sac Tumor,TYST
msk_impact_2017,P-0005778,P-0005778-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005779,P-0005779-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005780,P-0005780-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005781,P-0005781-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005782,P-0005782-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005783,P-0005783-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005784,P-0005784-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0005785,P-0005785-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005786,P-0005786-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005787,P-0005787-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005787,P-0005787-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005788,P-0005788-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005789,P-0005789-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0005790,P-0005790-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005791,P-0005791-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0005792,P-0005792-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005793,P-0005793-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005794,P-0005794-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005795,P-0005795-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005796,P-0005796-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0005797,P-0005797-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005799,P-0005799-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005800,P-0005800-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0005801,P-0005801-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005802,P-0005802-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005803,P-0005803-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005804,P-0005804-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005805,P-0005805-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0005806,P-0005806-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005807,P-0005807-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005808,P-0005808-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005810,P-0005810-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005811,P-0005811-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005812,P-0005812-T01-IM5,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0005813,P-0005813-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005814,P-0005814-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0005815,P-0005815-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005816,P-0005816-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005817,P-0005817-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0005818,P-0005818-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005819,P-0005819-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005820,P-0005820-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005821,P-0005821-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005822,P-0005822-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005823,P-0005823-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005824,P-0005824-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005825,P-0005825-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0005826,P-0005826-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0005827,P-0005827-T01-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0005828,P-0005828-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0005829,P-0005829-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005830,P-0005830-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0005831,P-0005831-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005832,P-0005832-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0005833,P-0005833-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005834,P-0005834-T01-IM5,Pleomorphic Xanthoastrocytoma,PXA
msk_impact_2017,P-0005835,P-0005835-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0005836,P-0005836-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005837,P-0005837-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005838,P-0005838-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0005839,P-0005839-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0005840,P-0005840-T01-IM5,Well-Differentiated Neuroendocrine Tumors of the Stomach,SWDNET
msk_impact_2017,P-0005841,P-0005841-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005842,P-0005842-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005843,P-0005843-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0005844,P-0005844-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0005845,P-0005845-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005845,P-0005845-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005846,P-0005846-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005847,P-0005847-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005848,P-0005848-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005849,P-0005849-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005850,P-0005850-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005851,P-0005851-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0005852,P-0005852-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005853,P-0005853-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005854,P-0005854-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0005855,P-0005855-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005856,P-0005856-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0005858,P-0005858-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0005859,P-0005859-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005860,P-0005860-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005862,P-0005862-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0005863,P-0005863-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005864,P-0005864-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005865,P-0005865-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005866,P-0005866-T01-IM5,Follicular Thyroid Cancer,THFO
msk_impact_2017,P-0005867,P-0005867-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005868,P-0005868-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005869,P-0005869-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0005870,P-0005870-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005871,P-0005871-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005872,P-0005872-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005873,P-0005873-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005874,P-0005874-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005875,P-0005875-T02-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0005876,P-0005876-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0005877,P-0005877-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005878,P-0005878-T01-IM5,Choriocarcinoma,BCCA
msk_impact_2017,P-0005879,P-0005879-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0005881,P-0005881-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005882,P-0005882-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0005883,P-0005883-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0005884,P-0005884-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0005884,P-0005884-T02-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0005885,P-0005885-T01-IM5,Anaplastic Ependymoma,APE
msk_impact_2017,P-0005886,P-0005886-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0005887,P-0005887-T02-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0005888,P-0005888-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005889,P-0005889-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0005890,P-0005890-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005891,P-0005891-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005893,P-0005893-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005895,P-0005895-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005896,P-0005896-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0005897,P-0005897-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005898,P-0005898-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005899,P-0005899-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0005900,P-0005900-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005901,P-0005901-T01-IM5,Renal Oncocytoma,ROCY
msk_impact_2017,P-0005901,P-0005901-T02-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0005902,P-0005902-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005903,P-0005903-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005904,P-0005904-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005905,P-0005905-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005906,P-0005906-T01-IM5,Atypical Meningioma,ATM
msk_impact_2017,P-0005907,P-0005907-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005908,P-0005908-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005909,P-0005909-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005910,P-0005910-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005911,P-0005911-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0005912,P-0005912-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005913,P-0005913-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005914,P-0005914-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005915,P-0005915-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005917,P-0005917-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0005918,P-0005918-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0005919,P-0005919-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0005920,P-0005920-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0005921,P-0005921-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005922,P-0005922-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0005923,P-0005923-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005924,P-0005924-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0005925,P-0005925-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005926,P-0005926-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005927,P-0005927-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005928,P-0005928-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005929,P-0005929-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005930,P-0005930-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005931,P-0005931-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0005932,P-0005932-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005933,P-0005933-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005934,P-0005934-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005935,P-0005935-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0005937,P-0005937-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005937,P-0005937-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005937,P-0005937-T03-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005938,P-0005938-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005939,P-0005939-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0005940,P-0005940-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005941,P-0005941-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005942,P-0005942-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005943,P-0005943-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0005944,P-0005944-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0005945,P-0005945-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0005946,P-0005946-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0005947,P-0005947-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0005948,P-0005948-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005949,P-0005949-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005950,P-0005950-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005951,P-0005951-T01-IM5,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0005952,P-0005952-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005953,P-0005953-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005953,P-0005953-T02-IM5,Prostate Small Cell Carcinoma,PRSCC
msk_impact_2017,P-0005954,P-0005954-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005956,P-0005956-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005957,P-0005957-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0005958,P-0005958-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005959,P-0005959-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005960,P-0005960-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0005961,P-0005961-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005962,P-0005962-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005963,P-0005963-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0005964,P-0005964-T01-IM5,Teratoma with Malignant Transformation,TMT
msk_impact_2017,P-0005965,P-0005965-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0005966,P-0005966-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0005967,P-0005967-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0005969,P-0005969-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0005970,P-0005970-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005970,P-0005970-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005970,P-0005970-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005971,P-0005971-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005971,P-0005971-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0005972,P-0005972-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0005973,P-0005973-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0005974,P-0005974-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005975,P-0005975-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005976,P-0005976-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0005977,P-0005977-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0005979,P-0005979-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0005980,P-0005980-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0005981,P-0005981-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005983,P-0005983-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0005984,P-0005984-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005985,P-0005985-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005986,P-0005986-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0005987,P-0005987-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005988,P-0005988-T01-IM5,Follicular Thyroid Cancer,THFO
msk_impact_2017,P-0005989,P-0005989-T01-IM5,Clear Cell Sarcoma,CCS
msk_impact_2017,P-0005990,P-0005990-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0005991,P-0005991-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005992,P-0005992-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0005993,P-0005993-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0005994,P-0005994-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0005995,P-0005995-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0005996,P-0005996-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005997,P-0005997-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0005998,P-0005998-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0005999,P-0005999-T01-IM5,Poorly Differentiated Carcinoma of the Stomach,SPDAC
msk_impact_2017,P-0006000,P-0006000-T02-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006001,P-0006001-T01-IM5,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0006002,P-0006002-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006003,P-0006003-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006004,P-0006004-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0006005,P-0006005-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0006006,P-0006006-T01-IM5,Sinonasal Undifferentiated Carcinoma,SNUC
msk_impact_2017,P-0006007,P-0006007-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0006008,P-0006008-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0006011,P-0006011-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006012,P-0006012-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006013,P-0006013-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006014,P-0006014-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0006015,P-0006015-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006016,P-0006016-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0006017,P-0006017-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0006018,P-0006018-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0006019,P-0006019-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006020,P-0006020-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006021,P-0006021-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006022,P-0006022-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006023,P-0006023-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006024,P-0006024-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0006025,P-0006025-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006026,P-0006026-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006027,P-0006027-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006028,P-0006028-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006029,P-0006029-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006030,P-0006030-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0006031,P-0006031-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0006032,P-0006032-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0006033,P-0006033-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0006034,P-0006034-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006035,P-0006035-T01-IM5,Sex Cord Stromal Tumor,SCST
msk_impact_2017,P-0006036,P-0006036-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0006037,P-0006037-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0006038,P-0006038-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006040,P-0006040-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0006042,P-0006042-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0006043,P-0006043-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006044,P-0006044-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0006045,P-0006045-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006045,P-0006045-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006046,P-0006046-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006047,P-0006047-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006048,P-0006048-T02-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006049,P-0006049-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0006050,P-0006050-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006051,P-0006051-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006052,P-0006052-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0006053,P-0006053-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0006054,P-0006054-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006055,P-0006055-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006056,P-0006056-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006057,P-0006057-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006058,P-0006058-T02-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0006059,P-0006059-T01-IM5,Follicular Dendritic Cell Sarcoma,FDCS
msk_impact_2017,P-0006060,P-0006060-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006061,P-0006061-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0006062,P-0006062-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006063,P-0006063-T01-IM5,Pleomorphic Carcinoma of the Lung,LUPC
msk_impact_2017,P-0006064,P-0006064-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0006065,P-0006065-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006066,P-0006066-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006067,P-0006067-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006068,P-0006068-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006069,P-0006069-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0006071,P-0006071-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006072,P-0006072-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006073,P-0006073-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006074,P-0006074-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006076,P-0006076-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0006077,P-0006077-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0006078,P-0006078-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006079,P-0006079-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006080,P-0006080-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0006081,P-0006081-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006082,P-0006082-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006083,P-0006083-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0006084,P-0006084-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006085,P-0006085-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006086,P-0006086-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006087,P-0006087-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0006088,P-0006088-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006089,P-0006089-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0006090,P-0006090-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006091,P-0006091-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006092,P-0006092-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0006093,P-0006093-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006094,P-0006094-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006095,P-0006095-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0006096,P-0006096-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006097,P-0006097-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006098,P-0006098-T01-IM5,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0006101,P-0006101-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0006102,P-0006102-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006103,P-0006103-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0006104,P-0006104-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006105,P-0006105-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006106,P-0006106-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006107,P-0006107-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0006108,P-0006108-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006108,P-0006108-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006108,P-0006108-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006109,P-0006109-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0006110,P-0006110-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006111,P-0006111-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0006112,P-0006112-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006112,P-0006112-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006113,P-0006113-T01-IM5,Alveolar Rhabdomyosarcoma,ARMS
msk_impact_2017,P-0006114,P-0006114-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006114,P-0006114-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006115,P-0006115-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006116,P-0006116-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006118,P-0006118-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006119,P-0006119-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006120,P-0006120-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006121,P-0006121-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0006122,P-0006122-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006123,P-0006123-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006124,P-0006124-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006125,P-0006125-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006126,P-0006126-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0006127,P-0006127-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006128,P-0006128-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006129,P-0006129-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006129,P-0006129-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006130,P-0006130-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0006131,P-0006131-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0006132,P-0006132-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0006133,P-0006133-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006134,P-0006134-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006135,P-0006135-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006136,P-0006136-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006137,P-0006137-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006138,P-0006138-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006139,P-0006139-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006140,P-0006140-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006141,P-0006141-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0006142,P-0006142-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006144,P-0006144-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0006145,P-0006145-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0006147,P-0006147-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006148,P-0006148-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006149,P-0006149-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006150,P-0006150-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006151,P-0006151-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006152,P-0006152-T01-IM5,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0006153,P-0006153-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006154,P-0006154-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0006155,P-0006155-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006156,P-0006156-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006157,P-0006157-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0006158,P-0006158-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006159,P-0006159-T01-IM5,Extraskeletal Myxoid Chondrosarcoma,EMCHS
msk_impact_2017,P-0006160,P-0006160-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0006161,P-0006161-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006161,P-0006161-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006161,P-0006161-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006162,P-0006162-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006163,P-0006163-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0006164,P-0006164-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006165,P-0006165-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006166,P-0006166-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006167,P-0006167-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0006169,P-0006169-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006170,P-0006170-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006171,P-0006171-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006172,P-0006172-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006173,P-0006173-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0006174,P-0006174-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0006175,P-0006175-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006176,P-0006176-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0006177,P-0006177-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006178,P-0006178-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006179,P-0006179-T01-IM5,Schwannoma,SCHW
msk_impact_2017,P-0006181,P-0006181-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0006182,P-0006182-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006183,P-0006183-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006184,P-0006184-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0006185,P-0006185-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006186,P-0006186-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0006187,P-0006187-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0006189,P-0006189-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006190,P-0006190-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0006191,P-0006191-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006192,P-0006192-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006193,P-0006193-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006194,P-0006194-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006195,P-0006195-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006196,P-0006196-T02-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0006197,P-0006197-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0006198,P-0006198-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006199,P-0006199-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006199,P-0006199-T03-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006199,P-0006199-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006200,P-0006200-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0006201,P-0006201-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0006202,P-0006202-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006203,P-0006203-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0006204,P-0006204-T01-IM5,Chordoma,CHDM
msk_impact_2017,P-0006205,P-0006205-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006206,P-0006206-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006207,P-0006207-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006208,P-0006208-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0006209,P-0006209-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006210,P-0006210-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006211,P-0006211-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006213,P-0006213-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006214,P-0006214-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006215,P-0006215-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006215,P-0006215-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006216,P-0006216-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0006217,P-0006217-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0006218,P-0006218-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006219,P-0006219-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006220,P-0006220-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0006221,P-0006221-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006222,P-0006222-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006223,P-0006223-T02-IM5,Non-Hodgkin Lymphoma,NHL
msk_impact_2017,P-0006225,P-0006225-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006226,P-0006226-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006226,P-0006226-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006227,P-0006227-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006228,P-0006228-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0006229,P-0006229-T01-IM5,Yolk Sac Tumor,TYST
msk_impact_2017,P-0006230,P-0006230-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006231,P-0006231-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006232,P-0006232-T01-IM5,Fibrosarcoma,FIBS
msk_impact_2017,P-0006233,P-0006233-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006234,P-0006234-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006235,P-0006235-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006236,P-0006236-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006237,P-0006237-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0006238,P-0006238-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0006239,P-0006239-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006240,P-0006240-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0006241,P-0006241-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0006242,P-0006242-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006243,P-0006243-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0006244,P-0006244-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006245,P-0006245-T02-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006246,P-0006246-T02-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0006246,P-0006246-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0006247,P-0006247-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006248,P-0006248-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006248,P-0006248-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006249,P-0006249-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006250,P-0006250-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0006251,P-0006251-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0006252,P-0006252-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006253,P-0006253-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006255,P-0006255-T01-IM5,Acute Myeloid Leukemia,AML
msk_impact_2017,P-0006256,P-0006256-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006257,P-0006257-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006258,P-0006258-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006259,P-0006259-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006260,P-0006260-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006261,P-0006261-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006262,P-0006262-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006264,P-0006264-T01-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0006265,P-0006265-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006266,P-0006266-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006267,P-0006267-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006268,P-0006268-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006269,P-0006269-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0006270,P-0006270-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0006271,P-0006271-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006272,P-0006272-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006273,P-0006273-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0006274,P-0006274-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0006275,P-0006275-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006277,P-0006277-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006278,P-0006278-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0006279,P-0006279-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006280,P-0006280-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006281,P-0006281-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006282,P-0006282-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006283,P-0006283-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006284,P-0006284-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006286,P-0006286-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006286,P-0006286-T02-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0006287,P-0006287-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006289,P-0006289-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006290,P-0006290-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006291,P-0006291-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006292,P-0006292-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006294,P-0006294-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006295,P-0006295-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006296,P-0006296-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006297,P-0006297-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0006299,P-0006299-T01-IM5,Ependymoma,EPM
msk_impact_2017,P-0006300,P-0006300-T01-IM5,Penile Squamous Cell Carcinoma,PSCC
msk_impact_2017,P-0006301,P-0006301-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0006302,P-0006302-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0006303,P-0006303-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0006304,P-0006304-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006305,P-0006305-T01-IM5,Cellular Schwannoma,CSCHW
msk_impact_2017,P-0006306,P-0006306-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006307,P-0006307-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0006308,P-0006308-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006309,P-0006309-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006310,P-0006310-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006311,P-0006311-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006311,P-0006311-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006312,P-0006312-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006312,P-0006312-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006313,P-0006313-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006314,P-0006314-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006315,P-0006315-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006316,P-0006316-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006317,P-0006317-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006318,P-0006318-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0006319,P-0006319-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006320,P-0006320-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006321,P-0006321-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006322,P-0006322-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006323,P-0006323-T01-IM5,Chordoma,CHDM
msk_impact_2017,P-0006324,P-0006324-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006325,P-0006325-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006326,P-0006326-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006327,P-0006327-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0006328,P-0006328-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006329,P-0006329-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006330,P-0006330-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006331,P-0006331-T01-IM5,Bladder Adenocarcinoma,BLAD
msk_impact_2017,P-0006332,P-0006332-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006333,P-0006333-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006334,P-0006334-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006335,P-0006335-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006336,P-0006336-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0006337,P-0006337-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006338,P-0006338-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0006339,P-0006339-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006340,P-0006340-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0006341,P-0006341-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006342,P-0006342-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006343,P-0006343-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006344,P-0006344-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0006345,P-0006345-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006346,P-0006346-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006347,P-0006347-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006348,P-0006348-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006349,P-0006349-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006350,P-0006350-T02-IM5,Immature Teratoma,BIMT
msk_impact_2017,P-0006350,P-0006350-T01-IM5,Immature Teratoma,OIMT
msk_impact_2017,P-0006351,P-0006351-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006352,P-0006352-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0006353,P-0006353-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0006354,P-0006354-T01-IM5,Retinoblastoma,RBL
msk_impact_2017,P-0006355,P-0006355-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006357,P-0006357-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006358,P-0006358-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006359,P-0006359-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006360,P-0006360-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006361,P-0006361-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006362,P-0006362-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006363,P-0006363-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006364,P-0006364-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006365,P-0006365-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006366,P-0006366-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0006367,P-0006367-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006368,P-0006368-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006369,P-0006369-T01-IM5,Perivascular Epithelioid Cell Tumor,PECOMA
msk_impact_2017,P-0006370,P-0006370-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006371,P-0006371-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006372,P-0006372-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006373,P-0006373-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006374,P-0006374-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006375,P-0006375-T01-IM5,Non-Hodgkin Lymphoma,NHL
msk_impact_2017,P-0006376,P-0006376-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006377,P-0006377-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006378,P-0006378-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006379,P-0006379-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006380,P-0006380-T01-IM5,Endometrioid Ovarian Cancer,EOV
msk_impact_2017,P-0006381,P-0006381-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006381,P-0006381-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006382,P-0006382-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0006382,P-0006382-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0006383,P-0006383-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006384,P-0006384-T01-IM5,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0006387,P-0006387-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006388,P-0006388-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006389,P-0006389-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006390,P-0006390-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006392,P-0006392-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006393,P-0006393-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006394,P-0006394-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0006395,P-0006395-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006396,P-0006396-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006397,P-0006397-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006398,P-0006398-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006399,P-0006399-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006400,P-0006400-T01-IM5,Cervical Adenosquamous Carcinoma,CEAS
msk_impact_2017,P-0006401,P-0006401-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006402,P-0006402-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006403,P-0006403-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006404,P-0006404-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0006405,P-0006405-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006406,P-0006406-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006407,P-0006407-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006408,P-0006408-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006409,P-0006409-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006410,P-0006410-T03-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006410,P-0006410-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006410,P-0006410-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006411,P-0006411-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0006412,P-0006412-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006413,P-0006413-T01-IM5,Yolk Sac Tumor,BYST
msk_impact_2017,P-0006414,P-0006414-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0006415,P-0006415-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006416,P-0006416-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006416,P-0006416-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006417,P-0006417-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006418,P-0006418-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0006419,P-0006419-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0006421,P-0006421-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006422,P-0006422-T01-IM5,Extramammary Paget Disease,EMPD
msk_impact_2017,P-0006423,P-0006423-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0006425,P-0006425-T01-IM5,Anaplastic Meningioma,ANM
msk_impact_2017,P-0006426,P-0006426-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0006427,P-0006427-T01-IM5,Embryonal Carcinoma,BEC
msk_impact_2017,P-0006428,P-0006428-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006429,P-0006429-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006430,P-0006430-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0006431,P-0006431-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0006432,P-0006432-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0006433,P-0006433-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006434,P-0006434-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006436,P-0006436-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006437,P-0006437-T01-IM5,Skin Adnexal Carcinoma,SKAC
msk_impact_2017,P-0006438,P-0006438-T01-IM5,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0006439,P-0006439-T01-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0006440,P-0006440-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006441,P-0006441-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006442,P-0006442-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006443,P-0006443-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0006444,P-0006444-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0006445,P-0006445-T01-IM5,Cervical Clear Cell Carcinoma,CECC
msk_impact_2017,P-0006446,P-0006446-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006447,P-0006447-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006448,P-0006448-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006449,P-0006449-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006450,P-0006450-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0006450,P-0006450-T02-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0006451,P-0006451-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0006452,P-0006452-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0006453,P-0006453-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0006454,P-0006454-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0006455,P-0006455-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006456,P-0006456-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0006457,P-0006457-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006458,P-0006458-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006459,P-0006459-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006460,P-0006460-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006461,P-0006461-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006462,P-0006462-T01-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0006463,P-0006463-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006464,P-0006464-T01-IM5,Rosette-forming Glioneuronal Tumor of the Fourth Ventricle,RGNT
msk_impact_2017,P-0006465,P-0006465-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0006466,P-0006466-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006467,P-0006467-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006468,P-0006468-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006469,P-0006469-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0006470,P-0006470-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0006471,P-0006471-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006472,P-0006472-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006473,P-0006473-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006474,P-0006474-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006475,P-0006475-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0006476,P-0006476-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006477,P-0006477-T01-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0006478,P-0006478-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0006479,P-0006479-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0006480,P-0006480-T01-IM5,Mammary Analogue Secretory Carcinoma of Salivary Gland Origin,HNMASC
msk_impact_2017,P-0006481,P-0006481-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0006482,P-0006482-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0006484,P-0006484-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0006485,P-0006485-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006486,P-0006486-T01-IM5,"Head and Neck Carcinoma, Other",OHNCA
msk_impact_2017,P-0006488,P-0006488-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006489,P-0006489-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006490,P-0006490-T01-IM5,Myxofibrosarcoma,MFS
msk_impact_2017,P-0006491,P-0006491-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006492,P-0006492-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0006493,P-0006493-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006494,P-0006494-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0006494,P-0006494-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0006495,P-0006495-T01-IM5,"Adenocarcinoma, NOS",ADNOS
msk_impact_2017,P-0006496,P-0006496-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0006497,P-0006497-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006498,P-0006498-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006498,P-0006498-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006498,P-0006498-T03-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006499,P-0006499-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006500,P-0006500-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006501,P-0006501-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006502,P-0006502-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006503,P-0006503-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006504,P-0006504-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006505,P-0006505-T01-IM5,Solid Pseudopapillary Neoplasm of the Pancreas,SPN
msk_impact_2017,P-0006505,P-0006505-T02-IM5,Solid Pseudopapillary Neoplasm of the Pancreas,SPN
msk_impact_2017,P-0006506,P-0006506-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0006507,P-0006507-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0006508,P-0006508-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006509,P-0006509-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006510,P-0006510-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006511,P-0006511-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006512,P-0006512-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0006514,P-0006514-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0006515,P-0006515-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006516,P-0006516-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006517,P-0006517-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006518,P-0006518-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0006519,P-0006519-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006520,P-0006520-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0006522,P-0006522-T01-IM5,Mesonephric Carcinoma,CEMN
msk_impact_2017,P-0006523,P-0006523-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006525,P-0006525-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0006526,P-0006526-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006527,P-0006527-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006528,P-0006528-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006529,P-0006529-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0006530,P-0006530-T02-IM5,Hemangioblastoma,HMBL
msk_impact_2017,P-0006531,P-0006531-T01-IM5,Endometrioid Ovarian Cancer,EOV
msk_impact_2017,P-0006532,P-0006532-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006533,P-0006533-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006535,P-0006535-T01-IM5,Sarcomatoid Carcinoma of the Urinary Bladder,SCB
msk_impact_2017,P-0006536,P-0006536-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006537,P-0006537-T01-IM5,High-Grade Neuroendocrine Carcinoma of the Ovary,HGONEC
msk_impact_2017,P-0006538,P-0006538-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006539,P-0006539-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006540,P-0006540-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006541,P-0006541-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0006541,P-0006541-T02-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0006542,P-0006542-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006543,P-0006543-T01-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0006544,P-0006544-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006544,P-0006544-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006545,P-0006545-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006546,P-0006546-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006546,P-0006546-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006547,P-0006547-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0006548,P-0006548-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0006549,P-0006549-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006550,P-0006550-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006551,P-0006551-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0006552,P-0006552-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0006553,P-0006553-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006554,P-0006554-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0006555,P-0006555-T01-IM5,Perivascular Epithelioid Cell Tumor,PECOMA
msk_impact_2017,P-0006556,P-0006556-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006557,P-0006557-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006558,P-0006558-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006559,P-0006559-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006560,P-0006560-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006561,P-0006561-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006562,P-0006562-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006563,P-0006563-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006564,P-0006564-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006565,P-0006565-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0006566,P-0006566-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006567,P-0006567-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0006568,P-0006568-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006569,P-0006569-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006570,P-0006570-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006570,P-0006570-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006571,P-0006571-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0006573,P-0006573-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006574,P-0006574-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006575,P-0006575-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006577,P-0006577-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006579,P-0006579-T01-IM5,Marginal Zone Lymphoma,MZL
msk_impact_2017,P-0006580,P-0006580-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006581,P-0006581-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006582,P-0006582-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006582,P-0006582-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006583,P-0006583-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006584,P-0006584-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006585,P-0006585-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0006586,P-0006586-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006587,P-0006587-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006588,P-0006588-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006589,P-0006589-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006590,P-0006590-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0006591,P-0006591-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006592,P-0006592-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006593,P-0006593-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006594,P-0006594-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006595,P-0006595-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006596,P-0006596-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006597,P-0006597-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006598,P-0006598-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0006599,P-0006599-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006600,P-0006600-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0006601,P-0006601-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006602,P-0006602-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006603,P-0006603-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006604,P-0006604-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006605,P-0006605-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006606,P-0006606-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006606,P-0006606-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006607,P-0006607-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006607,P-0006607-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006608,P-0006608-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006609,P-0006609-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006610,P-0006610-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006611,P-0006611-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0006612,P-0006612-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006613,P-0006613-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006614,P-0006614-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006615,P-0006615-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006616,P-0006616-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006617,P-0006617-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006618,P-0006618-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006619,P-0006619-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006620,P-0006620-T02-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006620,P-0006620-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006621,P-0006621-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006622,P-0006622-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006623,P-0006623-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006624,P-0006624-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0006625,P-0006625-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0006626,P-0006626-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006628,P-0006628-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006629,P-0006629-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0006630,P-0006630-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006631,P-0006631-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006632,P-0006632-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0006633,P-0006633-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006634,P-0006634-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0006635,P-0006635-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006636,P-0006636-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006637,P-0006637-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006638,P-0006638-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006639,P-0006639-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006640,P-0006640-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006641,P-0006641-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0006642,P-0006642-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006643,P-0006643-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0006644,P-0006644-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006645,P-0006645-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006646,P-0006646-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006647,P-0006647-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006648,P-0006648-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0006649,P-0006649-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006650,P-0006650-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006651,P-0006651-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0006652,P-0006652-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006653,P-0006653-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006654,P-0006654-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006655,P-0006655-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006656,P-0006656-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0006657,P-0006657-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006658,P-0006658-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006659,P-0006659-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006660,P-0006660-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0006661,P-0006661-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006662,P-0006662-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0006663,P-0006663-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006664,P-0006664-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006665,P-0006665-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006666,P-0006666-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006667,P-0006667-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0006668,P-0006668-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006669,P-0006669-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006670,P-0006670-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006671,P-0006671-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006672,P-0006672-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006673,P-0006673-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0006674,P-0006674-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0006675,P-0006675-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006676,P-0006676-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006678,P-0006678-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006679,P-0006679-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006680,P-0006680-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006681,P-0006681-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006682,P-0006682-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0006683,P-0006683-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006684,P-0006684-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006685,P-0006685-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006686,P-0006686-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006687,P-0006687-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006688,P-0006688-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0006689,P-0006689-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006690,P-0006690-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0006691,P-0006691-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006692,P-0006692-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006693,P-0006693-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006694,P-0006694-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0006694,P-0006694-T02-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0006695,P-0006695-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006696,P-0006696-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006697,P-0006697-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006698,P-0006698-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006699,P-0006699-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006700,P-0006700-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006701,P-0006701-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006702,P-0006702-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006703,P-0006703-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006704,P-0006704-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006705,P-0006705-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0006706,P-0006706-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006707,P-0006707-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006708,P-0006708-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006709,P-0006709-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006710,P-0006710-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0006711,P-0006711-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006712,P-0006712-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006713,P-0006713-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006713,P-0006713-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006714,P-0006714-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006715,P-0006715-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006716,P-0006716-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006717,P-0006717-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006718,P-0006718-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006719,P-0006719-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006720,P-0006720-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006721,P-0006721-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006722,P-0006722-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006723,P-0006723-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006724,P-0006724-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0006725,P-0006725-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006726,P-0006726-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006727,P-0006727-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0006728,P-0006728-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006729,P-0006729-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006730,P-0006730-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006731,P-0006731-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0006732,P-0006732-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006733,P-0006733-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0006734,P-0006734-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006735,P-0006735-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006736,P-0006736-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0006737,P-0006737-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006738,P-0006738-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006740,P-0006740-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006741,P-0006741-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006742,P-0006742-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006743,P-0006743-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006744,P-0006744-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006745,P-0006745-T01-IM5,Soft Tissue Myoepithelial Carcinoma,STMYEC
msk_impact_2017,P-0006746,P-0006746-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0006747,P-0006747-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006748,P-0006748-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006749,P-0006749-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006750,P-0006750-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006751,P-0006751-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006752,P-0006752-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006753,P-0006753-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006754,P-0006754-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0006755,P-0006755-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006756,P-0006756-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0006757,P-0006757-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006758,P-0006758-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0006759,P-0006759-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006760,P-0006760-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006761,P-0006761-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006762,P-0006762-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006763,P-0006763-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006764,P-0006764-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006765,P-0006765-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006766,P-0006766-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006767,P-0006767-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0006768,P-0006768-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006769,P-0006769-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006770,P-0006770-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006771,P-0006771-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006772,P-0006772-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006773,P-0006773-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0006775,P-0006775-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006776,P-0006776-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006777,P-0006777-T01-IM5,Basal Cell Carcinoma,BCC
msk_impact_2017,P-0006778,P-0006778-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006779,P-0006779-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006780,P-0006780-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006781,P-0006781-T01-IM5,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0006782,P-0006782-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006782,P-0006782-T02-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006783,P-0006783-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006784,P-0006784-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0006785,P-0006785-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006786,P-0006786-T02-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0006786,P-0006786-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006787,P-0006787-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006788,P-0006788-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006789,P-0006789-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006790,P-0006790-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006791,P-0006791-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0006792,P-0006792-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0006793,P-0006793-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006794,P-0006794-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006795,P-0006795-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006796,P-0006796-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006797,P-0006797-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0006798,P-0006798-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006799,P-0006799-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006800,P-0006800-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006801,P-0006801-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0006802,P-0006802-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0006804,P-0006804-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0006805,P-0006805-T02-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0006805,P-0006805-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0006806,P-0006806-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006807,P-0006807-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006808,P-0006808-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006809,P-0006809-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006810,P-0006810-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006811,P-0006811-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006812,P-0006812-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0006813,P-0006813-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006814,P-0006814-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006815,P-0006815-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006816,P-0006816-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006817,P-0006817-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0006818,P-0006818-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006819,P-0006819-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006821,P-0006821-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006822,P-0006822-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006823,P-0006823-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006824,P-0006824-T01-IM5,Histiocytic and Dendritic Cell Neoplasms,HDCN
msk_impact_2017,P-0006825,P-0006825-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006826,P-0006826-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0006827,P-0006827-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006828,P-0006828-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006829,P-0006829-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0006830,P-0006830-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0006831,P-0006831-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006833,P-0006833-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0006834,P-0006834-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0006835,P-0006835-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006836,P-0006836-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0006837,P-0006837-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006837,P-0006837-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006838,P-0006838-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0006839,P-0006839-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006840,P-0006840-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006841,P-0006841-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0006842,P-0006842-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006843,P-0006843-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006844,P-0006844-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006844,P-0006844-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006845,P-0006845-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006846,P-0006846-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006847,P-0006847-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006848,P-0006848-T01-IM5,Gliosarcoma,GSARC
msk_impact_2017,P-0006849,P-0006849-T01-IM5,Uterine Undifferentiated Carcinoma,UUC
msk_impact_2017,P-0006850,P-0006850-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0006851,P-0006851-T01-IM5,Embryonal Rhabdomyosarcoma,ERMS
msk_impact_2017,P-0006852,P-0006852-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006853,P-0006853-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006854,P-0006854-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006855,P-0006855-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006856,P-0006856-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006857,P-0006857-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0006858,P-0006858-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0006859,P-0006859-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006860,P-0006860-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0006861,P-0006861-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006862,P-0006862-T02-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0006863,P-0006863-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0006864,P-0006864-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006865,P-0006865-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0006866,P-0006866-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006867,P-0006867-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0006868,P-0006868-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0006869,P-0006869-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006870,P-0006870-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006871,P-0006871-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0006872,P-0006872-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006873,P-0006873-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006874,P-0006874-T01-IM5,"Adenocarcinoma, NOS",ADNOS
msk_impact_2017,P-0006875,P-0006875-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006876,P-0006876-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006877,P-0006877-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006878,P-0006878-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006879,P-0006879-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006880,P-0006880-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006881,P-0006881-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006882,P-0006882-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0006883,P-0006883-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006884,P-0006884-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0006885,P-0006885-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0006886,P-0006886-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006887,P-0006887-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006888,P-0006888-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006889,P-0006889-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006890,P-0006890-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006891,P-0006891-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0006892,P-0006892-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0006893,P-0006893-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0006894,P-0006894-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006895,P-0006895-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006896,P-0006896-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006897,P-0006897-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0006898,P-0006898-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0006899,P-0006899-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0006901,P-0006901-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006902,P-0006902-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006903,P-0006903-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0006904,P-0006904-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006905,P-0006905-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006906,P-0006906-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006907,P-0006907-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006908,P-0006908-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006909,P-0006909-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006910,P-0006910-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006911,P-0006911-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006911,P-0006911-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0006912,P-0006912-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006913,P-0006913-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006914,P-0006914-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0006915,P-0006915-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006916,P-0006916-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006917,P-0006917-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0006918,P-0006918-T01-IM5,Renal Medullary Carcinoma,MRC
msk_impact_2017,P-0006919,P-0006919-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0006920,P-0006920-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006921,P-0006921-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006922,P-0006922-T02-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006923,P-0006923-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006924,P-0006924-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006925,P-0006925-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0006926,P-0006926-T02-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006926,P-0006926-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006927,P-0006927-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006928,P-0006928-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006929,P-0006929-T01-IM5,Marginal Zone Lymphoma,MZL
msk_impact_2017,P-0006930,P-0006930-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006931,P-0006931-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006932,P-0006932-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006933,P-0006933-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006934,P-0006934-T01-IM5,Urethral Urothelial Carcinoma,UCU
msk_impact_2017,P-0006935,P-0006935-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006936,P-0006936-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006937,P-0006937-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0006938,P-0006938-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006939,P-0006939-T01-IM5,Adenoid Cystic Breast Cancer,ACBC
msk_impact_2017,P-0006940,P-0006940-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006941,P-0006941-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006942,P-0006942-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006945,P-0006945-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0006946,P-0006946-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0006947,P-0006947-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0006948,P-0006948-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006949,P-0006949-T01-IM5,Intestinal Type Mucinous Carcinoma,ICEMU
msk_impact_2017,P-0006950,P-0006950-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006952,P-0006952-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006953,P-0006953-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0006954,P-0006954-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006958,P-0006958-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0006959,P-0006959-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0006960,P-0006960-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006961,P-0006961-T01-IM5,Myofibroma,MF
msk_impact_2017,P-0006962,P-0006962-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006963,P-0006963-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006964,P-0006964-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006965,P-0006965-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006966,P-0006966-T01-IM5,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0006967,P-0006967-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006968,P-0006968-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0006969,P-0006969-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006970,P-0006970-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006970,P-0006970-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0006971,P-0006971-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0006972,P-0006972-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0006973,P-0006973-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0006974,P-0006974-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0006975,P-0006975-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0006976,P-0006976-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0006977,P-0006977-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0006978,P-0006978-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006979,P-0006979-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006980,P-0006980-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0006981,P-0006981-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006982,P-0006982-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0006983,P-0006983-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0006984,P-0006984-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0006985,P-0006985-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0006986,P-0006986-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0006988,P-0006988-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0006989,P-0006989-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0006990,P-0006990-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006991,P-0006991-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0006992,P-0006992-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006993,P-0006993-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006994,P-0006994-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006995,P-0006995-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0006996,P-0006996-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0006997,P-0006997-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0006999,P-0006999-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007000,P-0007000-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007001,P-0007001-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0007002,P-0007002-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007003,P-0007003-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0007004,P-0007004-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007005,P-0007005-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007006,P-0007006-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007007,P-0007007-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0007009,P-0007009-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007009,P-0007009-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007010,P-0007010-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007010,P-0007010-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007011,P-0007011-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0007012,P-0007012-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007013,P-0007013-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0007014,P-0007014-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007015,P-0007015-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007016,P-0007016-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007017,P-0007017-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007018,P-0007018-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007020,P-0007020-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0007021,P-0007021-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007022,P-0007022-T01-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0007023,P-0007023-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0007024,P-0007024-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0007025,P-0007025-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007026,P-0007026-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007027,P-0007027-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007028,P-0007028-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007029,P-0007029-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007030,P-0007030-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0007031,P-0007031-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007032,P-0007032-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007033,P-0007033-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0007034,P-0007034-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0007035,P-0007035-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007036,P-0007036-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007036,P-0007036-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007037,P-0007037-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007039,P-0007039-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007040,P-0007040-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007041,P-0007041-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007042,P-0007042-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007043,P-0007043-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007044,P-0007044-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007045,P-0007045-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007046,P-0007046-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0007047,P-0007047-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007048,P-0007048-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007049,P-0007049-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0007050,P-0007050-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007051,P-0007051-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007052,P-0007052-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0007053,P-0007053-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0007054,P-0007054-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007055,P-0007055-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007056,P-0007056-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0007057,P-0007057-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007058,P-0007058-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0007059,P-0007059-T01-IM5,Uterine Perivascular Epithelioid Cell Tumor,UPECOMA
msk_impact_2017,P-0007060,P-0007060-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007061,P-0007061-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0007062,P-0007062-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007063,P-0007063-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007064,P-0007064-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0007065,P-0007065-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007066,P-0007066-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007067,P-0007067-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007068,P-0007068-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0007069,P-0007069-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007070,P-0007070-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007071,P-0007071-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0007072,P-0007072-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007073,P-0007073-T01-IM5,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0007074,P-0007074-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007075,P-0007075-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007076,P-0007076-T03-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0007076,P-0007076-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0007078,P-0007078-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007079,P-0007079-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007080,P-0007080-T02-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007081,P-0007081-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007082,P-0007082-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007084,P-0007084-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007085,P-0007085-T02-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007086,P-0007086-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007087,P-0007087-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007088,P-0007088-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007089,P-0007089-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007090,P-0007090-T02-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007091,P-0007091-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0007092,P-0007092-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007093,P-0007093-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007094,P-0007094-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0007095,P-0007095-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0007096,P-0007096-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007097,P-0007097-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007098,P-0007098-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007099,P-0007099-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007100,P-0007100-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007101,P-0007101-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007102,P-0007102-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007103,P-0007103-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0007104,P-0007104-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007105,P-0007105-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0007106,P-0007106-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0007107,P-0007107-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007108,P-0007108-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007109,P-0007109-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007110,P-0007110-T01-IM5,Yolk Sac Tumor,VYST
msk_impact_2017,P-0007111,P-0007111-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0007112,P-0007112-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007113,P-0007113-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007114,P-0007114-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007115,P-0007115-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007116,P-0007116-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0007117,P-0007117-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0007118,P-0007118-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0007119,P-0007119-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007120,P-0007120-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007120,P-0007120-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007121,P-0007121-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007123,P-0007123-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007124,P-0007124-T01-IM5,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0007125,P-0007125-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007126,P-0007126-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007127,P-0007127-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007128,P-0007128-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007129,P-0007129-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007129,P-0007129-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007130,P-0007130-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0007131,P-0007131-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007131,P-0007131-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007132,P-0007132-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007133,P-0007133-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007134,P-0007134-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0007135,P-0007135-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007136,P-0007136-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007137,P-0007137-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007138,P-0007138-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0007139,P-0007139-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007140,P-0007140-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007141,P-0007141-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007142,P-0007142-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007143,P-0007143-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007144,P-0007144-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007145,P-0007145-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007146,P-0007146-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007147,P-0007147-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007148,P-0007148-T01-IM5,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0007149,P-0007149-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007150,P-0007150-T01-IM5,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0007151,P-0007151-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0007152,P-0007152-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0007153,P-0007153-T01-IM5,Hodgkin Lymphoma,HL
msk_impact_2017,P-0007154,P-0007154-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007155,P-0007155-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0007156,P-0007156-T02-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0007157,P-0007157-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0007158,P-0007158-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0007159,P-0007159-T01-IM5,Intestinal Type Stomach Adenocarcinoma,ISTAD
msk_impact_2017,P-0007160,P-0007160-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0007161,P-0007161-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007162,P-0007162-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007163,P-0007163-T01-IM5,Poorly Differentiated Carcinoma of the Stomach,SPDAC
msk_impact_2017,P-0007164,P-0007164-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0007165,P-0007165-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007166,P-0007166-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0007167,P-0007167-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007168,P-0007168-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007169,P-0007169-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007170,P-0007170-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007171,P-0007171-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0007172,P-0007172-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0007173,P-0007173-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0007174,P-0007174-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007175,P-0007175-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007176,P-0007176-T01-IM5,Myxofibrosarcoma,MFS
msk_impact_2017,P-0007177,P-0007177-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007178,P-0007178-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0007179,P-0007179-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007179,P-0007179-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007180,P-0007180-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007181,P-0007181-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007182,P-0007182-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007183,P-0007183-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0007184,P-0007184-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007185,P-0007185-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007186,P-0007186-T01-IM5,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,CLLSLL
msk_impact_2017,P-0007202,P-0007202-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007203,P-0007203-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007204,P-0007204-T01-IM5,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0007205,P-0007205-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007206,P-0007206-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0007207,P-0007207-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007208,P-0007208-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0007209,P-0007209-T01-IM5,Alveolar Rhabdomyosarcoma,ARMS
msk_impact_2017,P-0007210,P-0007210-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007211,P-0007211-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007213,P-0007213-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007214,P-0007214-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007215,P-0007215-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007216,P-0007216-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007217,P-0007217-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0007218,P-0007218-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007219,P-0007219-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007220,P-0007220-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007221,P-0007221-T01-IM5,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0007222,P-0007222-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007223,P-0007223-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0007224,P-0007224-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007225,P-0007225-T01-IM5,Small Cell Carcinoma of Unknown Primary,SCUP
msk_impact_2017,P-0007226,P-0007226-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007227,P-0007227-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0007227,P-0007227-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0007228,P-0007228-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0007229,P-0007229-T01-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0007230,P-0007230-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007231,P-0007231-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007233,P-0007233-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0007234,P-0007234-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007235,P-0007235-T01-IM5,Mucosal Melanoma of the Esophagus,ESMM
msk_impact_2017,P-0007236,P-0007236-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007237,P-0007237-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0007238,P-0007238-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007239,P-0007239-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007240,P-0007240-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007241,P-0007241-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007266,P-0007266-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007267,P-0007267-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007268,P-0007268-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007268,P-0007268-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007269,P-0007269-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0007270,P-0007270-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007271,P-0007271-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0007272,P-0007272-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007273,P-0007273-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007274,P-0007274-T01-IM5,Urethral Adenocarcinoma,UAD
msk_impact_2017,P-0007275,P-0007275-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0007276,P-0007276-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007277,P-0007277-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0007278,P-0007278-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007279,P-0007279-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007280,P-0007280-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0007281,P-0007281-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007282,P-0007282-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007283,P-0007283-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0007284,P-0007284-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007285,P-0007285-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007286,P-0007286-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007286,P-0007286-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007287,P-0007287-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007288,P-0007288-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007289,P-0007289-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007290,P-0007290-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0007291,P-0007291-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0007293,P-0007293-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0007294,P-0007294-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007295,P-0007295-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0007296,P-0007296-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007297,P-0007297-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0007298,P-0007298-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0007299,P-0007299-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007299,P-0007299-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007300,P-0007300-T01-IM5,Mucinous Cystic Neoplasm,MCN
msk_impact_2017,P-0007301,P-0007301-T01-IM5,Dedifferentiated Chondrosarcoma,DDCHS
msk_impact_2017,P-0007302,P-0007302-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007303,P-0007303-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007304,P-0007304-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007305,P-0007305-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007306,P-0007306-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007307,P-0007307-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007307,P-0007307-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007308,P-0007308-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0007309,P-0007309-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007310,P-0007310-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007311,P-0007311-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0007312,P-0007312-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007313,P-0007313-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007314,P-0007314-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007315,P-0007315-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007316,P-0007316-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0007317,P-0007317-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007318,P-0007318-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0007319,P-0007319-T01-IM5,Basaloid Penile Squamous Cell Carcinoma,BPSCC
msk_impact_2017,P-0007320,P-0007320-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007321,P-0007321-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0007322,P-0007322-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007323,P-0007323-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0007324,P-0007324-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0007325,P-0007325-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0007327,P-0007327-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007328,P-0007328-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007330,P-0007330-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007331,P-0007331-T01-IM5,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,PMBL
msk_impact_2017,P-0007332,P-0007332-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007333,P-0007333-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007334,P-0007334-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007335,P-0007335-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007335,P-0007335-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007336,P-0007336-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007337,P-0007337-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007338,P-0007338-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007339,P-0007339-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0007340,P-0007340-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007341,P-0007341-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007342,P-0007342-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007343,P-0007343-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007344,P-0007344-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007345,P-0007345-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007346,P-0007346-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007347,P-0007347-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007348,P-0007348-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0007349,P-0007349-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007350,P-0007350-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007351,P-0007351-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007352,P-0007352-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0007353,P-0007353-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0007354,P-0007354-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007355,P-0007355-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0007356,P-0007356-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007357,P-0007357-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007358,P-0007358-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007359,P-0007359-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007360,P-0007360-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0007361,P-0007361-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007362,P-0007362-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007363,P-0007363-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007364,P-0007364-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007365,P-0007365-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007366,P-0007366-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007368,P-0007368-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007369,P-0007369-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0007370,P-0007370-T01-IM5,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0007371,P-0007371-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0007372,P-0007372-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0007373,P-0007373-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007374,P-0007374-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007375,P-0007375-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0007376,P-0007376-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007377,P-0007377-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007379,P-0007379-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0007380,P-0007380-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007381,P-0007381-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007382,P-0007382-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0007383,P-0007383-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0007384,P-0007384-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007385,P-0007385-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0007386,P-0007386-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0007387,P-0007387-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007388,P-0007388-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007389,P-0007389-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007390,P-0007390-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0007391,P-0007391-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007392,P-0007392-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0007393,P-0007393-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007394,P-0007394-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0007395,P-0007395-T01-IM5,Ependymoma,EPM
msk_impact_2017,P-0007396,P-0007396-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007397,P-0007397-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0007398,P-0007398-T02-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0007398,P-0007398-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0007399,P-0007399-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007400,P-0007400-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0007401,P-0007401-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0007402,P-0007402-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007403,P-0007403-T01-IM5,Basaloid Large Cell Carcinoma of the Lung,BLCLC
msk_impact_2017,P-0007404,P-0007404-T01-IM5,"Craniopharyngioma, Adamantinomatous Type",ACPG
msk_impact_2017,P-0007405,P-0007405-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007406,P-0007406-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007407,P-0007407-T01-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0007408,P-0007408-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007409,P-0007409-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0007410,P-0007410-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007411,P-0007411-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007412,P-0007412-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0007413,P-0007413-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007414,P-0007414-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007415,P-0007415-T01-IM5,Anaplastic Ependymoma,APE
msk_impact_2017,P-0007416,P-0007416-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007416,P-0007416-T02-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0007417,P-0007417-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0007418,P-0007418-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007419,P-0007419-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007420,P-0007420-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007421,P-0007421-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0007422,P-0007422-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007423,P-0007423-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007424,P-0007424-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007424,P-0007424-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007425,P-0007425-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0007426,P-0007426-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0007427,P-0007427-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0007428,P-0007428-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007483,P-0007483-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007484,P-0007484-T01-IM5,Urethral Adenocarcinoma,UAD
msk_impact_2017,P-0007485,P-0007485-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0007486,P-0007486-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007487,P-0007487-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007488,P-0007488-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007489,P-0007489-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007490,P-0007490-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007491,P-0007491-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007492,P-0007492-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007493,P-0007493-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007494,P-0007494-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007495,P-0007495-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0007496,P-0007496-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007497,P-0007497-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007498,P-0007498-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0007499,P-0007499-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007500,P-0007500-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007501,P-0007501-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007502,P-0007502-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007503,P-0007503-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007504,P-0007504-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007505,P-0007505-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0007506,P-0007506-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0007507,P-0007507-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007508,P-0007508-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007509,P-0007509-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007510,P-0007510-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0007511,P-0007511-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007512,P-0007512-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007513,P-0007513-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007513,P-0007513-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007513,P-0007513-T03-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007514,P-0007514-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0007515,P-0007515-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007516,P-0007516-T01-IM5,Uterine Adenosarcoma,UAS
msk_impact_2017,P-0007517,P-0007517-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007518,P-0007518-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007519,P-0007519-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007520,P-0007520-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007521,P-0007521-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007522,P-0007522-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0007523,P-0007523-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0007524,P-0007524-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0007525,P-0007525-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007526,P-0007526-T02-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0007527,P-0007527-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0007528,P-0007528-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0007529,P-0007529-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007530,P-0007530-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0007531,P-0007531-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0007531,P-0007531-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0007532,P-0007532-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007533,P-0007533-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007534,P-0007534-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007535,P-0007535-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0007536,P-0007536-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0007538,P-0007538-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007539,P-0007539-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007540,P-0007540-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007541,P-0007541-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007542,P-0007542-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007543,P-0007543-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0007544,P-0007544-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007545,P-0007545-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007546,P-0007546-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007547,P-0007547-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007548,P-0007548-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007549,P-0007549-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007550,P-0007550-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007551,P-0007551-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007552,P-0007552-T01-IM5,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0007554,P-0007554-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007555,P-0007555-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007556,P-0007556-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007557,P-0007557-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007558,P-0007558-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007559,P-0007559-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007560,P-0007560-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007561,P-0007561-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007562,P-0007562-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0007563,P-0007563-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007564,P-0007564-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007565,P-0007565-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007566,P-0007566-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007567,P-0007567-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007568,P-0007568-T01-IM5,Anaplastic Large Cell Lymphoma,ALCL
msk_impact_2017,P-0007570,P-0007570-T02-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0007571,P-0007571-T01-IM5,Endometrioid Ovarian Cancer,EOV
msk_impact_2017,P-0007572,P-0007572-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0007573,P-0007573-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007574,P-0007574-T01-IM5,"Squamous Cell Carcinoma, NOS",SCCNOS
msk_impact_2017,P-0007575,P-0007575-T01-IM5,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0007576,P-0007576-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007577,P-0007577-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007578,P-0007578-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0007579,P-0007579-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007580,P-0007580-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007581,P-0007581-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007582,P-0007582-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007583,P-0007583-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007584,P-0007584-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007585,P-0007585-T01-IM5,Chordoma,CHDM
msk_impact_2017,P-0007586,P-0007586-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007587,P-0007587-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007588,P-0007588-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007589,P-0007589-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0007590,P-0007590-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007591,P-0007591-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007592,P-0007592-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007593,P-0007593-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007594,P-0007594-T01-IM5,Sweat Gland Carcinoma/Apocrine Eccrine Carcinoma,AECA
msk_impact_2017,P-0007595,P-0007595-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0007596,P-0007596-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007597,P-0007597-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007598,P-0007598-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0007599,P-0007599-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007600,P-0007600-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007601,P-0007601-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0007602,P-0007602-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007604,P-0007604-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007605,P-0007605-T01-IM5,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0007606,P-0007606-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007607,P-0007607-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007608,P-0007608-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0007619,P-0007619-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007620,P-0007620-T02-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0007620,P-0007620-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0007622,P-0007622-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0007623,P-0007623-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007624,P-0007624-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007625,P-0007625-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007626,P-0007626-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0007627,P-0007627-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007628,P-0007628-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0007629,P-0007629-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007630,P-0007630-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0007631,P-0007631-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007632,P-0007632-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007633,P-0007633-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007634,P-0007634-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007635,P-0007635-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007637,P-0007637-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0007638,P-0007638-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007639,P-0007639-T02-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0007640,P-0007640-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007641,P-0007641-T01-IM5,Sclerosing Epithelioid Fibrosarcoma,SEF
msk_impact_2017,P-0007642,P-0007642-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0007643,P-0007643-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007644,P-0007644-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007645,P-0007645-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007646,P-0007646-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007647,P-0007647-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007647,P-0007647-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007647,P-0007647-T03-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0007648,P-0007648-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0007649,P-0007649-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0007650,P-0007650-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0007651,P-0007651-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0007652,P-0007652-T01-IM5,Renal Oncocytoma,ROCY
msk_impact_2017,P-0007653,P-0007653-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0007654,P-0007654-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007655,P-0007655-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007656,P-0007656-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007657,P-0007657-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007658,P-0007658-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007660,P-0007660-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0007661,P-0007661-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007662,P-0007662-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0007663,P-0007663-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007664,P-0007664-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007665,P-0007665-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007666,P-0007666-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0007667,P-0007667-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0007668,P-0007668-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0007669,P-0007669-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007670,P-0007670-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007671,P-0007671-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007672,P-0007672-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0007673,P-0007673-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0007675,P-0007675-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0007676,P-0007676-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007677,P-0007677-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0007678,P-0007678-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007679,P-0007679-T01-IM5,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0007680,P-0007680-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0007681,P-0007681-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007682,P-0007682-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007683,P-0007683-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007684,P-0007684-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007685,P-0007685-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0007685,P-0007685-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007686,P-0007686-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007688,P-0007688-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007689,P-0007689-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0007690,P-0007690-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0007691,P-0007691-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007692,P-0007692-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0007693,P-0007693-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007694,P-0007694-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0007695,P-0007695-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0007696,P-0007696-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0007697,P-0007697-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007698,P-0007698-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007699,P-0007699-T02-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007699,P-0007699-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007700,P-0007700-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007701,P-0007701-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007702,P-0007702-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007703,P-0007703-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0007705,P-0007705-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007734,P-0007734-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007735,P-0007735-T01-IM5,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0007736,P-0007736-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007737,P-0007737-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0007738,P-0007738-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0007739,P-0007739-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007740,P-0007740-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007741,P-0007741-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0007742,P-0007742-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0007744,P-0007744-T01-IM5,Anaplastic Pleomorphic Xanthoastrocytoma,APXA
msk_impact_2017,P-0007745,P-0007745-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007746,P-0007746-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0007747,P-0007747-T01-IM5,Diffuse Intrinsic Pontine Glioma,DIPG
msk_impact_2017,P-0007748,P-0007748-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0007749,P-0007749-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007750,P-0007750-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007751,P-0007751-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007752,P-0007752-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007753,P-0007753-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007754,P-0007754-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007755,P-0007755-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007756,P-0007756-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007758,P-0007758-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007759,P-0007759-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007770,P-0007770-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007771,P-0007771-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007772,P-0007772-T01-IM5,Mammary Analogue Secretory Carcinoma of Salivary Gland Origin,HNMASC
msk_impact_2017,P-0007772,P-0007772-T02-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0007772,P-0007772-T03-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0007773,P-0007773-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0007774,P-0007774-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007775,P-0007775-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007776,P-0007776-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007777,P-0007777-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007778,P-0007778-T01-IM5,Embryonal Carcinoma,BEC
msk_impact_2017,P-0007779,P-0007779-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007780,P-0007780-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007781,P-0007781-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007782,P-0007782-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0007783,P-0007783-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0007784,P-0007784-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0007785,P-0007785-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0007786,P-0007786-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007787,P-0007787-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0007788,P-0007788-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007788,P-0007788-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007790,P-0007790-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0007791,P-0007791-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007792,P-0007792-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0007793,P-0007793-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007794,P-0007794-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007804,P-0007804-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007805,P-0007805-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007806,P-0007806-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007807,P-0007807-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0007808,P-0007808-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007809,P-0007809-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007810,P-0007810-T02-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0007811,P-0007811-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007813,P-0007813-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007814,P-0007814-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0007815,P-0007815-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0007816,P-0007816-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007821,P-0007821-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007831,P-0007831-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007832,P-0007832-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0007833,P-0007833-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007834,P-0007834-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007835,P-0007835-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007836,P-0007836-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007837,P-0007837-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007838,P-0007838-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007839,P-0007839-T02-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0007839,P-0007839-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0007841,P-0007841-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007842,P-0007842-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0007843,P-0007843-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007844,P-0007844-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007845,P-0007845-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0007846,P-0007846-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007847,P-0007847-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007848,P-0007848-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007849,P-0007849-T02-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007849,P-0007849-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007850,P-0007850-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0007851,P-0007851-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0007852,P-0007852-T02-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0007852,P-0007852-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0007853,P-0007853-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007854,P-0007854-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007855,P-0007855-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0007856,P-0007856-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007857,P-0007857-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0007858,P-0007858-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007859,P-0007859-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007860,P-0007860-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007861,P-0007861-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007862,P-0007862-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0007863,P-0007863-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007864,P-0007864-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007865,P-0007865-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007866,P-0007866-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007868,P-0007868-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007869,P-0007869-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0007870,P-0007870-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007871,P-0007871-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0007872,P-0007872-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0007873,P-0007873-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0007874,P-0007874-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007875,P-0007875-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007876,P-0007876-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007877,P-0007877-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007879,P-0007879-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007880,P-0007880-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007881,P-0007881-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007882,P-0007882-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007883,P-0007883-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0007884,P-0007884-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0007885,P-0007885-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007886,P-0007886-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0007887,P-0007887-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007888,P-0007888-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007889,P-0007889-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007890,P-0007890-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007891,P-0007891-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0007893,P-0007893-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007894,P-0007894-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0007895,P-0007895-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0007896,P-0007896-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007897,P-0007897-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0007898,P-0007898-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007899,P-0007899-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0007900,P-0007900-T01-IM5,Prostate Neuroendocrine Carcinoma,PRNE
msk_impact_2017,P-0007901,P-0007901-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007902,P-0007902-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007903,P-0007903-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0007904,P-0007904-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007905,P-0007905-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0007906,P-0007906-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007907,P-0007907-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0007908,P-0007908-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0007909,P-0007909-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007910,P-0007910-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007911,P-0007911-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007911,P-0007911-T02-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0007912,P-0007912-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007913,P-0007913-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0007914,P-0007914-T01-IM5,Diffuse Intrinsic Pontine Glioma,DIPG
msk_impact_2017,P-0007915,P-0007915-T01-IM5,Myxopapillary Ependymoma,MPE
msk_impact_2017,P-0007916,P-0007916-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007917,P-0007917-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007917,P-0007917-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007918,P-0007918-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007919,P-0007919-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007920,P-0007920-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0007921,P-0007921-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0007922,P-0007922-T01-IM5,Cervical Adenosquamous Carcinoma,CEAS
msk_impact_2017,P-0007923,P-0007923-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007924,P-0007924-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0007925,P-0007925-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007926,P-0007926-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007927,P-0007927-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0007929,P-0007929-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007930,P-0007930-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007930,P-0007930-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007931,P-0007931-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007932,P-0007932-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0007961,P-0007961-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007965,P-0007965-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007966,P-0007966-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007967,P-0007967-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007968,P-0007968-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0007969,P-0007969-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0007970,P-0007970-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007971,P-0007971-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007971,P-0007971-T02-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007972,P-0007972-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0007973,P-0007973-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0007974,P-0007974-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0007975,P-0007975-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0007976,P-0007976-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007977,P-0007977-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0007978,P-0007978-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0007979,P-0007979-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0007980,P-0007980-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007981,P-0007981-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0007981,P-0007981-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0007982,P-0007982-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007983,P-0007983-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0007984,P-0007984-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007985,P-0007985-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0007986,P-0007986-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0007987,P-0007987-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0007988,P-0007988-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0007989,P-0007989-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007990,P-0007990-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007991,P-0007991-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0007992,P-0007992-T01-IM5,Teratoma with Malignant Transformation,TMT
msk_impact_2017,P-0007993,P-0007993-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0007994,P-0007994-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0007995,P-0007995-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0007995,P-0007995-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0007996,P-0007996-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007997,P-0007997-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007998,P-0007998-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007998,P-0007998-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0007999,P-0007999-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008000,P-0008000-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0008001,P-0008001-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0008002,P-0008002-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008003,P-0008003-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008004,P-0008004-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0008005,P-0008005-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008006,P-0008006-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008007,P-0008007-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008008,P-0008008-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008008,P-0008008-T02-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008009,P-0008009-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008010,P-0008010-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008011,P-0008011-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0008012,P-0008012-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0008013,P-0008013-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008014,P-0008014-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008015,P-0008015-T01-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0008016,P-0008016-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0008017,P-0008017-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008018,P-0008018-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0008019,P-0008019-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008020,P-0008020-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0008022,P-0008022-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008023,P-0008023-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008025,P-0008025-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0008026,P-0008026-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0008027,P-0008027-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008028,P-0008028-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008029,P-0008029-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008030,P-0008030-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0008031,P-0008031-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008032,P-0008032-T01-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0008033,P-0008033-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0008034,P-0008034-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0008035,P-0008035-T01-IM5,"Low-Grade Glioma, NOS",LGGNOS
msk_impact_2017,P-0008036,P-0008036-T01-IM5,Hypopharynx Squamous Cell Carcinoma,HPHSC
msk_impact_2017,P-0008037,P-0008037-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0008038,P-0008038-T01-IM5,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0008039,P-0008039-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008040,P-0008040-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0008041,P-0008041-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008042,P-0008042-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008043,P-0008043-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0008044,P-0008044-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008045,P-0008045-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0008046,P-0008046-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008047,P-0008047-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008048,P-0008048-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008049,P-0008049-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008050,P-0008050-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008051,P-0008051-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0008052,P-0008052-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0008053,P-0008053-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008054,P-0008054-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008055,P-0008055-T02-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0008055,P-0008055-T01-IM5,Histiocytic and Dendritic Cell Neoplasms,HDCN
msk_impact_2017,P-0008056,P-0008056-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008057,P-0008057-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008058,P-0008058-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008059,P-0008059-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008060,P-0008060-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0008061,P-0008061-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008062,P-0008062-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008063,P-0008063-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008064,P-0008064-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0008065,P-0008065-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008066,P-0008066-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0008067,P-0008067-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008068,P-0008068-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008069,P-0008069-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008069,P-0008069-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008071,P-0008071-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008072,P-0008072-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0008073,P-0008073-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0008074,P-0008074-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008075,P-0008075-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008077,P-0008077-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008077,P-0008077-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008078,P-0008078-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008079,P-0008079-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008080,P-0008080-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008081,P-0008081-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0008082,P-0008082-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008083,P-0008083-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008084,P-0008084-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008084,P-0008084-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008085,P-0008085-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0008094,P-0008094-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008095,P-0008095-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008097,P-0008097-T01-IM5,Hypopharynx Squamous Cell Carcinoma,HPHSC
msk_impact_2017,P-0008098,P-0008098-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008099,P-0008099-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008100,P-0008100-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008101,P-0008101-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008102,P-0008102-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0008103,P-0008103-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0008104,P-0008104-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008105,P-0008105-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0008106,P-0008106-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0008123,P-0008123-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0008124,P-0008124-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008125,P-0008125-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0008126,P-0008126-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008127,P-0008127-T02-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0008127,P-0008127-T01-IM5,"Pleural Mesothelioma, Biphasic Type",PLBMESO
msk_impact_2017,P-0008128,P-0008128-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008129,P-0008129-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0008130,P-0008130-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0008131,P-0008131-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008132,P-0008132-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008133,P-0008133-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008134,P-0008134-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008135,P-0008135-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0008136,P-0008136-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008137,P-0008137-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008138,P-0008138-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0008139,P-0008139-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008139,P-0008139-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008140,P-0008140-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0008141,P-0008141-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008142,P-0008142-T02-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0008143,P-0008143-T01-IM5,Mucinous Carcinoma,CEMU
msk_impact_2017,P-0008144,P-0008144-T01-IM5,Marginal Zone Lymphoma,MZL
msk_impact_2017,P-0008145,P-0008145-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0008145,P-0008145-T02-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0008146,P-0008146-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0008147,P-0008147-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008148,P-0008148-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0008149,P-0008149-T01-IM5,Small Cell Bladder Cancer,SCBC
msk_impact_2017,P-0008150,P-0008150-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0008151,P-0008151-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0008152,P-0008152-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008153,P-0008153-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0008154,P-0008154-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008155,P-0008155-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008156,P-0008156-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0008157,P-0008157-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008158,P-0008158-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008159,P-0008159-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008160,P-0008160-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008160,P-0008160-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008161,P-0008161-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008161,P-0008161-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008162,P-0008162-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0008163,P-0008163-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0008164,P-0008164-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008165,P-0008165-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008166,P-0008166-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008167,P-0008167-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008167,P-0008167-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008168,P-0008168-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0008169,P-0008169-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0008171,P-0008171-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0008172,P-0008172-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008173,P-0008173-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008174,P-0008174-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0008175,P-0008175-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008176,P-0008176-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008177,P-0008177-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0008178,P-0008178-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008179,P-0008179-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008180,P-0008180-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008181,P-0008181-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008182,P-0008182-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0008184,P-0008184-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0008185,P-0008185-T01-IM5,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0008186,P-0008186-T01-IM5,Glomangiosarcoma,GS
msk_impact_2017,P-0008187,P-0008187-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008188,P-0008188-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008189,P-0008189-T01-IM5,Anaplastic Pleomorphic Xanthoastrocytoma,APXA
msk_impact_2017,P-0008191,P-0008191-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0008192,P-0008192-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0008204,P-0008204-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008205,P-0008205-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008206,P-0008206-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008207,P-0008207-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0008208,P-0008208-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008210,P-0008210-T01-IM5,"Salivary Carcinoma, Other",OSACA
msk_impact_2017,P-0008211,P-0008211-T02-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0008211,P-0008211-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008212,P-0008212-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0008213,P-0008213-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008213,P-0008213-T01-IM3,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008214,P-0008214-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0008215,P-0008215-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008224,P-0008224-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008225,P-0008225-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0008226,P-0008226-T02-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008227,P-0008227-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0008228,P-0008228-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008229,P-0008229-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0008230,P-0008230-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0008231,P-0008231-T01-IM5,Yolk Sac Tumor,TYST
msk_impact_2017,P-0008232,P-0008232-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008233,P-0008233-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0008234,P-0008234-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008235,P-0008235-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008236,P-0008236-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0008237,P-0008237-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0008239,P-0008239-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008240,P-0008240-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008241,P-0008241-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008242,P-0008242-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0008243,P-0008243-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008244,P-0008244-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0008244,P-0008244-T02-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0008245,P-0008245-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008246,P-0008246-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008247,P-0008247-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008248,P-0008248-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0008249,P-0008249-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008257,P-0008257-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008258,P-0008258-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008259,P-0008259-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008260,P-0008260-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008261,P-0008261-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008262,P-0008262-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008263,P-0008263-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0008264,P-0008264-T01-IM5,Proximal-Type Epithelioid Sarcoma,PTES
msk_impact_2017,P-0008265,P-0008265-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0008266,P-0008266-T01-IM5,Dedifferentiated Chondrosarcoma,DDCHS
msk_impact_2017,P-0008267,P-0008267-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008268,P-0008268-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008269,P-0008269-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0008270,P-0008270-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0008271,P-0008271-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0008282,P-0008282-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008283,P-0008283-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008285,P-0008285-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008286,P-0008286-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0008287,P-0008287-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0008288,P-0008288-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008289,P-0008289-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008290,P-0008290-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008291,P-0008291-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008292,P-0008292-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008295,P-0008295-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008296,P-0008296-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0008297,P-0008297-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008299,P-0008299-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008299,P-0008299-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008300,P-0008300-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008301,P-0008301-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008302,P-0008302-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008303,P-0008303-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0008304,P-0008304-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008305,P-0008305-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0008306,P-0008306-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008307,P-0008307-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008308,P-0008308-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008309,P-0008309-T01-IM5,Mixed Germ Cell Tumor,BMGCT
msk_impact_2017,P-0008310,P-0008310-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008311,P-0008311-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008312,P-0008312-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0008313,P-0008313-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0008314,P-0008314-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0008315,P-0008315-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008316,P-0008316-T01-IM5,Cervical Adenosquamous Carcinoma,CEAS
msk_impact_2017,P-0008317,P-0008317-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008318,P-0008318-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0008319,P-0008319-T01-IM5,Clear Cell Papillary Renal Cell Carcinoma,CCPRC
msk_impact_2017,P-0008320,P-0008320-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0008321,P-0008321-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008322,P-0008322-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008323,P-0008323-T01-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0008324,P-0008324-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008325,P-0008325-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0008326,P-0008326-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008327,P-0008327-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008328,P-0008328-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0008329,P-0008329-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0008330,P-0008330-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008330,P-0008330-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008331,P-0008331-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008332,P-0008332-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008333,P-0008333-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0008334,P-0008334-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008335,P-0008335-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008336,P-0008336-T01-IM5,Urethral Urothelial Carcinoma,UCU
msk_impact_2017,P-0008337,P-0008337-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0008338,P-0008338-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008339,P-0008339-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008340,P-0008340-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0008340,P-0008340-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0008341,P-0008341-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0008342,P-0008342-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0008343,P-0008343-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008344,P-0008344-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008345,P-0008345-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0008346,P-0008346-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008347,P-0008347-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0008348,P-0008348-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008348,P-0008348-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008349,P-0008349-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0008350,P-0008350-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008351,P-0008351-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008352,P-0008352-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0008353,P-0008353-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0008354,P-0008354-T01-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0008355,P-0008355-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0008356,P-0008356-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008357,P-0008357-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008358,P-0008358-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0008359,P-0008359-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008360,P-0008360-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0008369,P-0008369-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008370,P-0008370-T02-IM5,Undifferentiated Carcinoma of the Pancreas,UCP
msk_impact_2017,P-0008370,P-0008370-T01-IM5,Undifferentiated Carcinoma of the Pancreas,UCP
msk_impact_2017,P-0008371,P-0008371-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008372,P-0008372-T01-IM5,Solid Pseudopapillary Neoplasm of the Pancreas,SPN
msk_impact_2017,P-0008373,P-0008373-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008374,P-0008374-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008375,P-0008375-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0008376,P-0008376-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008377,P-0008377-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008378,P-0008378-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0008380,P-0008380-T02-IM5,Gliosarcoma,GSARC
msk_impact_2017,P-0008380,P-0008380-T01-IM5,Gliosarcoma,GSARC
msk_impact_2017,P-0008381,P-0008381-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0008382,P-0008382-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008383,P-0008383-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008384,P-0008384-T01-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0008385,P-0008385-T01-IM5,Adenoid Cystic Breast Cancer,ACBC
msk_impact_2017,P-0008386,P-0008386-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008387,P-0008387-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008388,P-0008388-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0008389,P-0008389-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0008390,P-0008390-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008391,P-0008391-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008391,P-0008391-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008392,P-0008392-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008393,P-0008393-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008394,P-0008394-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0008395,P-0008395-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0008396,P-0008396-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008397,P-0008397-T01-IM5,Medulloblastoma,MBL
msk_impact_2017,P-0008398,P-0008398-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008399,P-0008399-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008400,P-0008400-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008401,P-0008401-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0008402,P-0008402-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0008403,P-0008403-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008404,P-0008404-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008404,P-0008404-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008405,P-0008405-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008406,P-0008406-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008407,P-0008407-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008408,P-0008408-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0008416,P-0008416-T01-IM5,Oligoastrocytoma,OAST
msk_impact_2017,P-0008417,P-0008417-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008418,P-0008418-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008419,P-0008419-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008420,P-0008420-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008421,P-0008421-T01-IM5,Follicular Dendritic Cell Sarcoma,FDCS
msk_impact_2017,P-0008422,P-0008422-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008424,P-0008424-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008425,P-0008425-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008426,P-0008426-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008427,P-0008427-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008428,P-0008428-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008429,P-0008429-T02-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008429,P-0008429-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008430,P-0008430-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008431,P-0008431-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008432,P-0008432-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008433,P-0008433-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008434,P-0008434-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008435,P-0008435-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008436,P-0008436-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008437,P-0008437-T01-IM5,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0008438,P-0008438-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008439,P-0008439-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008440,P-0008440-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008441,P-0008441-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008442,P-0008442-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008443,P-0008443-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008444,P-0008444-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0008445,P-0008445-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008446,P-0008446-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008447,P-0008447-T01-IM5,Alveolar Soft Part Sarcoma,ASPS
msk_impact_2017,P-0008448,P-0008448-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008449,P-0008449-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008450,P-0008450-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008452,P-0008452-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008453,P-0008453-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0008455,P-0008455-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008456,P-0008456-T01-IM5,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0008457,P-0008457-T02-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008458,P-0008458-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008459,P-0008459-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008460,P-0008460-T02-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008461,P-0008461-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008462,P-0008462-T02-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008464,P-0008464-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008465,P-0008465-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008466,P-0008466-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0008467,P-0008467-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008468,P-0008468-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008469,P-0008469-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008470,P-0008470-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008471,P-0008471-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0008472,P-0008472-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008473,P-0008473-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008474,P-0008474-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0008475,P-0008475-T01-IM5,Classical Hodgkin Lymphoma,CHL
msk_impact_2017,P-0008476,P-0008476-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008477,P-0008477-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0008478,P-0008478-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008479,P-0008479-T01-IM5,Hemangioblastoma,HMBL
msk_impact_2017,P-0008480,P-0008480-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0008481,P-0008481-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008482,P-0008482-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008483,P-0008483-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008484,P-0008484-T02-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0008485,P-0008485-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008486,P-0008486-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008487,P-0008487-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008488,P-0008488-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008489,P-0008489-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008490,P-0008490-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008490,P-0008490-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008492,P-0008492-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008493,P-0008493-T02-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0008494,P-0008494-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0008514,P-0008514-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008515,P-0008515-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0008515,P-0008515-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0008516,P-0008516-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0008517,P-0008517-T01-IM5,Mesenchymal Chondrosarcoma,MCHS
msk_impact_2017,P-0008518,P-0008518-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0008519,P-0008519-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0008520,P-0008520-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0008521,P-0008521-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008522,P-0008522-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008523,P-0008523-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0008524,P-0008524-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0008525,P-0008525-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008526,P-0008526-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008527,P-0008527-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008528,P-0008528-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0008529,P-0008529-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008530,P-0008530-T01-IM5,Teratoma with Malignant Transformation,TMT
msk_impact_2017,P-0008531,P-0008531-T02-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0008532,P-0008532-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0008533,P-0008533-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0008534,P-0008534-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008535,P-0008535-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008536,P-0008536-T02-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0008537,P-0008537-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0008538,P-0008538-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008539,P-0008539-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008540,P-0008540-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008541,P-0008541-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008542,P-0008542-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008542,P-0008542-T03-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008543,P-0008543-T01-IM5,Alveolar Rhabdomyosarcoma,ARMS
msk_impact_2017,P-0008544,P-0008544-T02-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008545,P-0008545-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008546,P-0008546-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0008547,P-0008547-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0008548,P-0008548-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008549,P-0008549-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008551,P-0008551-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008552,P-0008552-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0008552,P-0008552-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0008553,P-0008553-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008554,P-0008554-T01-IM5,Myoepithelial Carcinoma,MYEC
msk_impact_2017,P-0008555,P-0008555-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0008556,P-0008556-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008557,P-0008557-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008558,P-0008558-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008559,P-0008559-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008560,P-0008560-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008561,P-0008561-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0008562,P-0008562-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008563,P-0008563-T01-IM5,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0008563,P-0008563-T02-IM5,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0008564,P-0008564-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0008565,P-0008565-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0008566,P-0008566-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008567,P-0008567-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0008568,P-0008568-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008569,P-0008569-T02-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008569,P-0008569-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008570,P-0008570-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008571,P-0008571-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008571,P-0008571-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008572,P-0008572-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008573,P-0008573-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0008574,P-0008574-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008575,P-0008575-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008576,P-0008576-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008577,P-0008577-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008577,P-0008577-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008578,P-0008578-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0008579,P-0008579-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008580,P-0008580-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0008581,P-0008581-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008582,P-0008582-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008583,P-0008583-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008584,P-0008584-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008586,P-0008586-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0008587,P-0008587-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0008588,P-0008588-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008589,P-0008589-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008589,P-0008589-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008590,P-0008590-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008591,P-0008591-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008592,P-0008592-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008593,P-0008593-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0008594,P-0008594-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008595,P-0008595-T02-IM5,Plasmacytoid/Signet Ring Cell Bladder Carcinoma,SRCBC
msk_impact_2017,P-0008595,P-0008595-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008596,P-0008596-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008597,P-0008597-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008598,P-0008598-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0008599,P-0008599-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008600,P-0008600-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008601,P-0008601-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008602,P-0008602-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008625,P-0008625-T03-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0008643,P-0008643-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0008644,P-0008644-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008645,P-0008645-T01-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0008646,P-0008646-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0008647,P-0008647-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008648,P-0008648-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0008649,P-0008649-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008650,P-0008650-T02-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0008650,P-0008650-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0008651,P-0008651-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008652,P-0008652-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008653,P-0008653-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0008654,P-0008654-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008655,P-0008655-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008656,P-0008656-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008657,P-0008657-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008658,P-0008658-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0008659,P-0008659-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008661,P-0008661-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008662,P-0008662-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008663,P-0008663-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008663,P-0008663-T02-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008664,P-0008664-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008665,P-0008665-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008666,P-0008666-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008667,P-0008667-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008668,P-0008668-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008669,P-0008669-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008670,P-0008670-T04-IM5,Embryonal Carcinoma,VOEC
msk_impact_2017,P-0008671,P-0008671-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0008672,P-0008672-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0008673,P-0008673-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008674,P-0008674-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008675,P-0008675-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008676,P-0008676-T01-IM5,Retinoblastoma,RBL
msk_impact_2017,P-0008677,P-0008677-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008678,P-0008678-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008679,P-0008679-T03-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008679,P-0008679-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008680,P-0008680-T01-IM5,Epithelioid Hemangioendothelioma,EHAE
msk_impact_2017,P-0008682,P-0008682-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008683,P-0008683-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008684,P-0008684-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0008685,P-0008685-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0008686,P-0008686-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0008687,P-0008687-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008688,P-0008688-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0008689,P-0008689-T02-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0008690,P-0008690-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008691,P-0008691-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008692,P-0008692-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0008693,P-0008693-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0008694,P-0008694-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008695,P-0008695-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008705,P-0008705-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008706,P-0008706-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008707,P-0008707-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0008708,P-0008708-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0008709,P-0008709-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008710,P-0008710-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008711,P-0008711-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008712,P-0008712-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008713,P-0008713-T01-IM5,Uterine Smooth Muscle Tumor of Uncertain Malignant Potential,USTUMP
msk_impact_2017,P-0008714,P-0008714-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0008715,P-0008715-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008716,P-0008716-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0008717,P-0008717-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0008718,P-0008718-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008719,P-0008719-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008720,P-0008720-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0008721,P-0008721-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008722,P-0008722-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0008723,P-0008723-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008724,P-0008724-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008725,P-0008725-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0008726,P-0008726-T01-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0008727,P-0008727-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008728,P-0008728-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008729,P-0008729-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008730,P-0008730-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0008731,P-0008731-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0008732,P-0008732-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0008733,P-0008733-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008734,P-0008734-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008735,P-0008735-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0008736,P-0008736-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008737,P-0008737-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0008744,P-0008744-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008744,P-0008744-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008745,P-0008745-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008746,P-0008746-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008747,P-0008747-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008748,P-0008748-T01-IM5,Undifferentiated Carcinoma of the Pancreas,UCP
msk_impact_2017,P-0008749,P-0008749-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0008750,P-0008750-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0008751,P-0008751-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008752,P-0008752-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008753,P-0008753-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008754,P-0008754-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008755,P-0008755-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0008756,P-0008756-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008757,P-0008757-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008758,P-0008758-T02-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0008759,P-0008759-T02-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0008760,P-0008760-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008761,P-0008761-T03-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008763,P-0008763-T01-IM5,"Adenocarcinoma, NOS",ADNOS
msk_impact_2017,P-0008764,P-0008764-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008765,P-0008765-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008766,P-0008766-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0008767,P-0008767-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008768,P-0008768-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0008769,P-0008769-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008770,P-0008770-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0008771,P-0008771-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008772,P-0008772-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0008773,P-0008773-T01-IM5,Bladder Squamous Cell Carcinoma,BLSC
msk_impact_2017,P-0008774,P-0008774-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008775,P-0008775-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0008776,P-0008776-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0008777,P-0008777-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008778,P-0008778-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0008779,P-0008779-T01-IM5,Extramammary Paget Disease,EMPD
msk_impact_2017,P-0008780,P-0008780-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008781,P-0008781-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0008782,P-0008782-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008783,P-0008783-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008784,P-0008784-T02-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0008785,P-0008785-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0008785,P-0008785-T02-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0008786,P-0008786-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008787,P-0008787-T01-IM5,Mixed Ovarian Carcinoma,MXOV
msk_impact_2017,P-0008788,P-0008788-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008789,P-0008789-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008790,P-0008790-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008791,P-0008791-T01-IM5,Spindle Cell Rhabdomyosarcoma,SCRMS
msk_impact_2017,P-0008792,P-0008792-T01-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0008794,P-0008794-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008795,P-0008795-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008796,P-0008796-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0008797,P-0008797-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0008798,P-0008798-T01-IM5,"Head and Neck Carcinoma, Other",OHNCA
msk_impact_2017,P-0008799,P-0008799-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0008800,P-0008800-T02-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0008809,P-0008809-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008810,P-0008810-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008811,P-0008811-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0008812,P-0008812-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008813,P-0008813-T02-IM5,Mature Teratoma,OMT
msk_impact_2017,P-0008813,P-0008813-T01-IM5,Mixed Germ Cell Tumor,OMGCT
msk_impact_2017,P-0008814,P-0008814-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0008815,P-0008815-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0008816,P-0008816-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0008817,P-0008817-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0008818,P-0008818-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008819,P-0008819-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008830,P-0008830-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0008831,P-0008831-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0008832,P-0008832-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008833,P-0008833-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008834,P-0008834-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008835,P-0008835-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008836,P-0008836-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008837,P-0008837-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008838,P-0008838-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008839,P-0008839-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008840,P-0008840-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008841,P-0008841-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008842,P-0008842-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008843,P-0008843-T01-IM5,Inflammatory Myofibroblastic Tumor,IMT
msk_impact_2017,P-0008844,P-0008844-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008845,P-0008845-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008846,P-0008846-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008847,P-0008847-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0008848,P-0008848-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0008849,P-0008849-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008850,P-0008850-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008851,P-0008851-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0008852,P-0008852-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008853,P-0008853-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008854,P-0008854-T01-IM5,Spindle Cell Carcinoma of the Lung,SPCC
msk_impact_2017,P-0008855,P-0008855-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008856,P-0008856-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008857,P-0008857-T02-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008857,P-0008857-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008858,P-0008858-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008859,P-0008859-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008860,P-0008860-T01-IM5,Epithelioid Sarcoma,EPIS
msk_impact_2017,P-0008861,P-0008861-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0008862,P-0008862-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008863,P-0008863-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008864,P-0008864-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0008865,P-0008865-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0008866,P-0008866-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0008867,P-0008867-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008868,P-0008868-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008869,P-0008869-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008870,P-0008870-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0008871,P-0008871-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008872,P-0008872-T01-IM5,Serous Cystadenoma of the Pancreas,PSC
msk_impact_2017,P-0008873,P-0008873-T01-IM5,Mixed Ovarian Carcinoma,MXOV
msk_impact_2017,P-0008874,P-0008874-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008875,P-0008875-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008876,P-0008876-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008877,P-0008877-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008878,P-0008878-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008879,P-0008879-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008880,P-0008880-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008881,P-0008881-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0008882,P-0008882-T01-IM5,Poorly Differentiated Carcinoma of the Stomach,SPDAC
msk_impact_2017,P-0008885,P-0008885-T03-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008885,P-0008885-T04-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008901,P-0008901-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008902,P-0008902-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008903,P-0008903-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0008904,P-0008904-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0008905,P-0008905-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0008906,P-0008906-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008907,P-0008907-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0008908,P-0008908-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008909,P-0008909-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008910,P-0008910-T02-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0008911,P-0008911-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008912,P-0008912-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0008913,P-0008913-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008914,P-0008914-T01-IM5,Paraganglioma,PGNG
msk_impact_2017,P-0008915,P-0008915-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0008916,P-0008916-T01-IM5,Marginal Zone Lymphoma,MZL
msk_impact_2017,P-0008917,P-0008917-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008918,P-0008918-T03-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008919,P-0008919-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008920,P-0008920-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008922,P-0008922-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008922,P-0008922-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008923,P-0008923-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0008924,P-0008924-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0008926,P-0008926-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0008927,P-0008927-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0008928,P-0008928-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008929,P-0008929-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008930,P-0008930-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008931,P-0008931-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008932,P-0008932-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0008932,P-0008932-T02-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0008933,P-0008933-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008934,P-0008934-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008935,P-0008935-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008936,P-0008936-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0008937,P-0008937-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0008938,P-0008938-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0008939,P-0008939-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0008940,P-0008940-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0008941,P-0008941-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0008942,P-0008942-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008943,P-0008943-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0008944,P-0008944-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008945,P-0008945-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008946,P-0008946-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008947,P-0008947-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0008948,P-0008948-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0008949,P-0008949-T01-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0008950,P-0008950-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008951,P-0008951-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0008952,P-0008952-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008953,P-0008953-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008954,P-0008954-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008955,P-0008955-T03-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0008956,P-0008956-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0008957,P-0008957-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008958,P-0008958-T01-IM5,Yolk Sac Tumor,TYST
msk_impact_2017,P-0008959,P-0008959-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0008960,P-0008960-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008961,P-0008961-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0008962,P-0008962-T02-IM5,Teratoma,TT
msk_impact_2017,P-0008963,P-0008963-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008964,P-0008964-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0008965,P-0008965-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0008966,P-0008966-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0008967,P-0008967-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0008968,P-0008968-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0008969,P-0008969-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0008970,P-0008970-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0008971,P-0008971-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0008972,P-0008972-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0008973,P-0008973-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0008974,P-0008974-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008975,P-0008975-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0008976,P-0008976-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008978,P-0008978-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0008994,P-0008994-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008995,P-0008995-T02-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0008995,P-0008995-T01-IM5,Mixed Germ Cell Tumor,MGCT
msk_impact_2017,P-0008996,P-0008996-T01-IM5,Salivary Carcinoma,SACA
msk_impact_2017,P-0008997,P-0008997-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0008998,P-0008998-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0008999,P-0008999-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009000,P-0009000-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009001,P-0009001-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009002,P-0009002-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009003,P-0009003-T01-IM5,Sebaceous Carcinoma,SEBA
msk_impact_2017,P-0009004,P-0009004-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009005,P-0009005-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009006,P-0009006-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009007,P-0009007-T01-IM5,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0009008,P-0009008-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0009009,P-0009009-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0009010,P-0009010-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0009011,P-0009011-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0009012,P-0009012-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009013,P-0009013-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009014,P-0009014-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009015,P-0009015-T01-IM5,Metaplastic Breast Cancer,MBC
msk_impact_2017,P-0009016,P-0009016-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009017,P-0009017-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009018,P-0009018-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009019,P-0009019-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0009020,P-0009020-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009021,P-0009021-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009022,P-0009022-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0009023,P-0009023-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0009024,P-0009024-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009025,P-0009025-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0009026,P-0009026-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0009027,P-0009027-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0009029,P-0009029-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009042,P-0009042-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009043,P-0009043-T01-IM5,Poorly Differentiated Carcinoma of the Stomach,SPDAC
msk_impact_2017,P-0009044,P-0009044-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009045,P-0009045-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009046,P-0009046-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0009047,P-0009047-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009048,P-0009048-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009050,P-0009050-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009051,P-0009051-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0009052,P-0009052-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009053,P-0009053-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009054,P-0009054-T01-IM5,Retinoblastoma,RBL
msk_impact_2017,P-0009055,P-0009055-T01-IM5,Esophageal Poorly Differentiated Carcinoma,EPDCA
msk_impact_2017,P-0009056,P-0009056-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009057,P-0009057-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009058,P-0009058-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009059,P-0009059-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009060,P-0009060-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009061,P-0009061-T02-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0009061,P-0009061-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009062,P-0009062-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009063,P-0009063-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009064,P-0009064-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009065,P-0009065-T02-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0009065,P-0009065-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0009066,P-0009066-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009067,P-0009067-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009068,P-0009068-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009069,P-0009069-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009070,P-0009070-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009071,P-0009071-T01-IM5,Sinonasal Adenocarcinoma,SNA
msk_impact_2017,P-0009072,P-0009072-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0009073,P-0009073-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009074,P-0009074-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0009075,P-0009075-T01-IM5,Endometrioid Ovarian Cancer,EOV
msk_impact_2017,P-0009076,P-0009076-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0009077,P-0009077-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009078,P-0009078-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009079,P-0009079-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0009080,P-0009080-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009081,P-0009081-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0009082,P-0009082-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009083,P-0009083-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009084,P-0009084-T02-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0009084,P-0009084-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0009085,P-0009085-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009086,P-0009086-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0009087,P-0009087-T01-IM5,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0009088,P-0009088-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0009089,P-0009089-T01-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0009090,P-0009090-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009091,P-0009091-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009092,P-0009092-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009093,P-0009093-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009094,P-0009094-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0009095,P-0009095-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0009096,P-0009096-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009097,P-0009097-T01-IM5,Pilocytic Astrocytoma,PAST
msk_impact_2017,P-0009098,P-0009098-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009099,P-0009099-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0009100,P-0009100-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0009101,P-0009101-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009102,P-0009102-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009103,P-0009103-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0009104,P-0009104-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009105,P-0009105-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0009106,P-0009106-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0009107,P-0009107-T01-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0009108,P-0009108-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0009109,P-0009109-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009110,P-0009110-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009111,P-0009111-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009112,P-0009112-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009113,P-0009113-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009114,P-0009114-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009115,P-0009115-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0009116,P-0009116-T01-IM5,Epithelioid Hemangioendothelioma,EHAE
msk_impact_2017,P-0009117,P-0009117-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009118,P-0009118-T01-IM5,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0009119,P-0009119-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009120,P-0009120-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0009121,P-0009121-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009122,P-0009122-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009132,P-0009132-T02-IM5,Skin Adnexal Carcinoma,SKAC
msk_impact_2017,P-0009137,P-0009137-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009138,P-0009138-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0009139,P-0009139-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009141,P-0009141-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009142,P-0009142-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009143,P-0009143-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0009144,P-0009144-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0009145,P-0009145-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009145,P-0009145-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009146,P-0009146-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009147,P-0009147-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0009148,P-0009148-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009149,P-0009149-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009151,P-0009151-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009152,P-0009152-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009153,P-0009153-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0009155,P-0009155-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009156,P-0009156-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009158,P-0009158-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009159,P-0009159-T02-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009160,P-0009160-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009161,P-0009161-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009162,P-0009162-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0009163,P-0009163-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009164,P-0009164-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009166,P-0009166-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0009167,P-0009167-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009168,P-0009168-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009169,P-0009169-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009170,P-0009170-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009171,P-0009171-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009172,P-0009172-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009173,P-0009173-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0009174,P-0009174-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0009175,P-0009175-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009176,P-0009176-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009177,P-0009177-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009178,P-0009178-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009179,P-0009179-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0009180,P-0009180-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009181,P-0009181-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009181,P-0009181-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009182,P-0009182-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009183,P-0009183-T01-IM5,Esophageal Squamous Cell Carcinoma,ESCC
msk_impact_2017,P-0009184,P-0009184-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0009185,P-0009185-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009186,P-0009186-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009187,P-0009187-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0009188,P-0009188-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0009189,P-0009189-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009190,P-0009190-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009191,P-0009191-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0009192,P-0009192-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009193,P-0009193-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0009194,P-0009194-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009195,P-0009195-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009196,P-0009196-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009197,P-0009197-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009198,P-0009198-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009199,P-0009199-T02-IM5,Choriocarcinoma,UCCA
msk_impact_2017,P-0009200,P-0009200-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009201,P-0009201-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009202,P-0009202-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0009203,P-0009203-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009204,P-0009204-T01-IM5,Pleomorphic Liposarcoma,PLLS
msk_impact_2017,P-0009205,P-0009205-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0009206,P-0009206-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009207,P-0009207-T02-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0009214,P-0009214-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009215,P-0009215-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009216,P-0009216-T02-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009216,P-0009216-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009217,P-0009217-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009218,P-0009218-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0009219,P-0009219-T01-IM5,Oligoastrocytoma,OAST
msk_impact_2017,P-0009220,P-0009220-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0009221,P-0009221-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009223,P-0009223-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009224,P-0009224-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009225,P-0009225-T01-IM5,Mucinous Cystic Neoplasm,MCN
msk_impact_2017,P-0009226,P-0009226-T02-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009228,P-0009228-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009238,P-0009238-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0009239,P-0009239-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0009240,P-0009240-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009241,P-0009241-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009242,P-0009242-T01-IM5,Solid Pseudopapillary Neoplasm of the Pancreas,SPN
msk_impact_2017,P-0009243,P-0009243-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009244,P-0009244-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009245,P-0009245-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009246,P-0009246-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0009248,P-0009248-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009249,P-0009249-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009250,P-0009250-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009251,P-0009251-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0009252,P-0009252-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009253,P-0009253-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009254,P-0009254-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009255,P-0009255-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0009256,P-0009256-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009257,P-0009257-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009258,P-0009258-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0009260,P-0009260-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009261,P-0009261-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009262,P-0009262-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009263,P-0009263-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009264,P-0009264-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0009265,P-0009265-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009266,P-0009266-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009267,P-0009267-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0009268,P-0009268-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009269,P-0009269-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009270,P-0009270-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009271,P-0009271-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009272,P-0009272-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009273,P-0009273-T01-IM5,Mixed Cervical Carcinoma,MCCE
msk_impact_2017,P-0009274,P-0009274-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009275,P-0009275-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009277,P-0009277-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009288,P-0009288-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009289,P-0009289-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009290,P-0009290-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0009291,P-0009291-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009292,P-0009292-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009293,P-0009293-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009294,P-0009294-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009295,P-0009295-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0009296,P-0009296-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0009297,P-0009297-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009297,P-0009297-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009299,P-0009299-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009300,P-0009300-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0009301,P-0009301-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009302,P-0009302-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009303,P-0009303-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009304,P-0009304-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009305,P-0009305-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009306,P-0009306-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009307,P-0009307-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009308,P-0009308-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009309,P-0009309-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0009310,P-0009310-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009311,P-0009311-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009312,P-0009312-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009313,P-0009313-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009314,P-0009314-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0009315,P-0009315-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0009316,P-0009316-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0009317,P-0009317-T02-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0009318,P-0009318-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0009319,P-0009319-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009320,P-0009320-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009321,P-0009321-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0009322,P-0009322-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0009323,P-0009323-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0009324,P-0009324-T02-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0009325,P-0009325-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009326,P-0009326-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0009327,P-0009327-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009328,P-0009328-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0009330,P-0009330-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009331,P-0009331-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0009333,P-0009333-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009334,P-0009334-T01-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0009335,P-0009335-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009336,P-0009336-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009337,P-0009337-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009338,P-0009338-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009339,P-0009339-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009339,P-0009339-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009341,P-0009341-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009343,P-0009343-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009344,P-0009344-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009345,P-0009345-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009345,P-0009345-T02-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0009346,P-0009346-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009347,P-0009347-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009348,P-0009348-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009349,P-0009349-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009350,P-0009350-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009351,P-0009351-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009352,P-0009352-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009353,P-0009353-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009355,P-0009355-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009356,P-0009356-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009357,P-0009357-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009358,P-0009358-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009359,P-0009359-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0009360,P-0009360-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0009361,P-0009361-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009362,P-0009362-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009363,P-0009363-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009364,P-0009364-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009365,P-0009365-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009366,P-0009366-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009367,P-0009367-T02-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009367,P-0009367-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009368,P-0009368-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009369,P-0009369-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009370,P-0009370-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009371,P-0009371-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009372,P-0009372-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009373,P-0009373-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0009374,P-0009374-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009375,P-0009375-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009376,P-0009376-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009377,P-0009377-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009378,P-0009378-T02-IM5,Sinonasal Undifferentiated Carcinoma,SNUC
msk_impact_2017,P-0009379,P-0009379-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009393,P-0009393-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009394,P-0009394-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009395,P-0009395-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009396,P-0009396-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009398,P-0009398-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0009399,P-0009399-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009400,P-0009400-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009401,P-0009401-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009403,P-0009403-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009404,P-0009404-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009405,P-0009405-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009406,P-0009406-T02-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009406,P-0009406-T01-IM3,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009408,P-0009408-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009408,P-0009408-T02-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009409,P-0009409-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009410,P-0009410-T01-IM5,Ependymoma,EPM
msk_impact_2017,P-0009411,P-0009411-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0009412,P-0009412-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009413,P-0009413-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009414,P-0009414-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009415,P-0009415-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009416,P-0009416-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009417,P-0009417-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009418,P-0009418-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009419,P-0009419-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009420,P-0009420-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009421,P-0009421-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0009422,P-0009422-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009423,P-0009423-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009425,P-0009425-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009426,P-0009426-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009427,P-0009427-T01-IM5,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0009428,P-0009428-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009430,P-0009430-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009431,P-0009431-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009432,P-0009432-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009433,P-0009433-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009434,P-0009434-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009435,P-0009435-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0009436,P-0009436-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009437,P-0009437-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009438,P-0009438-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009439,P-0009439-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009440,P-0009440-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009441,P-0009441-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009442,P-0009442-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009443,P-0009443-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009444,P-0009444-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009445,P-0009445-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009446,P-0009446-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009447,P-0009447-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0009448,P-0009448-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009449,P-0009449-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009450,P-0009450-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0009451,P-0009451-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009452,P-0009452-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0009453,P-0009453-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009454,P-0009454-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0009455,P-0009455-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0009456,P-0009456-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0009457,P-0009457-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0009458,P-0009458-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0009459,P-0009459-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0009460,P-0009460-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009462,P-0009462-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009463,P-0009463-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009464,P-0009464-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0009465,P-0009465-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009466,P-0009466-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009467,P-0009467-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009468,P-0009468-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009469,P-0009469-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009470,P-0009470-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009471,P-0009471-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0009472,P-0009472-T01-IM5,Ependymoma,EPM
msk_impact_2017,P-0009473,P-0009473-T01-IM5,Lung Adenosquamous Carcinoma,LUAS
msk_impact_2017,P-0009474,P-0009474-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009475,P-0009475-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009476,P-0009476-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009477,P-0009477-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009478,P-0009478-T01-IM5,Squamous Cell Carcinoma of the Vulva/Vagina,VSC
msk_impact_2017,P-0009479,P-0009479-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0009480,P-0009480-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009481,P-0009481-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009482,P-0009482-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0009483,P-0009483-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009484,P-0009484-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0009486,P-0009486-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0009487,P-0009487-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009488,P-0009488-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009490,P-0009490-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009491,P-0009491-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009492,P-0009492-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009497,P-0009497-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0009498,P-0009498-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009499,P-0009499-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009500,P-0009500-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0009501,P-0009501-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009503,P-0009503-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009505,P-0009505-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009506,P-0009506-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0009507,P-0009507-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009508,P-0009508-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009509,P-0009509-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0009510,P-0009510-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0009511,P-0009511-T02-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0009512,P-0009512-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009513,P-0009513-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009514,P-0009514-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009515,P-0009515-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0009516,P-0009516-T01-IM5,Solitary Fibrous Tumor of the Central Nervous System,SFTCNS
msk_impact_2017,P-0009517,P-0009517-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009518,P-0009518-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0009519,P-0009519-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009520,P-0009520-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009521,P-0009521-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0009523,P-0009523-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009524,P-0009524-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0009525,P-0009525-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0009526,P-0009526-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009527,P-0009527-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009528,P-0009528-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009529,P-0009529-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0009530,P-0009530-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009531,P-0009531-T01-IM5,Myxofibrosarcoma,MFS
msk_impact_2017,P-0009532,P-0009532-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009533,P-0009533-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0009534,P-0009534-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0009535,P-0009535-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009536,P-0009536-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009537,P-0009537-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0009538,P-0009538-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009539,P-0009539-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009540,P-0009540-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0009541,P-0009541-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0009542,P-0009542-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009543,P-0009543-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009543,P-0009543-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009544,P-0009544-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0009546,P-0009546-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009547,P-0009547-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0009555,P-0009555-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009556,P-0009556-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009557,P-0009557-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009558,P-0009558-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0009559,P-0009559-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009560,P-0009560-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0009561,P-0009561-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009562,P-0009562-T01-IM5,Ependymoma,EPM
msk_impact_2017,P-0009563,P-0009563-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0009564,P-0009564-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009565,P-0009565-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009565,P-0009565-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009583,P-0009583-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0009584,P-0009584-T01-IM5,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0009585,P-0009585-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0009586,P-0009586-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009587,P-0009587-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009588,P-0009588-T01-IM5,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0009589,P-0009589-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009590,P-0009590-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009590,P-0009590-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009591,P-0009591-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009592,P-0009592-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0009593,P-0009593-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009594,P-0009594-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009595,P-0009595-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0009596,P-0009596-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009597,P-0009597-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0009598,P-0009598-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009599,P-0009599-T01-IM5,Primitive Neuroectodermal Tumor,PNET
msk_impact_2017,P-0009600,P-0009600-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009601,P-0009601-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009602,P-0009602-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0009603,P-0009603-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009604,P-0009604-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009605,P-0009605-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0009606,P-0009606-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009607,P-0009607-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009608,P-0009608-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009609,P-0009609-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009610,P-0009610-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009610,P-0009610-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009611,P-0009611-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009612,P-0009612-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009613,P-0009613-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0009614,P-0009614-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009615,P-0009615-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009617,P-0009617-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009618,P-0009618-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009619,P-0009619-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009621,P-0009621-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009622,P-0009622-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009623,P-0009623-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009624,P-0009624-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009625,P-0009625-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009626,P-0009626-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009627,P-0009627-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009629,P-0009629-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009630,P-0009630-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009631,P-0009631-T01-IM5,Esophagogastric Adenocarcinoma,EGC
msk_impact_2017,P-0009632,P-0009632-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009633,P-0009633-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009634,P-0009634-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009635,P-0009635-T01-IM5,Pancreatoblastoma,PB
msk_impact_2017,P-0009636,P-0009636-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009637,P-0009637-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009638,P-0009638-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009639,P-0009639-T01-IM5,"Pleural Mesothelioma, Sarcomatoid Type",PLSMESO
msk_impact_2017,P-0009640,P-0009640-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009641,P-0009641-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009642,P-0009642-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0009643,P-0009643-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009644,P-0009644-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0009645,P-0009645-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009646,P-0009646-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009647,P-0009647-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009648,P-0009648-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0009649,P-0009649-T01-IM5,Gliosarcoma,GSARC
msk_impact_2017,P-0009650,P-0009650-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009651,P-0009651-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0009652,P-0009652-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0009653,P-0009653-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0009654,P-0009654-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009655,P-0009655-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009656,P-0009656-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009657,P-0009657-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0009658,P-0009658-T01-IM5,Langerhans Cell Histiocytosis,LCH
msk_impact_2017,P-0009660,P-0009660-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009661,P-0009661-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009662,P-0009662-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009663,P-0009663-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009664,P-0009664-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0009680,P-0009680-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009682,P-0009682-T01-IM5,Gastric Type Mucinous Carcinoma,GCEMU
msk_impact_2017,P-0009683,P-0009683-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009684,P-0009684-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009685,P-0009685-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0009686,P-0009686-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009687,P-0009687-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009688,P-0009688-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009689,P-0009689-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009690,P-0009690-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009691,P-0009691-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009692,P-0009692-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009693,P-0009693-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0009694,P-0009694-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0009695,P-0009695-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009696,P-0009696-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0009697,P-0009697-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0009698,P-0009698-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0009699,P-0009699-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009700,P-0009700-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009701,P-0009701-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009702,P-0009702-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009703,P-0009703-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009704,P-0009704-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009705,P-0009705-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009706,P-0009706-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009707,P-0009707-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009708,P-0009708-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009709,P-0009709-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0009710,P-0009710-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009711,P-0009711-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009712,P-0009712-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009713,P-0009713-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0009714,P-0009714-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009715,P-0009715-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009716,P-0009716-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009717,P-0009717-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009725,P-0009725-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009726,P-0009726-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009727,P-0009727-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009728,P-0009728-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009729,P-0009729-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0009730,P-0009730-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0009731,P-0009731-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009732,P-0009732-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009733,P-0009733-T01-IM5,Desmoplastic Small-Round-Cell Tumor,DSRCT
msk_impact_2017,P-0009734,P-0009734-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0009735,P-0009735-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0009736,P-0009736-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009737,P-0009737-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009738,P-0009738-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009739,P-0009739-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009740,P-0009740-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009741,P-0009741-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009742,P-0009742-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009743,P-0009743-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009744,P-0009744-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009745,P-0009745-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009746,P-0009746-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009747,P-0009747-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009748,P-0009748-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009749,P-0009749-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0009750,P-0009750-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009751,P-0009751-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009752,P-0009752-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009753,P-0009753-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009754,P-0009754-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0009755,P-0009755-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009756,P-0009756-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009757,P-0009757-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009758,P-0009758-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009759,P-0009759-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009760,P-0009760-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009761,P-0009761-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0009762,P-0009762-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009763,P-0009763-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009764,P-0009764-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009765,P-0009765-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009785,P-0009785-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009786,P-0009786-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009786,P-0009786-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009787,P-0009787-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009788,P-0009788-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0009789,P-0009789-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009790,P-0009790-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009791,P-0009791-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009792,P-0009792-T01-IM5,Medulloblastoma,MBL
msk_impact_2017,P-0009793,P-0009793-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009794,P-0009794-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0009795,P-0009795-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0009796,P-0009796-T02-IM5,Wilms' Tumor,WT
msk_impact_2017,P-0009797,P-0009797-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0009798,P-0009798-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009799,P-0009799-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0009813,P-0009813-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009814,P-0009814-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0009815,P-0009815-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009816,P-0009816-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009817,P-0009817-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009818,P-0009818-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009819,P-0009819-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009821,P-0009821-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009822,P-0009822-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009823,P-0009823-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009824,P-0009824-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009825,P-0009825-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0009826,P-0009826-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009827,P-0009827-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009828,P-0009828-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009828,P-0009828-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009829,P-0009829-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009830,P-0009830-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009831,P-0009831-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0009832,P-0009832-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0009833,P-0009833-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009834,P-0009834-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009835,P-0009835-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0009836,P-0009836-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009837,P-0009837-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009838,P-0009838-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009839,P-0009839-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0009840,P-0009840-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0009841,P-0009841-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009842,P-0009842-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009843,P-0009843-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009844,P-0009844-T01-IM5,Skin Adnexal Carcinoma,SKAC
msk_impact_2017,P-0009845,P-0009845-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009846,P-0009846-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009847,P-0009847-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009848,P-0009848-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009849,P-0009849-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0009850,P-0009850-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009851,P-0009851-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009852,P-0009852-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009853,P-0009853-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009853,P-0009853-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009854,P-0009854-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009855,P-0009855-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0009856,P-0009856-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009857,P-0009857-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009858,P-0009858-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009859,P-0009859-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009860,P-0009860-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009861,P-0009861-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009862,P-0009862-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009863,P-0009863-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009864,P-0009864-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009865,P-0009865-T01-IM5,Retinoblastoma,RBL
msk_impact_2017,P-0009867,P-0009867-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0009868,P-0009868-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009869,P-0009869-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009870,P-0009870-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009871,P-0009871-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0009872,P-0009872-T02-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009872,P-0009872-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0009873,P-0009873-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009874,P-0009874-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009875,P-0009875-T01-IM5,Duodenal Adenocarcinoma,DA
msk_impact_2017,P-0009876,P-0009876-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009878,P-0009878-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009879,P-0009879-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009892,P-0009892-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009893,P-0009893-T01-IM5,Bladder Adenocarcinoma,BLAD
msk_impact_2017,P-0009894,P-0009894-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009895,P-0009895-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0009896,P-0009896-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0009897,P-0009897-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009898,P-0009898-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0009899,P-0009899-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0009900,P-0009900-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0009901,P-0009901-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009902,P-0009902-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009903,P-0009903-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009904,P-0009904-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009905,P-0009905-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009906,P-0009906-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009907,P-0009907-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009908,P-0009908-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009909,P-0009909-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0009910,P-0009910-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0009911,P-0009911-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009912,P-0009912-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0009913,P-0009913-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0009914,P-0009914-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009915,P-0009915-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009916,P-0009916-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0009917,P-0009917-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0009918,P-0009918-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0009919,P-0009919-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0009920,P-0009920-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009921,P-0009921-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0009922,P-0009922-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009923,P-0009923-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009924,P-0009924-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009925,P-0009925-T01-IM5,Classical Hodgkin Lymphoma,CHL
msk_impact_2017,P-0009926,P-0009926-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0009927,P-0009927-T01-IM5,Mixed Cancer Types,MIXED
msk_impact_2017,P-0009928,P-0009928-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009930,P-0009930-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0009931,P-0009931-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0009932,P-0009932-T01-IM5,Sinonasal Adenocarcinoma,SNA
msk_impact_2017,P-0009933,P-0009933-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009934,P-0009934-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0009935,P-0009935-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009936,P-0009936-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0009937,P-0009937-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009938,P-0009938-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0009939,P-0009939-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009940,P-0009940-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0009941,P-0009941-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009942,P-0009942-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009943,P-0009943-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009944,P-0009944-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0009945,P-0009945-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0009946,P-0009946-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0009947,P-0009947-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009947,P-0009947-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0009948,P-0009948-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009948,P-0009948-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009949,P-0009949-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009950,P-0009950-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0009951,P-0009951-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009952,P-0009952-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0009953,P-0009953-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009954,P-0009954-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009955,P-0009955-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0009956,P-0009956-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009957,P-0009957-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009958,P-0009958-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009959,P-0009959-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009960,P-0009960-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009961,P-0009961-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0009962,P-0009962-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0009963,P-0009963-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009964,P-0009964-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009964,P-0009964-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009965,P-0009965-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009966,P-0009966-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0009967,P-0009967-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0009968,P-0009968-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0009969,P-0009969-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0009970,P-0009970-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0009971,P-0009971-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009972,P-0009972-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009973,P-0009973-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0009974,P-0009974-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009975,P-0009975-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009981,P-0009981-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0009982,P-0009982-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009984,P-0009984-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009985,P-0009985-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0009986,P-0009986-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009987,P-0009987-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0009988,P-0009988-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0009989,P-0009989-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009990,P-0009990-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0009991,P-0009991-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0009992,P-0009992-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0009993,P-0009993-T01-IM3,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009993,P-0009993-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0009995,P-0009995-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0009996,P-0009996-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0009997,P-0009997-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0009998,P-0009998-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0010001,P-0010001-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0010002,P-0010002-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010003,P-0010003-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0010004,P-0010004-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010005,P-0010005-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010006,P-0010006-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0010007,P-0010007-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010008,P-0010008-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010009,P-0010009-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010010,P-0010010-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010011,P-0010011-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010012,P-0010012-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0010013,P-0010013-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0010014,P-0010014-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010015,P-0010015-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010016,P-0010016-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010017,P-0010017-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0010018,P-0010018-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010019,P-0010019-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0010020,P-0010020-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010021,P-0010021-T01-IM5,Mixed Cancer Types,MIXED
msk_impact_2017,P-0010022,P-0010022-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010023,P-0010023-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0010024,P-0010024-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010025,P-0010025-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010026,P-0010026-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0010027,P-0010027-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010028,P-0010028-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0010029,P-0010029-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010030,P-0010030-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010031,P-0010031-T01-IM5,Goblet Cell Carcinoid of the Appendix,GCCAP
msk_impact_2017,P-0010032,P-0010032-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010033,P-0010033-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0010034,P-0010034-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010035,P-0010035-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010041,P-0010041-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010042,P-0010042-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0010043,P-0010043-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010044,P-0010044-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010046,P-0010046-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0010048,P-0010048-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0010049,P-0010049-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010050,P-0010050-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0010051,P-0010051-T01-IM5,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0010052,P-0010052-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0010053,P-0010053-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010054,P-0010054-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010055,P-0010055-T01-IM5,"Neuroendocrine Carcinoma, NOS",NECNOS
msk_impact_2017,P-0010056,P-0010056-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010057,P-0010057-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0010058,P-0010058-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010059,P-0010059-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010060,P-0010060-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010061,P-0010061-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0010062,P-0010062-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010063,P-0010063-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010064,P-0010064-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0010065,P-0010065-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0010066,P-0010066-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010067,P-0010067-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010068,P-0010068-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010069,P-0010069-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0010070,P-0010070-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0010071,P-0010071-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010072,P-0010072-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0010073,P-0010073-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0010074,P-0010074-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010075,P-0010075-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010076,P-0010076-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010077,P-0010077-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010078,P-0010078-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010079,P-0010079-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010080,P-0010080-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010081,P-0010081-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010082,P-0010082-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0010083,P-0010083-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010084,P-0010084-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010085,P-0010085-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0010086,P-0010086-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0010087,P-0010087-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010088,P-0010088-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0010089,P-0010089-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010090,P-0010090-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010091,P-0010091-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010092,P-0010092-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010093,P-0010093-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010094,P-0010094-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010095,P-0010095-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010097,P-0010097-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010098,P-0010098-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010099,P-0010099-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0010100,P-0010100-T01-IM5,"Adenocarcinoma, NOS",ADNOS
msk_impact_2017,P-0010101,P-0010101-T01-IM5,Perivascular Epithelioid Cell Tumor,PECOMA
msk_impact_2017,P-0010102,P-0010102-T01-IM5,Extrahepatic Cholangiocarcinoma,EHCH
msk_impact_2017,P-0010103,P-0010103-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0010104,P-0010104-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0010105,P-0010105-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010106,P-0010106-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010107,P-0010107-T01-IM5,Yolk Sac Tumor,VYST
msk_impact_2017,P-0010108,P-0010108-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010109,P-0010109-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0010110,P-0010110-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010111,P-0010111-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0010112,P-0010112-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010113,P-0010113-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0010114,P-0010114-T01-IM5,Gastric Type Mucinous Carcinoma,GCEMU
msk_impact_2017,P-0010115,P-0010115-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0010116,P-0010116-T01-IM5,Duodenal Adenocarcinoma,DA
msk_impact_2017,P-0010117,P-0010117-T01-IM5,Breast Angiosarcoma,BA
msk_impact_2017,P-0010118,P-0010118-T01-IM5,Signet Ring Cell Adenocarcinoma of the Colon and Rectum,SRCCR
msk_impact_2017,P-0010119,P-0010119-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0010124,P-0010124-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010125,P-0010125-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010126,P-0010126-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010127,P-0010127-T01-IM5,Pineal Parenchymal Tumor of Intermediate Differentiation,PPTID
msk_impact_2017,P-0010128,P-0010128-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0010129,P-0010129-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010130,P-0010130-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010130,P-0010130-T02-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010131,P-0010131-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010132,P-0010132-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010133,P-0010133-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010134,P-0010134-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010135,P-0010135-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0010136,P-0010136-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010137,P-0010137-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010138,P-0010138-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010139,P-0010139-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010141,P-0010141-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010142,P-0010142-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010143,P-0010143-T01-IM5,Sertoli-Leydig Cell Tumor,SLCT
msk_impact_2017,P-0010144,P-0010144-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010145,P-0010145-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0010146,P-0010146-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010147,P-0010147-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010148,P-0010148-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0010149,P-0010149-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0010158,P-0010158-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010159,P-0010159-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010160,P-0010160-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010161,P-0010161-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0010162,P-0010162-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010163,P-0010163-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010164,P-0010164-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0010165,P-0010165-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010166,P-0010166-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010167,P-0010167-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010168,P-0010168-T01-IM5,Cervical Endometrioid Carcinoma,CEEN
msk_impact_2017,P-0010169,P-0010169-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010170,P-0010170-T01-IM5,Atypical Meningioma,ATM
msk_impact_2017,P-0010171,P-0010171-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010172,P-0010172-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010173,P-0010173-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010174,P-0010174-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0010175,P-0010175-T02-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0010176,P-0010176-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010177,P-0010177-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010178,P-0010178-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010179,P-0010179-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010180,P-0010180-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010181,P-0010181-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010182,P-0010182-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0010183,P-0010183-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0010184,P-0010184-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0010185,P-0010185-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0010195,P-0010195-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010196,P-0010196-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0010197,P-0010197-T01-IM5,Poorly Differentiated Carcinoma of the Stomach,SPDAC
msk_impact_2017,P-0010198,P-0010198-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0010199,P-0010199-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0010200,P-0010200-T01-IM5,Erdheim-Chester Disease,ECD
msk_impact_2017,P-0010201,P-0010201-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010202,P-0010202-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010203,P-0010203-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010205,P-0010205-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0010206,P-0010206-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0010207,P-0010207-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010208,P-0010208-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010209,P-0010209-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010210,P-0010210-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010210,P-0010210-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010211,P-0010211-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010212,P-0010212-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010213,P-0010213-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010214,P-0010214-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010215,P-0010215-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010216,P-0010216-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010217,P-0010217-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0010218,P-0010218-T01-IM5,Ependymoma,EPM
msk_impact_2017,P-0010219,P-0010219-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010220,P-0010220-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0010221,P-0010221-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0010222,P-0010222-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010222,P-0010222-T02-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010223,P-0010223-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010224,P-0010224-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0010225,P-0010225-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0010226,P-0010226-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0010227,P-0010227-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0010228,P-0010228-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010229,P-0010229-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0010231,P-0010231-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010232,P-0010232-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010234,P-0010234-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010235,P-0010235-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010236,P-0010236-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010237,P-0010237-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010238,P-0010238-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010239,P-0010239-T01-IM5,Atypical Meningioma,ATM
msk_impact_2017,P-0010240,P-0010240-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010241,P-0010241-T01-IM5,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0010242,P-0010242-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010243,P-0010243-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010244,P-0010244-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0010245,P-0010245-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010246,P-0010246-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010247,P-0010247-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010249,P-0010249-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010250,P-0010250-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010251,P-0010251-T01-IM5,Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma,HCCIHCH
msk_impact_2017,P-0010252,P-0010252-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0010253,P-0010253-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010255,P-0010255-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010256,P-0010256-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010257,P-0010257-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010258,P-0010258-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010259,P-0010259-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0010260,P-0010260-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010261,P-0010261-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010261,P-0010261-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010262,P-0010262-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010264,P-0010264-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010265,P-0010265-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0010266,P-0010266-T01-IM5,Fibrolamellar Carcinoma,FLC
msk_impact_2017,P-0010267,P-0010267-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010268,P-0010268-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010269,P-0010269-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010270,P-0010270-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0010271,P-0010271-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010272,P-0010272-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010273,P-0010273-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010275,P-0010275-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010276,P-0010276-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0010277,P-0010277-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010278,P-0010278-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0010279,P-0010279-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010281,P-0010281-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0010283,P-0010283-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0010296,P-0010296-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010297,P-0010297-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010298,P-0010298-T02-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010299,P-0010299-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010300,P-0010300-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010301,P-0010301-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0010302,P-0010302-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010303,P-0010303-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010304,P-0010304-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0010305,P-0010305-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0010306,P-0010306-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010307,P-0010307-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010308,P-0010308-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010309,P-0010309-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010310,P-0010310-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0010311,P-0010311-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010312,P-0010312-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010313,P-0010313-T01-IM5,Adenocarcinoma of the Gastroesophageal Junction,GEJ
msk_impact_2017,P-0010314,P-0010314-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0010316,P-0010316-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010317,P-0010317-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0010318,P-0010318-T01-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0010319,P-0010319-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0010320,P-0010320-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0010321,P-0010321-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010326,P-0010326-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010327,P-0010327-T01-IM5,Mucosal Melanoma of the Esophagus,ESMM
msk_impact_2017,P-0010328,P-0010328-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010329,P-0010329-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010330,P-0010330-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010331,P-0010331-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010332,P-0010332-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010333,P-0010333-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010334,P-0010334-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010335,P-0010335-T01-IM5,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0010336,P-0010336-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010337,P-0010337-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010338,P-0010338-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010339,P-0010339-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0010340,P-0010340-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0010341,P-0010341-T01-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0010342,P-0010342-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010343,P-0010343-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010344,P-0010344-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010345,P-0010345-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010345,P-0010345-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010346,P-0010346-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0010347,P-0010347-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0010348,P-0010348-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010349,P-0010349-T01-IM5,Breast Ductal Carcinoma In Situ,DCIS
msk_impact_2017,P-0010350,P-0010350-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010351,P-0010351-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010352,P-0010352-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010353,P-0010353-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0010354,P-0010354-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0010355,P-0010355-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010356,P-0010356-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0010357,P-0010357-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010358,P-0010358-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010359,P-0010359-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010360,P-0010360-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010361,P-0010361-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010362,P-0010362-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010363,P-0010363-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010364,P-0010364-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010365,P-0010365-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010367,P-0010367-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010368,P-0010368-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010369,P-0010369-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0010372,P-0010372-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010373,P-0010373-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010374,P-0010374-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010375,P-0010375-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010376,P-0010376-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010378,P-0010378-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010380,P-0010380-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010381,P-0010381-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010382,P-0010382-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010383,P-0010383-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010385,P-0010385-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010386,P-0010386-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010387,P-0010387-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010388,P-0010388-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0010389,P-0010389-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010391,P-0010391-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010392,P-0010392-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0010393,P-0010393-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010394,P-0010394-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010397,P-0010397-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010398,P-0010398-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0010400,P-0010400-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010401,P-0010401-T01-IM5,Granulosa Cell Tumor,GRCT
msk_impact_2017,P-0010402,P-0010402-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0010403,P-0010403-T01-IM5,Myxoma,MYXO
msk_impact_2017,P-0010404,P-0010404-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010405,P-0010405-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010406,P-0010406-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010407,P-0010407-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010420,P-0010420-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0010421,P-0010421-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010422,P-0010422-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010423,P-0010423-T01-IM5,Langerhans Cell Histiocytosis,LCH
msk_impact_2017,P-0010424,P-0010424-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010425,P-0010425-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010426,P-0010426-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010427,P-0010427-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010428,P-0010428-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010429,P-0010429-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0010431,P-0010431-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010432,P-0010432-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010441,P-0010441-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010442,P-0010442-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010443,P-0010443-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010445,P-0010445-T01-IM5,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0010449,P-0010449-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0010450,P-0010450-T01-IM5,Head and Neck Squamous Cell Carcinoma of Unknown Primary,HNSCUP
msk_impact_2017,P-0010451,P-0010451-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0010452,P-0010452-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010453,P-0010453-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010454,P-0010454-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010455,P-0010455-T01-IM5,Embryonal Carcinoma,VOEC
msk_impact_2017,P-0010456,P-0010456-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0010457,P-0010457-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010458,P-0010458-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010459,P-0010459-T01-IM5,Nasopharyngeal Carcinoma,NPC
msk_impact_2017,P-0010460,P-0010460-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010462,P-0010462-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0010463,P-0010463-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010464,P-0010464-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010465,P-0010465-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010466,P-0010466-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010467,P-0010467-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010483,P-0010483-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010484,P-0010484-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0010485,P-0010485-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0010486,P-0010486-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010487,P-0010487-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010488,P-0010488-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010489,P-0010489-T01-IM5,Non-Hodgkin Lymphoma,NHL
msk_impact_2017,P-0010490,P-0010490-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010491,P-0010491-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010492,P-0010492-T01-IM5,Signet Ring Cell Carcinoma of the Stomach,SSRCC
msk_impact_2017,P-0010493,P-0010493-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0010494,P-0010494-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0010495,P-0010495-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010496,P-0010496-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010497,P-0010497-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010498,P-0010498-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010499,P-0010499-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010500,P-0010500-T01-IM5,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0010501,P-0010501-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0010503,P-0010503-T01-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0010504,P-0010504-T01-IM5,Medullary Carcinoma of the Colon,CMC
msk_impact_2017,P-0010505,P-0010505-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010506,P-0010506-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010507,P-0010507-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010508,P-0010508-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010509,P-0010509-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010510,P-0010510-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010511,P-0010511-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0010512,P-0010512-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0010513,P-0010513-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010514,P-0010514-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0010515,P-0010515-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0010516,P-0010516-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0010517,P-0010517-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010518,P-0010518-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010519,P-0010519-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010520,P-0010520-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010521,P-0010521-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0010522,P-0010522-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010523,P-0010523-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010524,P-0010524-T01-IM5,"Serous Borderline Ovarian Tumor, Micropapillary",SBMOV
msk_impact_2017,P-0010525,P-0010525-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010526,P-0010526-T01-IM5,Adrenocortical Carcinoma,ACC
msk_impact_2017,P-0010527,P-0010527-T01-IM5,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0010528,P-0010528-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010529,P-0010529-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010530,P-0010530-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0010531,P-0010531-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010532,P-0010532-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010533,P-0010533-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010534,P-0010534-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010535,P-0010535-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010537,P-0010537-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010538,P-0010538-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010553,P-0010553-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010554,P-0010554-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010555,P-0010555-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010555,P-0010555-T02-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010556,P-0010556-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010557,P-0010557-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010558,P-0010558-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010559,P-0010559-T01-IM5,Granular Cell Tumor,GCT
msk_impact_2017,P-0010560,P-0010560-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010561,P-0010561-T01-IM5,Lung Carcinoid,LUCA
msk_impact_2017,P-0010562,P-0010562-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0010563,P-0010563-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010564,P-0010564-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010565,P-0010565-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010566,P-0010566-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010567,P-0010567-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0010568,P-0010568-T01-IM5,Classical Hodgkin Lymphoma,CHL
msk_impact_2017,P-0010569,P-0010569-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010570,P-0010570-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010571,P-0010571-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0010572,P-0010572-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010573,P-0010573-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010574,P-0010574-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0010575,P-0010575-T02-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0010576,P-0010576-T01-IM5,Thymoma,THYM
msk_impact_2017,P-0010577,P-0010577-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010578,P-0010578-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010579,P-0010579-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0010580,P-0010580-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0010581,P-0010581-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010582,P-0010582-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010584,P-0010584-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0010585,P-0010585-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010587,P-0010587-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010588,P-0010588-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0010589,P-0010589-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0010590,P-0010590-T01-IM5,Hodgkin Lymphoma,HL
msk_impact_2017,P-0010591,P-0010591-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0010592,P-0010592-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010594,P-0010594-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010595,P-0010595-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0010596,P-0010596-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010597,P-0010597-T01-IM5,Thymic Carcinoma,THYC
msk_impact_2017,P-0010598,P-0010598-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010599,P-0010599-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010600,P-0010600-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010601,P-0010601-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010602,P-0010602-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0010603,P-0010603-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0010604,P-0010604-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010605,P-0010605-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010606,P-0010606-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0010607,P-0010607-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0010608,P-0010608-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010609,P-0010609-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010610,P-0010610-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0010611,P-0010611-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010612,P-0010612-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010613,P-0010613-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010614,P-0010614-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0010615,P-0010615-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010627,P-0010627-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010628,P-0010628-T01-IM5,"Poorly Differentiated Carcinoma, NOS",PDC
msk_impact_2017,P-0010629,P-0010629-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0010630,P-0010630-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0010631,P-0010631-T01-IM5,Signet Ring Cell Type of the Appendix,SRAP
msk_impact_2017,P-0010632,P-0010632-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010633,P-0010633-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0010634,P-0010634-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010635,P-0010635-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010636,P-0010636-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010637,P-0010637-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010638,P-0010638-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010639,P-0010639-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010640,P-0010640-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010641,P-0010641-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010642,P-0010642-T01-IM5,Histiocytic and Dendritic Cell Neoplasms,HDCN
msk_impact_2017,P-0010643,P-0010643-T01-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0010643,P-0010643-T02-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0010644,P-0010644-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0010645,P-0010645-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010646,P-0010646-T01-IM5,Embryonal Carcinoma,VOEC
msk_impact_2017,P-0010647,P-0010647-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0010648,P-0010648-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010649,P-0010649-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0010650,P-0010650-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0010651,P-0010651-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0010652,P-0010652-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010653,P-0010653-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0010654,P-0010654-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0010655,P-0010655-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010656,P-0010656-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010657,P-0010657-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010658,P-0010658-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0010659,P-0010659-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010660,P-0010660-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0010661,P-0010661-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010662,P-0010662-T01-IM5,Undifferentiated Carcinoma of the Pancreas,UCP
msk_impact_2017,P-0010663,P-0010663-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0010664,P-0010664-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0010665,P-0010665-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010668,P-0010668-T01-IM5,Mammary Analogue Secretory Carcinoma of Salivary Gland Origin,HNMASC
msk_impact_2017,P-0010669,P-0010669-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010670,P-0010670-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0010671,P-0010671-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0010672,P-0010672-T02-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0010672,P-0010672-T01-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0010673,P-0010673-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010674,P-0010674-T01-IM5,Translocation-Associated Renal Cell Carcinoma,TRCC
msk_impact_2017,P-0010675,P-0010675-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010676,P-0010676-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0010677,P-0010677-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0010678,P-0010678-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0010679,P-0010679-T01-IM5,"Pleural Mesothelioma, Biphasic Type",PLBMESO
msk_impact_2017,P-0010680,P-0010680-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010681,P-0010681-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010682,P-0010682-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010683,P-0010683-T01-IM5,Myofibroma,MF
msk_impact_2017,P-0010684,P-0010684-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010685,P-0010685-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0010686,P-0010686-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010687,P-0010687-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010688,P-0010688-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010689,P-0010689-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010690,P-0010690-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010691,P-0010691-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010692,P-0010692-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010700,P-0010700-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010701,P-0010701-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0010702,P-0010702-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0010703,P-0010703-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010704,P-0010704-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010705,P-0010705-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010706,P-0010706-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0010707,P-0010707-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0010708,P-0010708-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0010709,P-0010709-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010710,P-0010710-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010711,P-0010711-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0010712,P-0010712-T01-IM5,Mixed Cancer Types,MIXED
msk_impact_2017,P-0010713,P-0010713-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010714,P-0010714-T01-IM5,Pleomorphic Rhabdomyosarcoma,PLRMS
msk_impact_2017,P-0010715,P-0010715-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0010716,P-0010716-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010717,P-0010717-T01-IM5,Thymic Carcinoma,THYC
msk_impact_2017,P-0010718,P-0010718-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0010719,P-0010719-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010720,P-0010720-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0010721,P-0010721-T01-IM5,Ciliated Muconodular Papillary Tumor of the Lung,CMPT
msk_impact_2017,P-0010722,P-0010722-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0010723,P-0010723-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0010724,P-0010724-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010725,P-0010725-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0010726,P-0010726-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0010728,P-0010728-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010728,P-0010728-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010729,P-0010729-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010730,P-0010730-T01-IM5,Soft Tissue Myoepithelial Carcinoma,STMYEC
msk_impact_2017,P-0010731,P-0010731-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010732,P-0010732-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0010733,P-0010733-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010734,P-0010734-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010735,P-0010735-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0010736,P-0010736-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010737,P-0010737-T01-IM5,Acral Melanoma,ACRM
msk_impact_2017,P-0010738,P-0010738-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010739,P-0010739-T01-IM5,"Salivary Carcinoma, Other",OSACA
msk_impact_2017,P-0010740,P-0010740-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010741,P-0010741-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010742,P-0010742-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010743,P-0010743-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010744,P-0010744-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0010745,P-0010745-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010746,P-0010746-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010747,P-0010747-T01-IM5,Signet Ring Cell Type of the Appendix,SRAP
msk_impact_2017,P-0010748,P-0010748-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0010749,P-0010749-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010750,P-0010750-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010751,P-0010751-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010752,P-0010752-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010753,P-0010753-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010754,P-0010754-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010755,P-0010755-T01-IM5,Head and Neck Squamous Cell Carcinoma of Unknown Primary,HNSCUP
msk_impact_2017,P-0010756,P-0010756-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0010757,P-0010757-T01-IM5,Chordoma,CHDM
msk_impact_2017,P-0010758,P-0010758-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010759,P-0010759-T01-IM5,Synovial Sarcoma,SYNS
msk_impact_2017,P-0010760,P-0010760-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010761,P-0010761-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0010762,P-0010762-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0010763,P-0010763-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010764,P-0010764-T01-IM5,Epithelial-Myoepithelial Carcinoma,EMYOCA
msk_impact_2017,P-0010765,P-0010765-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0010779,P-0010779-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0010780,P-0010780-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0010781,P-0010781-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010782,P-0010782-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0010783,P-0010783-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010784,P-0010784-T01-IM5,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0010785,P-0010785-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010786,P-0010786-T01-IM5,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0010787,P-0010787-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0010788,P-0010788-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010789,P-0010789-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0010790,P-0010790-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010791,P-0010791-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0010792,P-0010792-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0010793,P-0010793-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010794,P-0010794-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010795,P-0010795-T01-IM5,Yolk Sac Tumor,VYST
msk_impact_2017,P-0010796,P-0010796-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010797,P-0010797-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0010798,P-0010798-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010799,P-0010799-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010800,P-0010800-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010801,P-0010801-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010802,P-0010802-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010803,P-0010803-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0010804,P-0010804-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010805,P-0010805-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010806,P-0010806-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010807,P-0010807-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010808,P-0010808-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010809,P-0010809-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010810,P-0010810-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0010811,P-0010811-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010812,P-0010812-T01-IM5,High-Grade Neuroendocrine Carcinoma of the Colon and Rectum,HGNEC
msk_impact_2017,P-0010813,P-0010813-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010814,P-0010814-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010815,P-0010815-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0010816,P-0010816-T01-IM5,Oropharynx Squamous Cell Carcinoma,OPHSC
msk_impact_2017,P-0010817,P-0010817-T01-IM5,Larynx Squamous Cell Carcinoma,LXSC
msk_impact_2017,P-0010818,P-0010818-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010819,P-0010819-T01-IM5,Chordoma,CHDM
msk_impact_2017,P-0010820,P-0010820-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0010821,P-0010821-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010822,P-0010822-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010823,P-0010823-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010824,P-0010824-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010825,P-0010825-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0010826,P-0010826-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0010827,P-0010827-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0010828,P-0010828-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0010829,P-0010829-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0010830,P-0010830-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0010831,P-0010831-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0010832,P-0010832-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010833,P-0010833-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0010834,P-0010834-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0010835,P-0010835-T01-IM5,Cervical Squamous Cell Carcinoma,CESC
msk_impact_2017,P-0010836,P-0010836-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010837,P-0010837-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010838,P-0010838-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010839,P-0010839-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010840,P-0010840-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010841,P-0010841-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010842,P-0010842-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010843,P-0010843-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010844,P-0010844-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010845,P-0010845-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0010846,P-0010846-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0010847,P-0010847-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010848,P-0010848-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0010849,P-0010849-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010850,P-0010850-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010851,P-0010851-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0010852,P-0010852-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010853,P-0010853-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010854,P-0010854-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010855,P-0010855-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010856,P-0010856-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0010857,P-0010857-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010858,P-0010858-T01-IM5,Tubular Stomach Adenocarcinoma,TSTAD
msk_impact_2017,P-0010859,P-0010859-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0010860,P-0010860-T02-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0010860,P-0010860-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0010861,P-0010861-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010862,P-0010862-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0010863,P-0010863-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010864,P-0010864-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010865,P-0010865-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0010866,P-0010866-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010867,P-0010867-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0010868,P-0010868-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0010869,P-0010869-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010870,P-0010870-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010890,P-0010890-T01-IM5,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0010891,P-0010891-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010892,P-0010892-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010893,P-0010893-T01-IM5,Non-Seminomatous Germ Cell Tumor,NSGCT
msk_impact_2017,P-0010894,P-0010894-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010895,P-0010895-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010896,P-0010896-T01-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0010897,P-0010897-T01-IM5,"High-Grade Glioma, NOS",HGGNOS
msk_impact_2017,P-0010898,P-0010898-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010899,P-0010899-T01-IM5,Acinar Cell Carcinoma of the Pancreas,PAAC
msk_impact_2017,P-0010900,P-0010900-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0010901,P-0010901-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0010902,P-0010902-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0010903,P-0010903-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0010904,P-0010904-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010911,P-0010911-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010912,P-0010912-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010914,P-0010914-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010915,P-0010915-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010916,P-0010916-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010917,P-0010917-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0010918,P-0010918-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0010919,P-0010919-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010920,P-0010920-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010921,P-0010921-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0010922,P-0010922-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010923,P-0010923-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0010924,P-0010924-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010925,P-0010925-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010926,P-0010926-T01-IM5,Solid Pseudopapillary Neoplasm of the Pancreas,SPN
msk_impact_2017,P-0010927,P-0010927-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010927,P-0010927-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010928,P-0010928-T01-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0010929,P-0010929-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010930,P-0010930-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010931,P-0010931-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0010932,P-0010932-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010933,P-0010933-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010934,P-0010934-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010935,P-0010935-T01-IM5,Pheochromocytoma,PHC
msk_impact_2017,P-0010936,P-0010936-T01-IM5,Chondrosarcoma,CHS
msk_impact_2017,P-0010937,P-0010937-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010938,P-0010938-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010939,P-0010939-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010940,P-0010940-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010941,P-0010941-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0010942,P-0010942-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010943,P-0010943-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0010945,P-0010945-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010946,P-0010946-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0010947,P-0010947-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010948,P-0010948-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010949,P-0010949-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0010950,P-0010950-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010951,P-0010951-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0010952,P-0010952-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010953,P-0010953-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0010954,P-0010954-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0010955,P-0010955-T01-IM5,Embryonal Carcinoma,VOEC
msk_impact_2017,P-0010957,P-0010957-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0010958,P-0010958-T01-IM5,Solitary Fibrous Tumor/Hemangiopericytoma,SFT
msk_impact_2017,P-0010959,P-0010959-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0010960,P-0010960-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010961,P-0010961-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0010962,P-0010962-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0010963,P-0010963-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0010965,P-0010965-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010966,P-0010966-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010967,P-0010967-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0010968,P-0010968-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010969,P-0010969-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0010970,P-0010970-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010971,P-0010971-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0010972,P-0010972-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0010973,P-0010973-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0010974,P-0010974-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0010975,P-0010975-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0010976,P-0010976-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010977,P-0010977-T01-IM5,Alveolar Soft Part Sarcoma,ASPS
msk_impact_2017,P-0010978,P-0010978-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010978,P-0010978-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010979,P-0010979-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010979,P-0010979-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010980,P-0010980-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010981,P-0010981-T01-IM5,Malignant Phyllodes Tumor of the Breast,MPT
msk_impact_2017,P-0010982,P-0010982-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0010983,P-0010983-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010984,P-0010984-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010985,P-0010985-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0010986,P-0010986-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010987,P-0010987-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0010988,P-0010988-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0010989,P-0010989-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010990,P-0010990-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0010991,P-0010991-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0010992,P-0010992-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0010993,P-0010993-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0010994,P-0010994-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010995,P-0010995-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0010996,P-0010996-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0010997,P-0010997-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0010998,P-0010998-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0010999,P-0010999-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0011001,P-0011001-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0011002,P-0011002-T01-IM5,Inflammatory Myofibroblastic Tumor,IMT
msk_impact_2017,P-0011003,P-0011003-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011004,P-0011004-T01-IM5,Endocervical Adenocarcinoma,ECAD
msk_impact_2017,P-0011005,P-0011005-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011006,P-0011006-T01-IM5,Neuroblastoma,NBL
msk_impact_2017,P-0011007,P-0011007-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0011008,P-0011008-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0011009,P-0011009-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0011010,P-0011010-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011011,P-0011011-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0011012,P-0011012-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011013,P-0011013-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011014,P-0011014-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011015,P-0011015-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011016,P-0011016-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011017,P-0011017-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011018,P-0011018-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011019,P-0011019-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011025,P-0011025-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011026,P-0011026-T01-IM5,Gliosarcoma,GSARC
msk_impact_2017,P-0011027,P-0011027-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011028,P-0011028-T01-IM5,Uterine Adenosarcoma,UAS
msk_impact_2017,P-0011029,P-0011029-T01-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0011029,P-0011029-T02-IM5,Mucosal Melanoma of the Vulva/Vagina,VMM
msk_impact_2017,P-0011030,P-0011030-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011031,P-0011031-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011032,P-0011032-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011033,P-0011033-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011034,P-0011034-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0011035,P-0011035-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011036,P-0011036-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011037,P-0011037-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0011038,P-0011038-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011039,P-0011039-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011040,P-0011040-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011041,P-0011041-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011042,P-0011042-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0011043,P-0011043-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0011043,P-0011043-T02-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011044,P-0011044-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011046,P-0011046-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011047,P-0011047-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0011050,P-0011050-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0011060,P-0011060-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011061,P-0011061-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011062,P-0011062-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011063,P-0011063-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011064,P-0011064-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011065,P-0011065-T01-IM5,Perihilar Cholangiocarcinoma,PHCH
msk_impact_2017,P-0011066,P-0011066-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011067,P-0011067-T01-IM5,Extraskeletal Myxoid Chondrosarcoma,EMCHS
msk_impact_2017,P-0011068,P-0011068-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011069,P-0011069-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011070,P-0011070-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0011071,P-0011071-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0011072,P-0011072-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011073,P-0011073-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0011074,P-0011074-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011075,P-0011075-T01-IM5,Clear Cell Papillary Renal Cell Carcinoma,CCPRC
msk_impact_2017,P-0011076,P-0011076-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0011077,P-0011077-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0011078,P-0011078-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011079,P-0011079-T01-IM5,Hurthle Cell Thyroid Cancer,THHC
msk_impact_2017,P-0011080,P-0011080-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011081,P-0011081-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0011082,P-0011082-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0011083,P-0011083-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0011085,P-0011085-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0011086,P-0011086-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0011087,P-0011087-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0011088,P-0011088-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011089,P-0011089-T01-IM5,Fibrosarcoma,FIBS
msk_impact_2017,P-0011090,P-0011090-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011091,P-0011091-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0011092,P-0011092-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011092,P-0011092-T02-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011093,P-0011093-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011094,P-0011094-T01-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0011094,P-0011094-T02-IM5,Dedifferentiated Liposarcoma,DDLS
msk_impact_2017,P-0011095,P-0011095-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0011095,P-0011095-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011096,P-0011096-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011097,P-0011097-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011098,P-0011098-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011099,P-0011099-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011100,P-0011100-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011101,P-0011101-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0011102,P-0011102-T01-IM5,Anal Squamous Cell Carcinoma,ANSC
msk_impact_2017,P-0011103,P-0011103-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0011104,P-0011104-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0011105,P-0011105-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0011106,P-0011106-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0011107,P-0011107-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011108,P-0011108-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011109,P-0011109-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011110,P-0011110-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011111,P-0011111-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011112,P-0011112-T01-IM5,Uterine Leiomyosarcoma,ULMS
msk_impact_2017,P-0011113,P-0011113-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011114,P-0011114-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0011115,P-0011115-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011117,P-0011117-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011119,P-0011119-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011120,P-0011120-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011123,P-0011123-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0011124,P-0011124-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011125,P-0011125-T01-IM5,Spindle Cell Carcinoma of the Lung,SPCC
msk_impact_2017,P-0011126,P-0011126-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0011127,P-0011127-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0011128,P-0011128-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0011129,P-0011129-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0011130,P-0011130-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0011131,P-0011131-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011132,P-0011132-T01-IM5,Non-Small Cell Lung Cancer,NSCLC
msk_impact_2017,P-0011133,P-0011133-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011134,P-0011134-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011135,P-0011135-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011136,P-0011136-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011137,P-0011137-T01-IM5,Yolk Sac Tumor,VYST
msk_impact_2017,P-0011138,P-0011138-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011139,P-0011139-T01-IM5,Angioimmunoblastic T-Cell Lymphoma,AITL
msk_impact_2017,P-0011140,P-0011140-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011141,P-0011141-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0011141,P-0011141-T02-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0011142,P-0011142-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011143,P-0011143-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0011144,P-0011144-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011145,P-0011145-T01-IM5,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,USC
msk_impact_2017,P-0011146,P-0011146-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011147,P-0011147-T01-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0011148,P-0011148-T01-IM5,Intimal Sarcoma,INTS
msk_impact_2017,P-0011149,P-0011149-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0011150,P-0011150-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011151,P-0011151-T01-IM5,Malignant Peripheral Nerve Sheath Tumor,MPNST
msk_impact_2017,P-0011152,P-0011152-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0011153,P-0011153-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0011154,P-0011154-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011155,P-0011155-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011156,P-0011156-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011157,P-0011157-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011158,P-0011158-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011159,P-0011159-T01-IM5,Follicular Thyroid Cancer,THFO
msk_impact_2017,P-0011160,P-0011160-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0011161,P-0011161-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011162,P-0011162-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011162,P-0011162-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011163,P-0011163-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0011174,P-0011174-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011175,P-0011175-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0011176,P-0011176-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0011177,P-0011177-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0011178,P-0011178-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0011179,P-0011179-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0011180,P-0011180-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011181,P-0011181-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0011182,P-0011182-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011183,P-0011183-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011184,P-0011184-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011185,P-0011185-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0011186,P-0011186-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011187,P-0011187-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0011188,P-0011188-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011189,P-0011189-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011190,P-0011190-T01-IM5,Paraganglioma,PGNG
msk_impact_2017,P-0011191,P-0011191-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011192,P-0011192-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011193,P-0011193-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011194,P-0011194-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011195,P-0011195-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011196,P-0011196-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011197,P-0011197-T01-IM5,Atypical Lung Carcinoid,ALUCA
msk_impact_2017,P-0011198,P-0011198-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011199,P-0011199-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011200,P-0011200-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0011201,P-0011201-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011202,P-0011202-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011203,P-0011203-T01-IM5,Salivary Duct Carcinoma,SDCA
msk_impact_2017,P-0011204,P-0011204-T01-IM5,Mantle Cell Lymphoma,MCL
msk_impact_2017,P-0011205,P-0011205-T01-IM5,Hepatoblastoma,LIHB
msk_impact_2017,P-0011206,P-0011206-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011207,P-0011207-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0011208,P-0011208-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011210,P-0011210-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0011211,P-0011211-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0011212,P-0011212-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0011213,P-0011213-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011214,P-0011214-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0011215,P-0011215-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011216,P-0011216-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0011217,P-0011217-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0011218,P-0011218-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0011219,P-0011219-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011220,P-0011220-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011221,P-0011221-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0011222,P-0011222-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011223,P-0011223-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011224,P-0011224-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011225,P-0011225-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011225,P-0011225-T02-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011226,P-0011226-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011234,P-0011234-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011234,P-0011234-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011235,P-0011235-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011236,P-0011236-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011237,P-0011237-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011238,P-0011238-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0011239,P-0011239-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011239,P-0011239-T02-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011240,P-0011240-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011241,P-0011241-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0011242,P-0011242-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011244,P-0011244-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011245,P-0011245-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0011246,P-0011246-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011247,P-0011247-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011248,P-0011248-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0011249,P-0011249-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011250,P-0011250-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011251,P-0011251-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011252,P-0011252-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0011253,P-0011253-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011254,P-0011254-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011255,P-0011255-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011256,P-0011256-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011257,P-0011257-T01-IM5,Astrocytoma,ASTR
msk_impact_2017,P-0011258,P-0011258-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011260,P-0011260-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011261,P-0011261-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011262,P-0011262-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0011263,P-0011263-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011264,P-0011264-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011265,P-0011265-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011266,P-0011266-T01-IM5,Poorly Differentiated Thyroid Cancer,THPD
msk_impact_2017,P-0011267,P-0011267-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011268,P-0011268-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0011269,P-0011269-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0011270,P-0011270-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0011271,P-0011271-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0011276,P-0011276-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011278,P-0011278-T01-IM5,Pleural Mesothelioma,PLMESO
msk_impact_2017,P-0011279,P-0011279-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0011280,P-0011280-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011281,P-0011281-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011282,P-0011282-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011283,P-0011283-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011284,P-0011284-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0011285,P-0011285-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011287,P-0011287-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011288,P-0011288-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011289,P-0011289-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0011290,P-0011290-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011291,P-0011291-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011292,P-0011292-T01-IM5,Pleomorphic Rhabdomyosarcoma,PLRMS
msk_impact_2017,P-0011293,P-0011293-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011294,P-0011294-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011295,P-0011295-T01-IM5,Well-Differentiated Liposarcoma,WDLS
msk_impact_2017,P-0011296,P-0011296-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011297,P-0011297-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0011298,P-0011298-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011299,P-0011299-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011300,P-0011300-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011302,P-0011302-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011303,P-0011303-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011304,P-0011304-T01-IM5,Intimal Sarcoma,INTS
msk_impact_2017,P-0011305,P-0011305-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011306,P-0011306-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011307,P-0011307-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011308,P-0011308-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011309,P-0011309-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011310,P-0011310-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011311,P-0011311-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011312,P-0011312-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0011319,P-0011319-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0011320,P-0011320-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0011321,P-0011321-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011322,P-0011322-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0011323,P-0011323-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011324,P-0011324-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011325,P-0011325-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0011326,P-0011326-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011328,P-0011328-T01-IM5,Esophageal Adenocarcinoma,ESCA
msk_impact_2017,P-0011329,P-0011329-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011330,P-0011330-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011331,P-0011331-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011332,P-0011332-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011333,P-0011333-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011334,P-0011334-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0011334,P-0011334-T02-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0011335,P-0011335-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011336,P-0011336-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0011337,P-0011337-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0011338,P-0011338-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0011339,P-0011339-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011341,P-0011341-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011342,P-0011342-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011343,P-0011343-T01-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0011344,P-0011344-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0011345,P-0011345-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0011346,P-0011346-T01-IM5,Renal Angiomyolipoma,RAML
msk_impact_2017,P-0011347,P-0011347-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011348,P-0011348-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011349,P-0011349-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0011350,P-0011350-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0011351,P-0011351-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011352,P-0011352-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011353,P-0011353-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011354,P-0011354-T01-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0011355,P-0011355-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011356,P-0011356-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0011357,P-0011357-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011358,P-0011358-T01-IM5,Dedifferentiated Chondrosarcoma,DDCHS
msk_impact_2017,P-0011359,P-0011359-T01-IM5,Plasma Cell Myeloma,PCM
msk_impact_2017,P-0011360,P-0011360-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0011361,P-0011361-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011362,P-0011362-T01-IM5,Langerhans Cell Histiocytosis,LCH
msk_impact_2017,P-0011363,P-0011363-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011364,P-0011364-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011365,P-0011365-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011366,P-0011366-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011367,P-0011367-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011368,P-0011368-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011369,P-0011369-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0011370,P-0011370-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011371,P-0011371-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011372,P-0011372-T01-IM5,Ependymomal Tumor,EPMT
msk_impact_2017,P-0011373,P-0011373-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0011374,P-0011374-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011375,P-0011375-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0011376,P-0011376-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011377,P-0011377-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011378,P-0011378-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0011379,P-0011379-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011380,P-0011380-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011381,P-0011381-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0011382,P-0011382-T01-IM5,Lung Neuroendocrine Tumor,LNET
msk_impact_2017,P-0011383,P-0011383-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0011384,P-0011384-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011385,P-0011385-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0011386,P-0011386-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011387,P-0011387-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0011388,P-0011388-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011389,P-0011389-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011390,P-0011390-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0011391,P-0011391-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0011392,P-0011392-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0011393,P-0011393-T01-IM5,Salivary Carcinoma,SACA
msk_impact_2017,P-0011394,P-0011394-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011395,P-0011395-T02-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011395,P-0011395-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011396,P-0011396-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011397,P-0011397-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011398,P-0011398-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011399,P-0011399-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011400,P-0011400-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0011401,P-0011401-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011402,P-0011402-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011403,P-0011403-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0011404,P-0011404-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0011405,P-0011405-T01-IM5,Mixed Cancer Types,MIXED
msk_impact_2017,P-0011412,P-0011412-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011413,P-0011413-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011414,P-0011414-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0011415,P-0011415-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011416,P-0011416-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011418,P-0011418-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011419,P-0011419-T01-IM5,Embryonal Carcinoma,VOEC
msk_impact_2017,P-0011420,P-0011420-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011421,P-0011421-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0011422,P-0011422-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0011423,P-0011423-T01-IM5,Clear Cell Sarcoma,CCS
msk_impact_2017,P-0011424,P-0011424-T01-IM5,Pineal Parenchymal Tumor of Intermediate Differentiation,PPTID
msk_impact_2017,P-0011425,P-0011425-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0011426,P-0011426-T01-IM5,Clear Cell Ovarian Cancer,CCOV
msk_impact_2017,P-0011427,P-0011427-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0011428,P-0011428-T01-IM5,Dermatofibrosarcoma Protuberans,DFSP
msk_impact_2017,P-0011429,P-0011429-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011430,P-0011430-T01-IM5,Mixed Germ Cell Tumor,VMGCT
msk_impact_2017,P-0011431,P-0011431-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0011432,P-0011432-T01-IM5,Head and Neck Squamous Cell Carcinoma of Unknown Primary,HNSCUP
msk_impact_2017,P-0011433,P-0011433-T01-IM5,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,UCS
msk_impact_2017,P-0011434,P-0011434-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011435,P-0011435-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011438,P-0011438-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0011439,P-0011439-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0011440,P-0011440-T01-IM5,Small Cell Bladder Cancer,SCBC
msk_impact_2017,P-0011441,P-0011441-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0011442,P-0011442-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0011443,P-0011443-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011444,P-0011444-T01-IM5,Appendiceal Adenocarcinoma,APAD
msk_impact_2017,P-0011445,P-0011445-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011446,P-0011446-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0011447,P-0011447-T01-IM5,Angiosarcoma,ANGS
msk_impact_2017,P-0011448,P-0011448-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011449,P-0011449-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011450,P-0011450-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011451,P-0011451-T01-IM5,Gastrointestinal Neuroendocrine Tumors,GINET
msk_impact_2017,P-0011452,P-0011452-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011453,P-0011453-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011454,P-0011454-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011455,P-0011455-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011456,P-0011456-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0011457,P-0011457-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0011458,P-0011458-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0011459,P-0011459-T01-IM5,Thymoma,THYM
msk_impact_2017,P-0011461,P-0011461-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011462,P-0011462-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011463,P-0011463-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011464,P-0011464-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0011465,P-0011465-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011466,P-0011466-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011467,P-0011467-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0011468,P-0011468-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011469,P-0011469-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011470,P-0011470-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011471,P-0011471-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011472,P-0011472-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011473,P-0011473-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011474,P-0011474-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0011475,P-0011475-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011476,P-0011476-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0011479,P-0011479-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0011480,P-0011480-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011481,P-0011481-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011482,P-0011482-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0011483,P-0011483-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011484,P-0011484-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011486,P-0011486-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0011499,P-0011499-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011500,P-0011500-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0011501,P-0011501-T01-IM5,Merkel Cell Carcinoma,MCC
msk_impact_2017,P-0011502,P-0011502-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0011503,P-0011503-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011504,P-0011504-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011505,P-0011505-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0011506,P-0011506-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0011507,P-0011507-T01-IM5,Medullary Thyroid Cancer,THME
msk_impact_2017,P-0011508,P-0011508-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0011509,P-0011509-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011510,P-0011510-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011511,P-0011511-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0011512,P-0011512-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011513,P-0011513-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011514,P-0011514-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0011515,P-0011515-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011516,P-0011516-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011517,P-0011517-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011518,P-0011518-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0011519,P-0011519-T01-IM5,Oral Cavity Squamous Cell Carcinoma,OCSC
msk_impact_2017,P-0011520,P-0011520-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011521,P-0011521-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0011522,P-0011522-T01-IM5,Renal Clear Cell Carcinoma with Sarcomatoid Features,SCCRCC
msk_impact_2017,P-0011523,P-0011523-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0011524,P-0011524-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0011525,P-0011525-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011526,P-0011526-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011527,P-0011527-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011528,P-0011528-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0011529,P-0011529-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011530,P-0011530-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0011531,P-0011531-T01-IM5,Stomach Adenocarcinoma,STAD
msk_impact_2017,P-0011532,P-0011532-T01-IM5,Anaplastic Oligoastrocytoma,AOAST
msk_impact_2017,P-0011533,P-0011533-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011534,P-0011534-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011535,P-0011535-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011536,P-0011536-T01-IM5,Yolk Sac Tumor,VYST
msk_impact_2017,P-0011537,P-0011537-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0011538,P-0011538-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0011539,P-0011539-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011540,P-0011540-T01-IM5,Small Bowel Cancer,SBC
msk_impact_2017,P-0011541,P-0011541-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011542,P-0011542-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011543,P-0011543-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011544,P-0011544-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011545,P-0011545-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0011546,P-0011546-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0011547,P-0011547-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011548,P-0011548-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011549,P-0011549-T01-IM5,"Sarcoma, NOS",SARCNOS
msk_impact_2017,P-0011550,P-0011550-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011551,P-0011551-T01-IM5,Pituitary Adenoma,PTAD
msk_impact_2017,P-0011552,P-0011552-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0011553,P-0011553-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011554,P-0011554-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011555,P-0011555-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0011556,P-0011556-T01-IM5,Intrahepatic Cholangiocarcinoma,IHCH
msk_impact_2017,P-0011557,P-0011557-T01-IM5,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0011558,P-0011558-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011559,P-0011559-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0011560,P-0011560-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0011560,P-0011560-T02-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0011560,P-0011560-T03-IM5,Renal Oncocytoma,ROCY
msk_impact_2017,P-0011561,P-0011561-T01-IM5,Head and Neck Squamous Cell Carcinoma of Unknown Primary,HNSCUP
msk_impact_2017,P-0011562,P-0011562-T01-IM5,Uterine Epithelioid Leiomyosarcoma,UELMS
msk_impact_2017,P-0011563,P-0011563-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0011564,P-0011564-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0011566,P-0011566-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0011568,P-0011568-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0011569,P-0011569-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011570,P-0011570-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011571,P-0011571-T01-IM5,Mixed Ovarian Carcinoma,MXOV
msk_impact_2017,P-0011573,P-0011573-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0011574,P-0011574-T01-IM5,Meningioma,MNG
msk_impact_2017,P-0011575,P-0011575-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0011576,P-0011576-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0011577,P-0011577-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0011578,P-0011578-T01-IM5,Thymoma,THYM
msk_impact_2017,P-0011579,P-0011579-T01-IM5,Chromophobe Renal Cell Carcinoma,CHRCC
msk_impact_2017,P-0011580,P-0011580-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0011581,P-0011581-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0011582,P-0011582-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0011585,P-0011585-T01-IM5,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT lymphoma),EMALT
msk_impact_2017,P-0011587,P-0011587-T01-IM5,Central Neurocytoma,CNC
msk_impact_2017,P-0011589,P-0011589-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0011590,P-0011590-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0011592,P-0011592-T01-IM5,Breast Mixed Ductal and Lobular Carcinoma,MDLC
msk_impact_2017,P-0011593,P-0011593-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0011594,P-0011594-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0012000,P-0012000-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012001,P-0012001-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012002,P-0012002-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0012003,P-0012003-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0012004,P-0012004-T01-IM5,Rhabdomyosarcoma,RMS
msk_impact_2017,P-0012005,P-0012005-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012006,P-0012006-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012007,P-0012007-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0012008,P-0012008-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012009,P-0012009-T01-IM5,Pancreatobiliary Ampullary Carcinoma,PAMPCA
msk_impact_2017,P-0012010,P-0012010-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012025,P-0012025-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012026,P-0012026-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012027,P-0012027-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012028,P-0012028-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0012029,P-0012029-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012030,P-0012030-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012031,P-0012031-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012032,P-0012032-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012033,P-0012033-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012034,P-0012034-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0012035,P-0012035-T01-IM5,Mucinous Adenocarcinoma of the Colon and Rectum,MACR
msk_impact_2017,P-0012036,P-0012036-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0012037,P-0012037-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0012038,P-0012038-T01-IM5,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0012039,P-0012039-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012040,P-0012040-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012041,P-0012041-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012042,P-0012042-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012043,P-0012043-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012046,P-0012046-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012047,P-0012047-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012048,P-0012048-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012049,P-0012049-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012050,P-0012050-T01-IM5,Embryonal Carcinoma,VOEC
msk_impact_2017,P-0012051,P-0012051-T01-IM5,Adenoid Cystic Carcinoma,ACYC
msk_impact_2017,P-0012054,P-0012054-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0012055,P-0012055-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012056,P-0012056-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012057,P-0012057-T01-IM5,Sarcomatoid Carcinoma of the Lung,SARCL
msk_impact_2017,P-0012058,P-0012058-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012059,P-0012059-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012060,P-0012060-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0012061,P-0012061-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012062,P-0012062-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012063,P-0012063-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012064,P-0012064-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012065,P-0012065-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012066,P-0012066-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012067,P-0012067-T01-IM5,Peritoneal Mesothelioma,PEMESO
msk_impact_2017,P-0012068,P-0012068-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012069,P-0012069-T01-IM5,Follicular Lymphoma,FL
msk_impact_2017,P-0012070,P-0012070-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0012071,P-0012071-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012072,P-0012072-T01-IM5,"Peripheral T-Cell lymphoma, NOS",PTCL
msk_impact_2017,P-0012073,P-0012073-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012074,P-0012074-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012075,P-0012075-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0012076,P-0012076-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012077,P-0012077-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0012079,P-0012079-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012080,P-0012080-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0012081,P-0012081-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012082,P-0012082-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012083,P-0012083-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012084,P-0012084-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0012086,P-0012086-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0012087,P-0012087-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012088,P-0012088-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012089,P-0012089-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012090,P-0012090-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012091,P-0012091-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0012092,P-0012092-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0012093,P-0012093-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012094,P-0012094-T01-IM5,Seminoma,SEM
msk_impact_2017,P-0012095,P-0012095-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012096,P-0012096-T01-IM5,Small Bowel Well-Differentiated Neuroendocrine Tumor,SBWDNET
msk_impact_2017,P-0012098,P-0012098-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012099,P-0012099-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012100,P-0012100-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012101,P-0012101-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0012102,P-0012102-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012102,P-0012102-T02-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012104,P-0012104-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012105,P-0012105-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012106,P-0012106-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012107,P-0012107-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012108,P-0012108-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012109,P-0012109-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012110,P-0012110-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012111,P-0012111-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012112,P-0012112-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012113,P-0012113-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012114,P-0012114-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012115,P-0012115-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012116,P-0012116-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012117,P-0012117-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0012118,P-0012118-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012119,P-0012119-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0012120,P-0012120-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012121,P-0012121-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012122,P-0012122-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012124,P-0012124-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0012125,P-0012125-T01-IM5,Uveal Melanoma,UM
msk_impact_2017,P-0012126,P-0012126-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0012127,P-0012127-T01-IM5,"Breast Invasive Cancer, NOS",BRCANOS
msk_impact_2017,P-0012128,P-0012128-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012129,P-0012129-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0012130,P-0012130-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0012131,P-0012131-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0012132,P-0012132-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012133,P-0012133-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012134,P-0012134-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0012135,P-0012135-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012136,P-0012136-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012137,P-0012137-T01-IM5,Renal Cell Carcinoma,RCC
msk_impact_2017,P-0012138,P-0012138-T01-IM5,"Pleural Mesothelioma, Epithelioid Type",PLEMESO
msk_impact_2017,P-0012139,P-0012139-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012140,P-0012140-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0012141,P-0012141-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012142,P-0012142-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012143,P-0012143-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012144,P-0012144-T01-IM5,Anorectal Mucosal Melanoma,ARMM
msk_impact_2017,P-0012145,P-0012145-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012147,P-0012147-T01-IM5,Colorectal Adenocarcinoma,COADREAD
msk_impact_2017,P-0012148,P-0012148-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0012149,P-0012149-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012150,P-0012150-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012151,P-0012151-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012152,P-0012152-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012153,P-0012153-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012154,P-0012154-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012155,P-0012155-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0012156,P-0012156-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0012157,P-0012157-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012158,P-0012158-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012159,P-0012159-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012160,P-0012160-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012161,P-0012161-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012173,P-0012173-T01-IM5,Low-Grade Serous Ovarian Cancer,LGSOC
msk_impact_2017,P-0012175,P-0012175-T01-IM5,Sinonasal Adenocarcinoma,SNA
msk_impact_2017,P-0012176,P-0012176-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012177,P-0012177-T01-IM5,Liposarcoma,LIPO
msk_impact_2017,P-0012178,P-0012178-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0012179,P-0012179-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012180,P-0012180-T01-IM5,Anaplastic Thyroid Cancer,THAP
msk_impact_2017,P-0012182,P-0012182-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012183,P-0012183-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0012184,P-0012184-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012186,P-0012186-T01-IM5,"Breast Invasive Carcinoma, NOS",BRCNOS
msk_impact_2017,P-0012187,P-0012187-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0012188,P-0012188-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012189,P-0012189-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012190,P-0012190-T01-IM5,Papillary Renal Cell Carcinoma,PRCC
msk_impact_2017,P-0012191,P-0012191-T01-IM5,Myxoid Chondrosarcoma,MYCHS
msk_impact_2017,P-0012193,P-0012193-T01-IM5,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,CLLSLL
msk_impact_2017,P-0012194,P-0012194-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0012195,P-0012195-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0012196,P-0012196-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012197,P-0012197-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012198,P-0012198-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012198,P-0012198-T02-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012199,P-0012199-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012200,P-0012200-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012201,P-0012201-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0012202,P-0012202-T01-IM5,Cutaneous Squamous Cell Carcinoma,CSCC
msk_impact_2017,P-0012205,P-0012205-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0012206,P-0012206-T01-IM5,Poorly Differentiated Non-Small Cell Lung Cancer,NSCLCPD
msk_impact_2017,P-0012207,P-0012207-T01-IM5,Upper Tract Urothelial Carcinoma,UTUC
msk_impact_2017,P-0012208,P-0012208-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012209,P-0012209-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0012210,P-0012210-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012213,P-0012213-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0012214,P-0012214-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012215,P-0012215-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012221,P-0012221-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012222,P-0012222-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012224,P-0012224-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012225,P-0012225-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0012226,P-0012226-T01-IM5,Unclassified Renal Cell Carcinoma,URCC
msk_impact_2017,P-0012227,P-0012227-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0012228,P-0012228-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0012230,P-0012230-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012231,P-0012231-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0012233,P-0012233-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012239,P-0012239-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012241,P-0012241-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0012241,P-0012241-T02-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0012242,P-0012242-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012243,P-0012243-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0012244,P-0012244-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0012245,P-0012245-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0012246,P-0012246-T01-IM5,Pancreatic Neuroendocrine Tumor,PANET
msk_impact_2017,P-0012247,P-0012247-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012248,P-0012248-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0012249,P-0012249-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012250,P-0012250-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0012251,P-0012251-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012252,P-0012252-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012253,P-0012253-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012254,P-0012254-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0012255,P-0012255-T01-IM5,Sinonasal Adenocarcinoma,SNA
msk_impact_2017,P-0012256,P-0012256-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012257,P-0012257-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0012258,P-0012258-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012259,P-0012259-T01-IM5,Anaplastic Oligodendroglioma,AODG
msk_impact_2017,P-0012260,P-0012260-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012261,P-0012261-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012262,P-0012262-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012263,P-0012263-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012264,P-0012264-T01-IM5,Osteosarcoma,OS
msk_impact_2017,P-0012265,P-0012265-T01-IM5,Mature B-Cell Neoplasms,MBN
msk_impact_2017,P-0012266,P-0012266-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012268,P-0012268-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012269,P-0012269-T01-IM5,Mucinous Adenocarcinoma of the Appendix,MAAP
msk_impact_2017,P-0012270,P-0012270-T01-IM5,Papillary Thyroid Cancer,THPA
msk_impact_2017,P-0012271,P-0012271-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012272,P-0012272-T01-IM5,Adenosquamous Carcinoma of the Pancreas,PAASC
msk_impact_2017,P-0012273,P-0012273-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012274,P-0012274-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012275,P-0012275-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012276,P-0012276-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012277,P-0012277-T01-IM5,Rectal Adenocarcinoma,READ
msk_impact_2017,P-0012279,P-0012279-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012280,P-0012280-T01-IM5,Small Cell Lung Cancer,SCLC
msk_impact_2017,P-0012282,P-0012282-T01-IM5,Mucosal Melanoma of the Esophagus,ESMM
msk_impact_2017,P-0012282,P-0012282-T02-IM5,Mucosal Melanoma of the Esophagus,ESMM
msk_impact_2017,P-0012283,P-0012283-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012284,P-0012284-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012285,P-0012285-T01-IM5,Thymoma,THYM
msk_impact_2017,P-0012287,P-0012287-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012288,P-0012288-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012289,P-0012289-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012290,P-0012290-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012302,P-0012302-T01-IM5,Ampullary Carcinoma,AMPCA
msk_impact_2017,P-0012303,P-0012303-T01-IM5,Anaplastic Astrocytoma,AASTR
msk_impact_2017,P-0012304,P-0012304-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012305,P-0012305-T01-IM5,Uterine Mixed Endometrial Carcinoma,UMEC
msk_impact_2017,P-0012306,P-0012306-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012307,P-0012307-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012308,P-0012308-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012310,P-0012310-T01-IM5,Mucinous Ovarian Cancer,MOV
msk_impact_2017,P-0012311,P-0012311-T01-IM5,Head and Neck Mucosal Melanoma,HNMUCM
msk_impact_2017,P-0012312,P-0012312-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0012313,P-0012313-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012314,P-0012314-T01-IM5,Uterine Clear Cell Carcinoma,UCCC
msk_impact_2017,P-0012315,P-0012315-T01-IM5,Melanoma of Unknown Primary,MUP
msk_impact_2017,P-0012316,P-0012316-T01-IM5,Ewing Sarcoma,ES
msk_impact_2017,P-0012317,P-0012317-T01-IM5,Hepatocellular Carcinoma,HCC
msk_impact_2017,P-0012318,P-0012318-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012320,P-0012320-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0012321,P-0012321-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012322,P-0012322-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012323,P-0012323-T01-IM5,Renal Cell Carcinoma,RCC
msk_impact_2017,P-0012324,P-0012324-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012325,P-0012325-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0012326,P-0012326-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012327,P-0012327-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012328,P-0012328-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012329,P-0012329-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012332,P-0012332-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012337,P-0012337-T01-IM5,Primitive Neuroectodermal Tumor,PNET
msk_impact_2017,P-0012338,P-0012338-T01-IM5,Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor,OCS
msk_impact_2017,P-0012341,P-0012341-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012357,P-0012357-T01-IM5,Lung Squamous Cell Carcinoma,LUSC
msk_impact_2017,P-0012358,P-0012358-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012359,P-0012359-T01-IM5,"Neuroendocrine Tumor, NOS",NETNOS
msk_impact_2017,P-0012360,P-0012360-T01-IM5,Glioblastoma Multiforme,GBM
msk_impact_2017,P-0012361,P-0012361-T01-IM5,Cutaneous Melanoma,SKCM
msk_impact_2017,P-0012362,P-0012362-T01-IM5,Breast Invasive Lobular Carcinoma,ILC
msk_impact_2017,P-0012363,P-0012363-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012364,P-0012364-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012365,P-0012365-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012366,P-0012366-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012367,P-0012367-T01-IM5,High-Grade Serous Ovarian Cancer,HGSOC
msk_impact_2017,P-0012368,P-0012368-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012370,P-0012370-T01-IM5,Head and Neck Squamous Cell Carcinoma,HNSC
msk_impact_2017,P-0012371,P-0012371-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012372,P-0012372-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012373,P-0012373-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012374,P-0012374-T01-IM5,Gallbladder Cancer,GBC
msk_impact_2017,P-0012375,P-0012375-T01-IM5,Prostate Adenocarcinoma,PRAD
msk_impact_2017,P-0012376,P-0012376-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0012377,P-0012377-T01-IM5,Leiomyosarcoma,LMS
msk_impact_2017,P-0012378,P-0012378-T01-IM5,Renal Clear Cell Carcinoma,CCRCC
msk_impact_2017,P-0012379,P-0012379-T01-IM5,Renal Mucinous Tubular Spindle Cell Carcinoma,MTSCC
msk_impact_2017,P-0012380,P-0012380-T01-IM5,Intraductal Papillary Mucinous Neoplasm,IPMN
msk_impact_2017,P-0012381,P-0012381-T01-IM5,Myxoid/Round-Cell Liposarcoma,MRLS
msk_impact_2017,P-0012393,P-0012393-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012394,P-0012394-T01-IM5,Cancer of Unknown Primary,CUP
msk_impact_2017,P-0012395,P-0012395-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012396,P-0012396-T01-IM5,Breast Invasive Ductal Carcinoma,IDC
msk_impact_2017,P-0012397,P-0012397-T01-IM5,Uterine Endometrioid Carcinoma,UEC
msk_impact_2017,P-0012398,P-0012398-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0012399,P-0012399-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012400,P-0012400-T01-IM5,Large Cell Neuroendocrine Carcinoma,LUNE
msk_impact_2017,P-0012401,P-0012401-T01-IM5,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,MFH
msk_impact_2017,P-0012402,P-0012402-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012403,P-0012403-T01-IM5,Gastrointestinal Stromal Tumor,GIST
msk_impact_2017,P-0012404,P-0012404-T01-IM5,Lung Adenocarcinoma,LUAD
msk_impact_2017,P-0012405,P-0012405-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012406,P-0012406-T01-IM5,Colon Adenocarcinoma,COAD
msk_impact_2017,P-0012423,P-0012423-T01-IM5,Cholangiocarcinoma,CHOL
msk_impact_2017,P-0012434,P-0012434-T01-IM5,Oligodendroglioma,ODG
msk_impact_2017,P-0012442,P-0012442-T01-IM5,Pancreatic Adenocarcinoma,PAAD
msk_impact_2017,P-0012500,P-0012500-T01-IM5,Invasive Breast Carcinoma,BRCA
msk_impact_2017,P-0012524,P-0012524-T01-IM5,"Diffuse Large B-Cell Lymphoma, NOS",DLBCLNOS
msk_impact_2017,P-0012557,P-0012557-T01-IM5,Bladder Urothelial Carcinoma,BLCA
msk_impact_2017,P-0012622,P-0012622-T01-IM5,"Sarcoma, NOS",SARCNOS